{"idB": "1347613_12_item1_p14_s1", "idA": "1347613_11_item1_p12_s0", "sentA": "We are also preparing to initiate a Phase 2b clinical trial of plecanatide for the treatment of IBS-C in patients during 2012.", "sentB": "We expect to release top-line data from this study in late 2012.", "type": 1, "words": ["<tag1>", "We", "are", "also", "preparing", "to", "initiate", "a", "Phase", "2b", "clinical", "trial", "of", "plecanatide", "for", "the", "treatment", "of", "IBS-C", "in", "patients", "during", "2012.", "<tag2>", "We", "expect", "to", "release", "top-line", "data", "from", "this", "study", "in", "late", "2012.", "<tag3>"], "wordsA": ["We", "are", "also", "preparing", "to", "initiate", "a", "Phase", "2b", "clinical", "trial", "of", "plecanatide", "for", "the", "treatment", "of", "IBS-C", "in", "patients", "during", "2012."], "wordsB": ["We", "expect", "to", "release", "top-line", "data", "from", "this", "study", "in", "late", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_12_item1_p22_s0", "idA": "1347613_11_item1_p34_s1", "sentA": "Most such applications for non-priority drug products are reviewed within 10 months.", "sentB": "We believe, based on the ongoing studies to date, that our current formulations of capsules/tablets are both cost effective and meet the stability requirements for pharmaceutical drug products.", "type": 1, "words": ["<tag1>", "Most", "such", "applications", "for", "non-priority", "drug", "products", "are", "reviewed", "within", "10", "months.", "<tag2>", "We", "believe,", "based", "on", "the", "ongoing", "studies", "to", "date,", "that", "our", "current", "formulations", "of", "capsules/tablets", "are", "both", "cost", "effective", "and", "meet", "the", "stability", "requirements", "for", "pharmaceutical", "drug", "products.", "<tag3>"], "wordsA": ["Most", "such", "applications", "for", "non-priority", "drug", "products", "are", "reviewed", "within", "10", "months."], "wordsB": ["We", "believe,", "based", "on", "the", "ongoing", "studies", "to", "date,", "that", "our", "current", "formulations", "of", "capsules/tablets", "are", "both", "cost", "effective", "and", "meet", "the", "stability", "requirements", "for", "pharmaceutical", "drug", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_12_item1_p53_s1", "idA": "1347613_11_item1_p52_s1", "sentA": "In April 2010, two parties filed an opposition to our granted patent with the European Patent Office.", "sentB": "An opposition hearing was held December 14, 2011, which resulted in the European Patent Office issuing the following statement: Account being taken of the amendments made by the patent proprietor during the opposition proceedings, the patent and the invention to which it relates are found to meet the requirements of the European Patent Convention (Art.101(3)(a)EPC).", "type": 1, "words": ["<tag1>", "In", "April", "2010,", "two", "parties", "filed", "an", "opposition", "to", "our", "granted", "patent", "with", "the", "European", "Patent", "Office.", "<tag2>", "An", "opposition", "hearing", "was", "held", "December", "14,", "2011,", "which", "resulted", "in", "the", "European", "Patent", "Office", "issuing", "the", "following", "statement:", "Account", "being", "taken", "of", "the", "amendments", "made", "by", "the", "patent", "proprietor", "during", "the", "opposition", "proceedings,", "the", "patent", "and", "the", "invention", "to", "which", "it", "relates", "are", "found", "to", "meet", "the", "requirements", "of", "the", "European", "Patent", "Convention", "(Art.101(3)(a)EPC).", "<tag3>"], "wordsA": ["In", "April", "2010,", "two", "parties", "filed", "an", "opposition", "to", "our", "granted", "patent", "with", "the", "European", "Patent", "Office."], "wordsB": ["An", "opposition", "hearing", "was", "held", "December", "14,", "2011,", "which", "resulted", "in", "the", "European", "Patent", "Office", "issuing", "the", "following", "statement:", "Account", "being", "taken", "of", "the", "amendments", "made", "by", "the", "patent", "proprietor", "during", "the", "opposition", "proceedings,", "the", "patent", "and", "the", "invention", "to", "which", "it", "relates", "are", "found", "to", "meet", "the", "requirements", "of", "the", "European", "Patent", "Convention", "(Art.101(3)(a)EPC)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_12_item1_p21_s0", "idA": "1347613_11_item1_p54_s1", "sentA": "We seek to protect our trade secrets by entering into confidentiality agreements with third parties, employees and consultants.", "sentB": "We continue to pursue additional API and drug product supply agreements with other manufacturers.", "type": 1, "words": ["<tag1>", "We", "seek", "to", "protect", "our", "trade", "secrets", "by", "entering", "into", "confidentiality", "agreements", "with", "third", "parties,", "employees", "and", "consultants.", "<tag2>", "We", "continue", "to", "pursue", "additional", "API", "and", "drug", "product", "supply", "agreements", "with", "other", "manufacturers.", "<tag3>"], "wordsA": ["We", "seek", "to", "protect", "our", "trade", "secrets", "by", "entering", "into", "confidentiality", "agreements", "with", "third", "parties,", "employees", "and", "consultants."], "wordsB": ["We", "continue", "to", "pursue", "additional", "API", "and", "drug", "product", "supply", "agreements", "with", "other", "manufacturers."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_12_item1_p53_s2", "idA": "1347613_11_item1_p9_s2", "sentA": "Additionally, no systemic absorption of plecanatide was detected in patients at any of the dose levels studied.", "sentB": "In particular, the composition-of-matter claim covering plecanatide was upheld.", "type": 1, "words": ["<tag1>", "Additionally,", "no", "systemic", "absorption", "of", "plecanatide", "was", "detected", "in", "patients", "at", "any", "of", "the", "dose", "levels", "studied.", "<tag2>", "In", "particular,", "the", "composition-of-matter", "claim", "covering", "plecanatide", "was", "upheld.", "<tag3>"], "wordsA": ["Additionally,", "no", "systemic", "absorption", "of", "plecanatide", "was", "detected", "in", "patients", "at", "any", "of", "the", "dose", "levels", "studied."], "wordsB": ["In", "particular,", "the", "composition-of-matter", "claim", "covering", "plecanatide", "was", "upheld."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p42_s1", "idA": "1347613_12_item1_p0_s0", "sentA": "We are a biopharmaceutical company focused primarily on the development of drugs to treat gastrointestinal, or GI, disorders and diseases.", "sentB": "At the time, Callisto was our largest stockholder and a development stage biopharmaceutical company.", "type": 1, "words": ["<tag1>", "We", "are", "a", "biopharmaceutical", "company", "focused", "primarily", "on", "the", "development", "of", "drugs", "to", "treat", "gastrointestinal,", "or", "GI,", "disorders", "and", "diseases.", "<tag2>", "At", "the", "time,", "Callisto", "was", "our", "largest", "stockholder", "and", "a", "development", "stage", "biopharmaceutical", "company.", "<tag3>"], "wordsA": ["We", "are", "a", "biopharmaceutical", "company", "focused", "primarily", "on", "the", "development", "of", "drugs", "to", "treat", "gastrointestinal,", "or", "GI,", "disorders", "and", "diseases."], "wordsB": ["At", "the", "time,", "Callisto", "was", "our", "largest", "stockholder", "and", "a", "development", "stage", "biopharmaceutical", "company."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p6_s0", "idA": "1347613_12_item1_p0_s0", "sentA": "We are a biopharmaceutical company focused primarily on the development of drugs to treat gastrointestinal, or GI, disorders and diseases.", "sentB": "There are a multitude of causes of constipation including other disease states and certain drug therapies (e.g., narcotics).", "type": 1, "words": ["<tag1>", "We", "are", "a", "biopharmaceutical", "company", "focused", "primarily", "on", "the", "development", "of", "drugs", "to", "treat", "gastrointestinal,", "or", "GI,", "disorders", "and", "diseases.", "<tag2>", "There", "are", "a", "multitude", "of", "causes", "of", "constipation", "including", "other", "disease", "states", "and", "certain", "drug", "therapies", "(e.g.,", "narcotics).", "<tag3>"], "wordsA": ["We", "are", "a", "biopharmaceutical", "company", "focused", "primarily", "on", "the", "development", "of", "drugs", "to", "treat", "gastrointestinal,", "or", "GI,", "disorders", "and", "diseases."], "wordsB": ["There", "are", "a", "multitude", "of", "causes", "of", "constipation", "including", "other", "disease", "states", "and", "certain", "drug", "therapies", "(e.g.,", "narcotics)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p23_s0", "idA": "1347613_12_item1_p12_s2", "sentA": "Additionally, no systemic absorption of plecanatide was detected in patients at any of the dose levels studied.", "sentB": "Evidence of increasing efficacy was seen at increasing dose levels.", "type": 1, "words": ["<tag1>", "Additionally,", "no", "systemic", "absorption", "of", "plecanatide", "was", "detected", "in", "patients", "at", "any", "of", "the", "dose", "levels", "studied.", "<tag2>", "Evidence", "of", "increasing", "efficacy", "was", "seen", "at", "increasing", "dose", "levels.", "<tag3>"], "wordsA": ["Additionally,", "no", "systemic", "absorption", "of", "plecanatide", "was", "detected", "in", "patients", "at", "any", "of", "the", "dose", "levels", "studied."], "wordsB": ["Evidence", "of", "increasing", "efficacy", "was", "seen", "at", "increasing", "dose", "levels."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p24_s0", "idA": "1347613_12_item1_p13_s0", "sentA": "Patients in all but the 0.3 mg plecanatide dose levels reported significant decreases in time to first bowel movement after dosing as compared to patients receiving placebo.", "sentB": "The incidence of diarrhea at 3 mg was observed to be 9.7% (compared to placebo incidence of 1.3%).", "type": 1, "words": ["<tag1>", "Patients", "in", "all", "but", "the", "0.3", "mg", "plecanatide", "dose", "levels", "reported", "significant", "decreases", "in", "time", "to", "first", "bowel", "movement", "after", "dosing", "as", "compared", "to", "patients", "receiving", "placebo.", "<tag2>", "The", "incidence", "of", "diarrhea", "at", "3", "mg", "was", "observed", "to", "be", "9.7%", "(compared", "to", "placebo", "incidence", "of", "1.3%).", "<tag3>"], "wordsA": ["Patients", "in", "all", "but", "the", "0.3", "mg", "plecanatide", "dose", "levels", "reported", "significant", "decreases", "in", "time", "to", "first", "bowel", "movement", "after", "dosing", "as", "compared", "to", "patients", "receiving", "placebo."], "wordsB": ["The", "incidence", "of", "diarrhea", "at", "3", "mg", "was", "observed", "to", "be", "9.7%", "(compared", "to", "placebo", "incidence", "of", "1.3%)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p32_s1", "idA": "1347613_12_item1_p14_s1", "sentA": "We expect to release top-line data from this study in late 2012.", "sentB": "We expect this trial will be completed during the first quarter of 2014.", "type": 1, "words": ["<tag1>", "We", "expect", "to", "release", "top-line", "data", "from", "this", "study", "in", "late", "2012.", "<tag2>", "We", "expect", "this", "trial", "will", "be", "completed", "during", "the", "first", "quarter", "of", "2014.", "<tag3>"], "wordsA": ["We", "expect", "to", "release", "top-line", "data", "from", "this", "study", "in", "late", "2012."], "wordsB": ["We", "expect", "this", "trial", "will", "be", "completed", "during", "the", "first", "quarter", "of", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p5_s2", "idA": "1347613_12_item1_p16_s2", "sentA": "Deficiency of this hormone is predicted to be one of the primary reasons for the formation of polyps that can lead to colon cancer, as well as debilitating and difficult-to-treat GI inflammatory disorders such as UC and Crohn s disease.", "sentB": "Orally-administered, plecanatide binds to the same receptors on the inside of the gastrointestinal tract as uroguanylin, and we believe it is capable of restoring the normal balance of fluid, thus restoring the regular function of the intestine in patients suffering from GI disorders such as CIC and IBS-C.", "type": 1, "words": ["<tag1>", "Deficiency", "of", "this", "hormone", "is", "predicted", "to", "be", "one", "of", "the", "primary", "reasons", "for", "the", "formation", "of", "polyps", "that", "can", "lead", "to", "colon", "cancer,", "as", "well", "as", "debilitating", "and", "difficult-to-treat", "GI", "inflammatory", "disorders", "such", "as", "UC", "and", "Crohn", "s", "disease.", "<tag2>", "Orally-administered,", "plecanatide", "binds", "to", "the", "same", "receptors", "on", "the", "inside", "of", "the", "gastrointestinal", "tract", "as", "uroguanylin,", "and", "we", "believe", "it", "is", "capable", "of", "restoring", "the", "normal", "balance", "of", "fluid,", "thus", "restoring", "the", "regular", "function", "of", "the", "intestine", "in", "patients", "suffering", "from", "GI", "disorders", "such", "as", "CIC", "and", "IBS-C.", "<tag3>"], "wordsA": ["Deficiency", "of", "this", "hormone", "is", "predicted", "to", "be", "one", "of", "the", "primary", "reasons", "for", "the", "formation", "of", "polyps", "that", "can", "lead", "to", "colon", "cancer,", "as", "well", "as", "debilitating", "and", "difficult-to-treat", "GI", "inflammatory", "disorders", "such", "as", "UC", "and", "Crohn", "s", "disease."], "wordsB": ["Orally-administered,", "plecanatide", "binds", "to", "the", "same", "receptors", "on", "the", "inside", "of", "the", "gastrointestinal", "tract", "as", "uroguanylin,", "and", "we", "believe", "it", "is", "capable", "of", "restoring", "the", "normal", "balance", "of", "fluid,", "thus", "restoring", "the", "regular", "function", "of", "the", "intestine", "in", "patients", "suffering", "from", "GI", "disorders", "such", "as", "CIC", "and", "IBS-C."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p21_s1", "idA": "1347613_12_item1_p17_s0", "sentA": "More than 500,000 Americans are afflicted with UC, a type of IBD that causes chronic inflammation of the colon.", "sentB": "Safety and tolerability were also assessed.", "type": 1, "words": ["<tag1>", "More", "than", "500,000", "Americans", "are", "afflicted", "with", "UC,", "a", "type", "of", "IBD", "that", "causes", "chronic", "inflammation", "of", "the", "colon.", "<tag2>", "Safety", "and", "tolerability", "were", "also", "assessed.", "<tag3>"], "wordsA": ["More", "than", "500,000", "Americans", "are", "afflicted", "with", "UC,", "a", "type", "of", "IBD", "that", "causes", "chronic", "inflammation", "of", "the", "colon."], "wordsB": ["Safety", "and", "tolerability", "were", "also", "assessed."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p26_s1", "idA": "1347613_12_item1_p17_s0", "sentA": "More than 500,000 Americans are afflicted with UC, a type of IBD that causes chronic inflammation of the colon.", "sentB": "As many as 1 in 6 or up to 50 million adult Americans suffer from IBS.", "type": 1, "words": ["<tag1>", "More", "than", "500,000", "Americans", "are", "afflicted", "with", "UC,", "a", "type", "of", "IBD", "that", "causes", "chronic", "inflammation", "of", "the", "colon.", "<tag2>", "As", "many", "as", "1", "in", "6", "or", "up", "to", "50", "million", "adult", "Americans", "suffer", "from", "IBS.", "<tag3>"], "wordsA": ["More", "than", "500,000", "Americans", "are", "afflicted", "with", "UC,", "a", "type", "of", "IBD", "that", "causes", "chronic", "inflammation", "of", "the", "colon."], "wordsB": ["As", "many", "as", "1", "in", "6", "or", "up", "to", "50", "million", "adult", "Americans", "suffer", "from", "IBS."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p27_s0", "idA": "1347613_12_item1_p17_s0", "sentA": "More than 500,000 Americans are afflicted with UC, a type of IBD that causes chronic inflammation of the colon.", "sentB": "IBS profoundly impacts patients physical, social and working lives.", "type": 1, "words": ["<tag1>", "More", "than", "500,000", "Americans", "are", "afflicted", "with", "UC,", "a", "type", "of", "IBD", "that", "causes", "chronic", "inflammation", "of", "the", "colon.", "<tag2>", "IBS", "profoundly", "impacts", "patients", "physical,", "social", "and", "working", "lives.", "<tag3>"], "wordsA": ["More", "than", "500,000", "Americans", "are", "afflicted", "with", "UC,", "a", "type", "of", "IBD", "that", "causes", "chronic", "inflammation", "of", "the", "colon."], "wordsB": ["IBS", "profoundly", "impacts", "patients", "physical,", "social", "and", "working", "lives."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p29_s0", "idA": "1347613_12_item1_p17_s0", "sentA": "More than 500,000 Americans are afflicted with UC, a type of IBD that causes chronic inflammation of the colon.", "sentB": "Healthcare systems spend billions of dollars annually to diagnose and treat this disorder.", "type": 1, "words": ["<tag1>", "More", "than", "500,000", "Americans", "are", "afflicted", "with", "UC,", "a", "type", "of", "IBD", "that", "causes", "chronic", "inflammation", "of", "the", "colon.", "<tag2>", "Healthcare", "systems", "spend", "billions", "of", "dollars", "annually", "to", "diagnose", "and", "treat", "this", "disorder.", "<tag3>"], "wordsA": ["More", "than", "500,000", "Americans", "are", "afflicted", "with", "UC,", "a", "type", "of", "IBD", "that", "causes", "chronic", "inflammation", "of", "the", "colon."], "wordsB": ["Healthcare", "systems", "spend", "billions", "of", "dollars", "annually", "to", "diagnose", "and", "treat", "this", "disorder."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p3_s0", "idA": "1347613_12_item1_p17_s0", "sentA": "More than 500,000 Americans are afflicted with UC, a type of IBD that causes chronic inflammation of the colon.", "sentB": "Our patented GI drug candidates were discovered and developed in-house by our scientists.", "type": 1, "words": ["<tag1>", "More", "than", "500,000", "Americans", "are", "afflicted", "with", "UC,", "a", "type", "of", "IBD", "that", "causes", "chronic", "inflammation", "of", "the", "colon.", "<tag2>", "Our", "patented", "GI", "drug", "candidates", "were", "discovered", "and", "developed", "in-house", "by", "our", "scientists.", "<tag3>"], "wordsA": ["More", "than", "500,000", "Americans", "are", "afflicted", "with", "UC,", "a", "type", "of", "IBD", "that", "causes", "chronic", "inflammation", "of", "the", "colon."], "wordsB": ["Our", "patented", "GI", "drug", "candidates", "were", "discovered", "and", "developed", "in-house", "by", "our", "scientists."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p6_s1", "idA": "1347613_12_item1_p19_s1", "sentA": "SP-333 is a second-generation guanylate cyclase C (GC-C) agonist with the potential to treat gastro-intestinal diseases such as UC.", "sentB": "CIC has no identifiable causes such as these diseases or drugs or physical anomalies.", "type": 1, "words": ["<tag1>", "SP-333", "is", "a", "second-generation", "guanylate", "cyclase", "C", "(GC-C)", "agonist", "with", "the", "potential", "to", "treat", "gastro-intestinal", "diseases", "such", "as", "UC.", "<tag2>", "CIC", "has", "no", "identifiable", "causes", "such", "as", "these", "diseases", "or", "drugs", "or", "physical", "anomalies.", "<tag3>"], "wordsA": ["SP-333", "is", "a", "second-generation", "guanylate", "cyclase", "C", "(GC-C)", "agonist", "with", "the", "potential", "to", "treat", "gastro-intestinal", "diseases", "such", "as", "UC."], "wordsB": ["CIC", "has", "no", "identifiable", "causes", "such", "as", "these", "diseases", "or", "drugs", "or", "physical", "anomalies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p27_s1", "idA": "1347613_12_item1_p1_s0", "sentA": "IBS-C is characterized by frequent and recurring abdominal pain and/or discomfort associated with chronic constipation.", "sentB": "A quarter of patients describe their abdominal pain as constant.", "type": 1, "words": ["<tag1>", "IBS-C", "is", "characterized", "by", "frequent", "and", "recurring", "abdominal", "pain", "and/or", "discomfort", "associated", "with", "chronic", "constipation.", "<tag2>", "A", "quarter", "of", "patients", "describe", "their", "abdominal", "pain", "as", "constant.", "<tag3>"], "wordsA": ["IBS-C", "is", "characterized", "by", "frequent", "and", "recurring", "abdominal", "pain", "and/or", "discomfort", "associated", "with", "chronic", "constipation."], "wordsB": ["A", "quarter", "of", "patients", "describe", "their", "abdominal", "pain", "as", "constant."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p7_s4", "idA": "1347613_12_item1_p22_s0", "sentA": "We believe, based on the ongoing studies to date, that our current formulations of capsules/tablets are both cost effective and meet the stability requirements for pharmaceutical drug products.", "sentB": "Plecanatide offers hope for a more effective and tolerable treatment that can relieve the significant burden CIC places on patients lives.", "type": 1, "words": ["<tag1>", "We", "believe,", "based", "on", "the", "ongoing", "studies", "to", "date,", "that", "our", "current", "formulations", "of", "capsules/tablets", "are", "both", "cost", "effective", "and", "meet", "the", "stability", "requirements", "for", "pharmaceutical", "drug", "products.", "<tag2>", "Plecanatide", "offers", "hope", "for", "a", "more", "effective", "and", "tolerable", "treatment", "that", "can", "relieve", "the", "significant", "burden", "CIC", "places", "on", "patients", "lives.", "<tag3>"], "wordsA": ["We", "believe,", "based", "on", "the", "ongoing", "studies", "to", "date,", "that", "our", "current", "formulations", "of", "capsules/tablets", "are", "both", "cost", "effective", "and", "meet", "the", "stability", "requirements", "for", "pharmaceutical", "drug", "products."], "wordsB": ["Plecanatide", "offers", "hope", "for", "a", "more", "effective", "and", "tolerable", "treatment", "that", "can", "relieve", "the", "significant", "burden", "CIC", "places", "on", "patients", "lives."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p43_s4", "idA": "1347613_12_item1_p25_s0", "sentA": "FDA review and approval of the NDA.", "sentB": "Upon consummation of the merger the related party balance due from Callisto, $3,305,636 as of December 31, 2012, was eliminated.", "type": 1, "words": ["<tag1>", "FDA", "review", "and", "approval", "of", "the", "NDA.", "<tag2>", "Upon", "consummation", "of", "the", "merger", "the", "related", "party", "balance", "due", "from", "Callisto,", "$3,305,636", "as", "of", "December", "31,", "2012,", "was", "eliminated.", "<tag3>"], "wordsA": ["FDA", "review", "and", "approval", "of", "the", "NDA."], "wordsB": ["Upon", "consummation", "of", "the", "merger", "the", "related", "party", "balance", "due", "from", "Callisto,", "$3,305,636", "as", "of", "December", "31,", "2012,", "was", "eliminated."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p38_s1", "idA": "1347613_12_item1_p26_s0", "sentA": "Preclinical tests include laboratory evaluation of the product candidate, as well as animal studies to assess the potential safety and efficacy of the product candidate.", "sentB": "The terms of the agreement provide for an initial base payment of $1 million, subsequent milestone payments covering (i) marketing (FDA) approval and (ii) achieving the milestone of aggregate net sales equal to or greater than $125 million, as well as a single digit royalty based on net sales.", "type": 1, "words": ["<tag1>", "Preclinical", "tests", "include", "laboratory", "evaluation", "of", "the", "product", "candidate,", "as", "well", "as", "animal", "studies", "to", "assess", "the", "potential", "safety", "and", "efficacy", "of", "the", "product", "candidate.", "<tag2>", "The", "terms", "of", "the", "agreement", "provide", "for", "an", "initial", "base", "payment", "of", "$1", "million,", "subsequent", "milestone", "payments", "covering", "(i)", "marketing", "(FDA)", "approval", "and", "(ii)", "achieving", "the", "milestone", "of", "aggregate", "net", "sales", "equal", "to", "or", "greater", "than", "$125", "million,", "as", "well", "as", "a", "single", "digit", "royalty", "based", "on", "net", "sales.", "<tag3>"], "wordsA": ["Preclinical", "tests", "include", "laboratory", "evaluation", "of", "the", "product", "candidate,", "as", "well", "as", "animal", "studies", "to", "assess", "the", "potential", "safety", "and", "efficacy", "of", "the", "product", "candidate."], "wordsB": ["The", "terms", "of", "the", "agreement", "provide", "for", "an", "initial", "base", "payment", "of", "$1", "million,", "subsequent", "milestone", "payments", "covering", "(i)", "marketing", "(FDA)", "approval", "and", "(ii)", "achieving", "the", "milestone", "of", "aggregate", "net", "sales", "equal", "to", "or", "greater", "than", "$125", "million,", "as", "well", "as", "a", "single", "digit", "royalty", "based", "on", "net", "sales."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p31_s0", "idA": "1347613_12_item1_p26_s2", "sentA": "We must submit the results of the preclinical tests, together with manufacturing information, analytical data and a proposed clinical trial protocol to the FDA as part of an IND, which must become effective before we may commence human clinical trials.", "sentB": "Abdominal pain is a major part of this syndrome and patients need to have pain scores of 3 or more (on a scale of 1 to 10) for 3 days in each of the two pre-treatment weeks.", "type": 1, "words": ["<tag1>", "We", "must", "submit", "the", "results", "of", "the", "preclinical", "tests,", "together", "with", "manufacturing", "information,", "analytical", "data", "and", "a", "proposed", "clinical", "trial", "protocol", "to", "the", "FDA", "as", "part", "of", "an", "IND,", "which", "must", "become", "effective", "before", "we", "may", "commence", "human", "clinical", "trials.", "<tag2>", "Abdominal", "pain", "is", "a", "major", "part", "of", "this", "syndrome", "and", "patients", "need", "to", "have", "pain", "scores", "of", "3", "or", "more", "(on", "a", "scale", "of", "1", "to", "10)", "for", "3", "days", "in", "each", "of", "the", "two", "pre-treatment", "weeks.", "<tag3>"], "wordsA": ["We", "must", "submit", "the", "results", "of", "the", "preclinical", "tests,", "together", "with", "manufacturing", "information,", "analytical", "data", "and", "a", "proposed", "clinical", "trial", "protocol", "to", "the", "FDA", "as", "part", "of", "an", "IND,", "which", "must", "become", "effective", "before", "we", "may", "commence", "human", "clinical", "trials."], "wordsB": ["Abdominal", "pain", "is", "a", "major", "part", "of", "this", "syndrome", "and", "patients", "need", "to", "have", "pain", "scores", "of", "3", "or", "more", "(on", "a", "scale", "of", "1", "to", "10)", "for", "3", "days", "in", "each", "of", "the", "two", "pre-treatment", "weeks."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p45_s2", "idA": "1347613_12_item1_p26_s7", "sentA": "An institutional review board may also require the clinical trial at the site to be halted, either temporarily or permanently, for failure to comply with the institutional review board s requirements or may impose other conditions.", "sentB": "The excess of our shares issued to Callisto shareholders over our shares held by Callisto is the result of a discount associated with the restricted nature of our shares to be received by Callisto shareholders.", "type": 1, "words": ["<tag1>", "An", "institutional", "review", "board", "may", "also", "require", "the", "clinical", "trial", "at", "the", "site", "to", "be", "halted,", "either", "temporarily", "or", "permanently,", "for", "failure", "to", "comply", "with", "the", "institutional", "review", "board", "s", "requirements", "or", "may", "impose", "other", "conditions.", "<tag2>", "The", "excess", "of", "our", "shares", "issued", "to", "Callisto", "shareholders", "over", "our", "shares", "held", "by", "Callisto", "is", "the", "result", "of", "a", "discount", "associated", "with", "the", "restricted", "nature", "of", "our", "shares", "to", "be", "received", "by", "Callisto", "shareholders.", "<tag3>"], "wordsA": ["An", "institutional", "review", "board", "may", "also", "require", "the", "clinical", "trial", "at", "the", "site", "to", "be", "halted,", "either", "temporarily", "or", "permanently,", "for", "failure", "to", "comply", "with", "the", "institutional", "review", "board", "s", "requirements", "or", "may", "impose", "other", "conditions."], "wordsB": ["The", "excess", "of", "our", "shares", "issued", "to", "Callisto", "shareholders", "over", "our", "shares", "held", "by", "Callisto", "is", "the", "result", "of", "a", "discount", "associated", "with", "the", "restricted", "nature", "of", "our", "shares", "to", "be", "received", "by", "Callisto", "shareholders."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p7_s3", "idA": "1347613_12_item1_p29_s0", "sentA": "identify possible adverse effects and safety risks.", "sentB": "The prescription drugs available have significant side effects and are only effective in less than half of patients treated.", "type": 1, "words": ["<tag1>", "identify", "possible", "adverse", "effects", "and", "safety", "risks.", "<tag2>", "The", "prescription", "drugs", "available", "have", "significant", "side", "effects", "and", "are", "only", "effective", "in", "less", "than", "half", "of", "patients", "treated.", "<tag3>"], "wordsA": ["identify", "possible", "adverse", "effects", "and", "safety", "risks."], "wordsB": ["The", "prescription", "drugs", "available", "have", "significant", "side", "effects", "and", "are", "only", "effective", "in", "less", "than", "half", "of", "patients", "treated."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p46_s0", "idA": "1347613_12_item1_p2_s0", "sentA": "We are currently developing plecanatide, a synthetic hexadecapeptide designed to mimic the actions of the GI hormone uroguanylin, for the treatment of CC and IBS-C. Plecanatide is an agonist of GC-C receptor.", "sentB": "On January 17, 2013, the effective date of the merger, we accounted for the merger by assuming Callisto s net liabilities, of approximately $1.7 million, principally trade payables.", "type": 1, "words": ["<tag1>", "We", "are", "currently", "developing", "plecanatide,", "a", "synthetic", "hexadecapeptide", "designed", "to", "mimic", "the", "actions", "of", "the", "GI", "hormone", "uroguanylin,", "for", "the", "treatment", "of", "CC", "and", "IBS-C.", "Plecanatide", "is", "an", "agonist", "of", "GC-C", "receptor.", "<tag2>", "On", "January", "17,", "2013,", "the", "effective", "date", "of", "the", "merger,", "we", "accounted", "for", "the", "merger", "by", "assuming", "Callisto", "s", "net", "liabilities,", "of", "approximately", "$1.7", "million,", "principally", "trade", "payables.", "<tag3>"], "wordsA": ["We", "are", "currently", "developing", "plecanatide,", "a", "synthetic", "hexadecapeptide", "designed", "to", "mimic", "the", "actions", "of", "the", "GI", "hormone", "uroguanylin,", "for", "the", "treatment", "of", "CC", "and", "IBS-C.", "Plecanatide", "is", "an", "agonist", "of", "GC-C", "receptor."], "wordsB": ["On", "January", "17,", "2013,", "the", "effective", "date", "of", "the", "merger,", "we", "accounted", "for", "the", "merger", "by", "assuming", "Callisto", "s", "net", "liabilities,", "of", "approximately", "$1.7", "million,", "principally", "trade", "payables."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p43_s2", "idA": "1347613_12_item1_p32_s0", "sentA": "The FDA may order the temporary or permanent discontinuation of a clinical trial at any time or impose other sanctions if it believes that the clinical trial is not being conducted in accordance with FDA requirements or presents an unacceptable risk to the clinical trial patients.", "sentB": "In addition, each stock option exercisable for shares of Callisto common stock that was outstanding on January 17, 2013 was assumed by us and converted into a stock option to purchase the number of shares of our common stock that the holder would have received if such holder had exercised such stock option for shares of Callisto common stock prior to the merger and exchanged such shares for shares of our common stock in accordance with the Exchange Ratio.", "type": 1, "words": ["<tag1>", "The", "FDA", "may", "order", "the", "temporary", "or", "permanent", "discontinuation", "of", "a", "clinical", "trial", "at", "any", "time", "or", "impose", "other", "sanctions", "if", "it", "believes", "that", "the", "clinical", "trial", "is", "not", "being", "conducted", "in", "accordance", "with", "FDA", "requirements", "or", "presents", "an", "unacceptable", "risk", "to", "the", "clinical", "trial", "patients.", "<tag2>", "In", "addition,", "each", "stock", "option", "exercisable", "for", "shares", "of", "Callisto", "common", "stock", "that", "was", "outstanding", "on", "January", "17,", "2013", "was", "assumed", "by", "us", "and", "converted", "into", "a", "stock", "option", "to", "purchase", "the", "number", "of", "shares", "of", "our", "common", "stock", "that", "the", "holder", "would", "have", "received", "if", "such", "holder", "had", "exercised", "such", "stock", "option", "for", "shares", "of", "Callisto", "common", "stock", "prior", "to", "the", "merger", "and", "exchanged", "such", "shares", "for", "shares", "of", "our", "common", "stock", "in", "accordance", "with", "the", "Exchange", "Ratio.", "<tag3>"], "wordsA": ["The", "FDA", "may", "order", "the", "temporary", "or", "permanent", "discontinuation", "of", "a", "clinical", "trial", "at", "any", "time", "or", "impose", "other", "sanctions", "if", "it", "believes", "that", "the", "clinical", "trial", "is", "not", "being", "conducted", "in", "accordance", "with", "FDA", "requirements", "or", "presents", "an", "unacceptable", "risk", "to", "the", "clinical", "trial", "patients."], "wordsB": ["In", "addition,", "each", "stock", "option", "exercisable", "for", "shares", "of", "Callisto", "common", "stock", "that", "was", "outstanding", "on", "January", "17,", "2013", "was", "assumed", "by", "us", "and", "converted", "into", "a", "stock", "option", "to", "purchase", "the", "number", "of", "shares", "of", "our", "common", "stock", "that", "the", "holder", "would", "have", "received", "if", "such", "holder", "had", "exercised", "such", "stock", "option", "for", "shares", "of", "Callisto", "common", "stock", "prior", "to", "the", "merger", "and", "exchanged", "such", "shares", "for", "shares", "of", "our", "common", "stock", "in", "accordance", "with", "the", "Exchange", "Ratio."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p45_s0", "idA": "1347613_12_item1_p33_s3", "sentA": "The FDA may refuse to file the NDA if it does not contain all pertinent information and data.", "sentB": "As Callisto did not have the required inputs, process or outputs, it does not meet the definition of a business under ASC 805, the merger will not be accounted for as a business combination.", "type": 1, "words": ["<tag1>", "The", "FDA", "may", "refuse", "to", "file", "the", "NDA", "if", "it", "does", "not", "contain", "all", "pertinent", "information", "and", "data.", "<tag2>", "As", "Callisto", "did", "not", "have", "the", "required", "inputs,", "process", "or", "outputs,", "it", "does", "not", "meet", "the", "definition", "of", "a", "business", "under", "ASC", "805,", "the", "merger", "will", "not", "be", "accounted", "for", "as", "a", "business", "combination.", "<tag3>"], "wordsA": ["The", "FDA", "may", "refuse", "to", "file", "the", "NDA", "if", "it", "does", "not", "contain", "all", "pertinent", "information", "and", "data."], "wordsB": ["As", "Callisto", "did", "not", "have", "the", "required", "inputs,", "process", "or", "outputs,", "it", "does", "not", "meet", "the", "definition", "of", "a", "business", "under", "ASC", "805,", "the", "merger", "will", "not", "be", "accounted", "for", "as", "a", "business", "combination."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p23_s1", "idA": "1347613_12_item1_p36_s3", "sentA": "FDA also typically inspects facilities responsible for performing animal testing, as well as clinical investigators who participate in clinical trials.", "sentB": "Notably, the 3 mg dose demonstrated a 19% (p=0.009) overall responder rate (compared to placebo of 10.7%), as well as demonstrating a mean increase in CSBMs over the 12-week treatment period of 2.13 (p 0.001).", "type": 1, "words": ["<tag1>", "FDA", "also", "typically", "inspects", "facilities", "responsible", "for", "performing", "animal", "testing,", "as", "well", "as", "clinical", "investigators", "who", "participate", "in", "clinical", "trials.", "<tag2>", "Notably,", "the", "3", "mg", "dose", "demonstrated", "a", "19%", "(p=0.009)", "overall", "responder", "rate", "(compared", "to", "placebo", "of", "10.7%),", "as", "well", "as", "demonstrating", "a", "mean", "increase", "in", "CSBMs", "over", "the", "12-week", "treatment", "period", "of", "2.13", "(p", "0.001).", "<tag3>"], "wordsA": ["FDA", "also", "typically", "inspects", "facilities", "responsible", "for", "performing", "animal", "testing,", "as", "well", "as", "clinical", "investigators", "who", "participate", "in", "clinical", "trials."], "wordsB": ["Notably,", "the", "3", "mg", "dose", "demonstrated", "a", "19%", "(p=0.009)", "overall", "responder", "rate", "(compared", "to", "placebo", "of", "10.7%),", "as", "well", "as", "demonstrating", "a", "mean", "increase", "in", "CSBMs", "over", "the", "12-week", "treatment", "period", "of", "2.13", "(p", "0.001)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p7_s2", "idA": "1347613_12_item1_p36_s4", "sentA": "The FDA may refuse to approve an NDA if applicable regulatory criteria are not satisfied, or may require additional testing or information.", "sentB": "Over-the counter medications offer only short term relief and are not indicated for chronic treatment.", "type": 1, "words": ["<tag1>", "The", "FDA", "may", "refuse", "to", "approve", "an", "NDA", "if", "applicable", "regulatory", "criteria", "are", "not", "satisfied,", "or", "may", "require", "additional", "testing", "or", "information.", "<tag2>", "Over-the", "counter", "medications", "offer", "only", "short", "term", "relief", "and", "are", "not", "indicated", "for", "chronic", "treatment.", "<tag3>"], "wordsA": ["The", "FDA", "may", "refuse", "to", "approve", "an", "NDA", "if", "applicable", "regulatory", "criteria", "are", "not", "satisfied,", "or", "may", "require", "additional", "testing", "or", "information."], "wordsB": ["Over-the", "counter", "medications", "offer", "only", "short", "term", "relief", "and", "are", "not", "indicated", "for", "chronic", "treatment."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p43_s0", "idA": "1347613_12_item1_p39_s2", "sentA": "The manufacturing facilities for our products must meet GMP requirements to the satisfaction of the FDA pursuant to a pre-approval inspection before we can use them to manufacture our products.", "sentB": "On January 17, 2013, we completed our acquisition of Callisto, pursuant to the Merger Agreement, as amended.", "type": 1, "words": ["<tag1>", "The", "manufacturing", "facilities", "for", "our", "products", "must", "meet", "GMP", "requirements", "to", "the", "satisfaction", "of", "the", "FDA", "pursuant", "to", "a", "pre-approval", "inspection", "before", "we", "can", "use", "them", "to", "manufacture", "our", "products.", "<tag2>", "On", "January", "17,", "2013,", "we", "completed", "our", "acquisition", "of", "Callisto,", "pursuant", "to", "the", "Merger", "Agreement,", "as", "amended.", "<tag3>"], "wordsA": ["The", "manufacturing", "facilities", "for", "our", "products", "must", "meet", "GMP", "requirements", "to", "the", "satisfaction", "of", "the", "FDA", "pursuant", "to", "a", "pre-approval", "inspection", "before", "we", "can", "use", "them", "to", "manufacture", "our", "products."], "wordsB": ["On", "January", "17,", "2013,", "we", "completed", "our", "acquisition", "of", "Callisto,", "pursuant", "to", "the", "Merger", "Agreement,", "as", "amended."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p42_s0", "idA": "1347613_12_item1_p47_s1", "sentA": "Our competitors include major pharmaceutical and biotechnology companies focusing on GI such as Ironwood Pharmaceuticals, Inc., Forest Laboratories, Inc., Takeda Pharmaceuticals America, Inc., Sucampo Pharmaceuticals, Inc., Salix Pharmaceuticals, Inc. and Shire Plc.", "sentB": "On July 20, 2012, we entered into an Agreement and Plan of Merger (the Merger Agreement ) with Callisto Pharmaceuticals, Inc., or Callisto, as amended on October 15, 2012.", "type": 1, "words": ["<tag1>", "Our", "competitors", "include", "major", "pharmaceutical", "and", "biotechnology", "companies", "focusing", "on", "GI", "such", "as", "Ironwood", "Pharmaceuticals,", "Inc.,", "Forest", "Laboratories,", "Inc.,", "Takeda", "Pharmaceuticals", "America,", "Inc.,", "Sucampo", "Pharmaceuticals,", "Inc.,", "Salix", "Pharmaceuticals,", "Inc.", "and", "Shire", "Plc.", "<tag2>", "On", "July", "20,", "2012,", "we", "entered", "into", "an", "Agreement", "and", "Plan", "of", "Merger", "(the", "Merger", "Agreement", ")", "with", "Callisto", "Pharmaceuticals,", "Inc.,", "or", "Callisto,", "as", "amended", "on", "October", "15,", "2012.", "<tag3>"], "wordsA": ["Our", "competitors", "include", "major", "pharmaceutical", "and", "biotechnology", "companies", "focusing", "on", "GI", "such", "as", "Ironwood", "Pharmaceuticals,", "Inc.,", "Forest", "Laboratories,", "Inc.,", "Takeda", "Pharmaceuticals", "America,", "Inc.,", "Sucampo", "Pharmaceuticals,", "Inc.,", "Salix", "Pharmaceuticals,", "Inc.", "and", "Shire", "Plc."], "wordsB": ["On", "July", "20,", "2012,", "we", "entered", "into", "an", "Agreement", "and", "Plan", "of", "Merger", "(the", "Merger", "Agreement", ")", "with", "Callisto", "Pharmaceuticals,", "Inc.,", "or", "Callisto,", "as", "amended", "on", "October", "15,", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p75_s1", "idA": "1347613_12_item1_p49_s0", "sentA": "Research and development costs include expenditures for an in-house research and development laboratory, salaries and staff costs, application and filing for regulatory approval of proposed products, purchased in-process research and development, regulatory and scientific consulting fees, as well as contract services, including clinical trial related patient costs, drug formulation and tableting, data collection, monitoring, insurance and FDA consultants.", "sentB": "In accordance with this guidance, we expense deferred research and development costs when drug compound is delivered and services are performed.", "type": 1, "words": ["<tag1>", "Research", "and", "development", "costs", "include", "expenditures", "for", "an", "in-house", "research", "and", "development", "laboratory,", "salaries", "and", "staff", "costs,", "application", "and", "filing", "for", "regulatory", "approval", "of", "proposed", "products,", "purchased", "in-process", "research", "and", "development,", "regulatory", "and", "scientific", "consulting", "fees,", "as", "well", "as", "contract", "services,", "including", "clinical", "trial", "related", "patient", "costs,", "drug", "formulation", "and", "tableting,", "data", "collection,", "monitoring,", "insurance", "and", "FDA", "consultants.", "<tag2>", "In", "accordance", "with", "this", "guidance,", "we", "expense", "deferred", "research", "and", "development", "costs", "when", "drug", "compound", "is", "delivered", "and", "services", "are", "performed.", "<tag3>"], "wordsA": ["Research", "and", "development", "costs", "include", "expenditures", "for", "an", "in-house", "research", "and", "development", "laboratory,", "salaries", "and", "staff", "costs,", "application", "and", "filing", "for", "regulatory", "approval", "of", "proposed", "products,", "purchased", "in-process", "research", "and", "development,", "regulatory", "and", "scientific", "consulting", "fees,", "as", "well", "as", "contract", "services,", "including", "clinical", "trial", "related", "patient", "costs,", "drug", "formulation", "and", "tableting,", "data", "collection,", "monitoring,", "insurance", "and", "FDA", "consultants."], "wordsB": ["In", "accordance", "with", "this", "guidance,", "we", "expense", "deferred", "research", "and", "development", "costs", "when", "drug", "compound", "is", "delivered", "and", "services", "are", "performed."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p21_s0", "idA": "1347613_12_item1_p4_s1", "sentA": "This study is being conducted at 110 sites in the United States and is designed to enroll 880 patients with CC to insure we have 800 evaluable patients at the end of the study.", "sentB": "The primary efficacy end point was a responder analysis based on patients achieving 3 or more complete spontaneous bowel movements (CSBM) per week (with an increase of at least 1 CSBM from baseline) in 9 of the 12 treatment weeks of the study.", "type": 1, "words": ["<tag1>", "This", "study", "is", "being", "conducted", "at", "110", "sites", "in", "the", "United", "States", "and", "is", "designed", "to", "enroll", "880", "patients", "with", "CC", "to", "insure", "we", "have", "800", "evaluable", "patients", "at", "the", "end", "of", "the", "study.", "<tag2>", "The", "primary", "efficacy", "end", "point", "was", "a", "responder", "analysis", "based", "on", "patients", "achieving", "3", "or", "more", "complete", "spontaneous", "bowel", "movements", "(CSBM)", "per", "week", "(with", "an", "increase", "of", "at", "least", "1", "CSBM", "from", "baseline)", "in", "9", "of", "the", "12", "treatment", "weeks", "of", "the", "study.", "<tag3>"], "wordsA": ["This", "study", "is", "being", "conducted", "at", "110", "sites", "in", "the", "United", "States", "and", "is", "designed", "to", "enroll", "880", "patients", "with", "CC", "to", "insure", "we", "have", "800", "evaluable", "patients", "at", "the", "end", "of", "the", "study."], "wordsB": ["The", "primary", "efficacy", "end", "point", "was", "a", "responder", "analysis", "based", "on", "patients", "achieving", "3", "or", "more", "complete", "spontaneous", "bowel", "movements", "(CSBM)", "per", "week", "(with", "an", "increase", "of", "at", "least", "1", "CSBM", "from", "baseline)", "in", "9", "of", "the", "12", "treatment", "weeks", "of", "the", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p31_s2", "idA": "1347613_12_item1_p4_s1", "sentA": "This study is being conducted at 110 sites in the United States and is designed to enroll 880 patients with CC to insure we have 800 evaluable patients at the end of the study.", "sentB": "At the end of treatment patients are followed for two weeks and return for an end of study visit.", "type": 1, "words": ["<tag1>", "This", "study", "is", "being", "conducted", "at", "110", "sites", "in", "the", "United", "States", "and", "is", "designed", "to", "enroll", "880", "patients", "with", "CC", "to", "insure", "we", "have", "800", "evaluable", "patients", "at", "the", "end", "of", "the", "study.", "<tag2>", "At", "the", "end", "of", "treatment", "patients", "are", "followed", "for", "two", "weeks", "and", "return", "for", "an", "end", "of", "study", "visit.", "<tag3>"], "wordsA": ["This", "study", "is", "being", "conducted", "at", "110", "sites", "in", "the", "United", "States", "and", "is", "designed", "to", "enroll", "880", "patients", "with", "CC", "to", "insure", "we", "have", "800", "evaluable", "patients", "at", "the", "end", "of", "the", "study."], "wordsB": ["At", "the", "end", "of", "treatment", "patients", "are", "followed", "for", "two", "weeks", "and", "return", "for", "an", "end", "of", "study", "visit."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p40_s2", "idA": "1347613_12_item1_p50_s1", "sentA": "Accordingly, patents or other proprietary rights are an essential element of our business.", "sentB": "It is a fundamental part of our commercial strategy to maintain two or more API suppliers to ensure continuity in our supply chain.", "type": 1, "words": ["<tag1>", "Accordingly,", "patents", "or", "other", "proprietary", "rights", "are", "an", "essential", "element", "of", "our", "business.", "<tag2>", "It", "is", "a", "fundamental", "part", "of", "our", "commercial", "strategy", "to", "maintain", "two", "or", "more", "API", "suppliers", "to", "ensure", "continuity", "in", "our", "supply", "chain.", "<tag3>"], "wordsA": ["Accordingly,", "patents", "or", "other", "proprietary", "rights", "are", "an", "essential", "element", "of", "our", "business."], "wordsB": ["It", "is", "a", "fundamental", "part", "of", "our", "commercial", "strategy", "to", "maintain", "two", "or", "more", "API", "suppliers", "to", "ensure", "continuity", "in", "our", "supply", "chain."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p43_s3", "idA": "1347613_12_item1_p50_s1", "sentA": "Accordingly, patents or other proprietary rights are an essential element of our business.", "sentB": "In addition, each Callisto stock option exercisable for shares of our common stock outstanding on January 17, 2013 was assumed by us and each outstanding warrant or obligation to issue a warrant to purchase shares of Callisto common stock, whether or not vested, was cancelled.", "type": 1, "words": ["<tag1>", "Accordingly,", "patents", "or", "other", "proprietary", "rights", "are", "an", "essential", "element", "of", "our", "business.", "<tag2>", "In", "addition,", "each", "Callisto", "stock", "option", "exercisable", "for", "shares", "of", "our", "common", "stock", "outstanding", "on", "January", "17,", "2013", "was", "assumed", "by", "us", "and", "each", "outstanding", "warrant", "or", "obligation", "to", "issue", "a", "warrant", "to", "purchase", "shares", "of", "Callisto", "common", "stock,", "whether", "or", "not", "vested,", "was", "cancelled.", "<tag3>"], "wordsA": ["Accordingly,", "patents", "or", "other", "proprietary", "rights", "are", "an", "essential", "element", "of", "our", "business."], "wordsB": ["In", "addition,", "each", "Callisto", "stock", "option", "exercisable", "for", "shares", "of", "our", "common", "stock", "outstanding", "on", "January", "17,", "2013", "was", "assumed", "by", "us", "and", "each", "outstanding", "warrant", "or", "obligation", "to", "issue", "a", "warrant", "to", "purchase", "shares", "of", "Callisto", "common", "stock,", "whether", "or", "not", "vested,", "was", "cancelled."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p44_s0", "idA": "1347613_12_item1_p50_s1", "sentA": "Accordingly, patents or other proprietary rights are an essential element of our business.", "sentB": "approximately 28,605,354 shares of our common stock to former Callisto stockholders in exchange for their shares of Callisto common stock.", "type": 1, "words": ["<tag1>", "Accordingly,", "patents", "or", "other", "proprietary", "rights", "are", "an", "essential", "element", "of", "our", "business.", "<tag2>", "approximately", "28,605,354", "shares", "of", "our", "common", "stock", "to", "former", "Callisto", "stockholders", "in", "exchange", "for", "their", "shares", "of", "Callisto", "common", "stock.", "<tag3>"], "wordsA": ["Accordingly,", "patents", "or", "other", "proprietary", "rights", "are", "an", "essential", "element", "of", "our", "business."], "wordsB": ["approximately", "28,605,354", "shares", "of", "our", "common", "stock", "to", "former", "Callisto", "stockholders", "in", "exchange", "for", "their", "shares", "of", "Callisto", "common", "stock."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p45_s1", "idA": "1347613_12_item1_p50_s1", "sentA": "Accordingly, patents or other proprietary rights are an essential element of our business.", "sentB": "The merger is expected to be accounted for as a recapitalization of us, effected through exchange of Callisto shares for our shares, and the cancellation of our shares held by Callisto.", "type": 1, "words": ["<tag1>", "Accordingly,", "patents", "or", "other", "proprietary", "rights", "are", "an", "essential", "element", "of", "our", "business.", "<tag2>", "The", "merger", "is", "expected", "to", "be", "accounted", "for", "as", "a", "recapitalization", "of", "us,", "effected", "through", "exchange", "of", "Callisto", "shares", "for", "our", "shares,", "and", "the", "cancellation", "of", "our", "shares", "held", "by", "Callisto.", "<tag3>"], "wordsA": ["Accordingly,", "patents", "or", "other", "proprietary", "rights", "are", "an", "essential", "element", "of", "our", "business."], "wordsB": ["The", "merger", "is", "expected", "to", "be", "accounted", "for", "as", "a", "recapitalization", "of", "us,", "effected", "through", "exchange", "of", "Callisto", "shares", "for", "our", "shares,", "and", "the", "cancellation", "of", "our", "shares", "held", "by", "Callisto."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p23_s2", "idA": "1347613_12_item1_p51_s5", "sentA": "In addition, we have three granted foreign patents which cover composition-of-matter of plecanatide and expire in 2022.", "sentB": "In addition, statistically significant improvements were seen in key secondary endpoints.", "type": 1, "words": ["<tag1>", "In", "addition,", "we", "have", "three", "granted", "foreign", "patents", "which", "cover", "composition-of-matter", "of", "plecanatide", "and", "expire", "in", "2022.", "<tag2>", "In", "addition,", "statistically", "significant", "improvements", "were", "seen", "in", "key", "secondary", "endpoints.", "<tag3>"], "wordsA": ["In", "addition,", "we", "have", "three", "granted", "foreign", "patents", "which", "cover", "composition-of-matter", "of", "plecanatide", "and", "expire", "in", "2022."], "wordsB": ["In", "addition,", "statistically", "significant", "improvements", "were", "seen", "in", "key", "secondary", "endpoints."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p81_s5", "idA": "1347613_12_item1_p51_s5", "sentA": "In addition, we have three granted foreign patents which cover composition-of-matter of plecanatide and expire in 2022.", "sentB": "We also have 44 additional foreign patents that cover the precursor and close analogs of FV-100 and there are also 2 FV-100 foreign patents pending.", "type": 1, "words": ["<tag1>", "In", "addition,", "we", "have", "three", "granted", "foreign", "patents", "which", "cover", "composition-of-matter", "of", "plecanatide", "and", "expire", "in", "2022.", "<tag2>", "We", "also", "have", "44", "additional", "foreign", "patents", "that", "cover", "the", "precursor", "and", "close", "analogs", "of", "FV-100", "and", "there", "are", "also", "2", "FV-100", "foreign", "patents", "pending.", "<tag3>"], "wordsA": ["In", "addition,", "we", "have", "three", "granted", "foreign", "patents", "which", "cover", "composition-of-matter", "of", "plecanatide", "and", "expire", "in", "2022."], "wordsB": ["We", "also", "have", "44", "additional", "foreign", "patents", "that", "cover", "the", "precursor", "and", "close", "analogs", "of", "FV-100", "and", "there", "are", "also", "2", "FV-100", "foreign", "patents", "pending."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p45_s3", "idA": "1347613_12_item1_p53_s3", "sentA": "In addition, we are aware that another pharmaceutical company has been issued a patent for the use of plecanatide for treatment of constipation or constipation predominant irritable bowel syndrome.", "sentB": "Therefore, considering this discount, the share exchange has been determined to be equal from a fair value stand point.", "type": 1, "words": ["<tag1>", "In", "addition,", "we", "are", "aware", "that", "another", "pharmaceutical", "company", "has", "been", "issued", "a", "patent", "for", "the", "use", "of", "plecanatide", "for", "treatment", "of", "constipation", "or", "constipation", "predominant", "irritable", "bowel", "syndrome.", "<tag2>", "Therefore,", "considering", "this", "discount,", "the", "share", "exchange", "has", "been", "determined", "to", "be", "equal", "from", "a", "fair", "value", "stand", "point.", "<tag3>"], "wordsA": ["In", "addition,", "we", "are", "aware", "that", "another", "pharmaceutical", "company", "has", "been", "issued", "a", "patent", "for", "the", "use", "of", "plecanatide", "for", "treatment", "of", "constipation", "or", "constipation", "predominant", "irritable", "bowel", "syndrome."], "wordsB": ["Therefore,", "considering", "this", "discount,", "the", "share", "exchange", "has", "been", "determined", "to", "be", "equal", "from", "a", "fair", "value", "stand", "point."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p71_s1", "idA": "1347613_12_item1_p53_s3", "sentA": "In addition, we are aware that another pharmaceutical company has been issued a patent for the use of plecanatide for treatment of constipation or constipation predominant irritable bowel syndrome.", "sentB": "From time to time, and in the future, our operations may involve the use of hazardous materials.", "type": 1, "words": ["<tag1>", "In", "addition,", "we", "are", "aware", "that", "another", "pharmaceutical", "company", "has", "been", "issued", "a", "patent", "for", "the", "use", "of", "plecanatide", "for", "treatment", "of", "constipation", "or", "constipation", "predominant", "irritable", "bowel", "syndrome.", "<tag2>", "From", "time", "to", "time,", "and", "in", "the", "future,", "our", "operations", "may", "involve", "the", "use", "of", "hazardous", "materials.", "<tag3>"], "wordsA": ["In", "addition,", "we", "are", "aware", "that", "another", "pharmaceutical", "company", "has", "been", "issued", "a", "patent", "for", "the", "use", "of", "plecanatide", "for", "treatment", "of", "constipation", "or", "constipation", "predominant", "irritable", "bowel", "syndrome."], "wordsB": ["From", "time", "to", "time,", "and", "in", "the", "future,", "our", "operations", "may", "involve", "the", "use", "of", "hazardous", "materials."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p46_s1", "idA": "1347613_12_item1_p55_s4", "sentA": "However, it is possible that these agreements may be breached or invalidated, and if so, there may not be an adequate corrective remedy available.", "sentB": "Our financial statements will not be restated retroactively to reflect the historical financial position or results of operations of Callisto.", "type": 1, "words": ["<tag1>", "However,", "it", "is", "possible", "that", "these", "agreements", "may", "be", "breached", "or", "invalidated,", "and", "if", "so,", "there", "may", "not", "be", "an", "adequate", "corrective", "remedy", "available.", "<tag2>", "Our", "financial", "statements", "will", "not", "be", "restated", "retroactively", "to", "reflect", "the", "historical", "financial", "position", "or", "results", "of", "operations", "of", "Callisto.", "<tag3>"], "wordsA": ["However,", "it", "is", "possible", "that", "these", "agreements", "may", "be", "breached", "or", "invalidated,", "and", "if", "so,", "there", "may", "not", "be", "an", "adequate", "corrective", "remedy", "available."], "wordsB": ["Our", "financial", "statements", "will", "not", "be", "restated", "retroactively", "to", "reflect", "the", "historical", "financial", "position", "or", "results", "of", "operations", "of", "Callisto."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p28_s1", "idA": "1347613_12_item1_p56_s2", "sentA": "If we are forced to defend ourselves against such claims, whether they are with or without merit and whether they are resolved in favor of, or against, our licensors or us, we may face costly litigation and the diversion of management s attention and resources.", "sentB": "Fewer than 1 in 10 patients say they are satisfied with available IBS treatments.", "type": 1, "words": ["<tag1>", "If", "we", "are", "forced", "to", "defend", "ourselves", "against", "such", "claims,", "whether", "they", "are", "with", "or", "without", "merit", "and", "whether", "they", "are", "resolved", "in", "favor", "of,", "or", "against,", "our", "licensors", "or", "us,", "we", "may", "face", "costly", "litigation", "and", "the", "diversion", "of", "management", "s", "attention", "and", "resources.", "<tag2>", "Fewer", "than", "1", "in", "10", "patients", "say", "they", "are", "satisfied", "with", "available", "IBS", "treatments.", "<tag3>"], "wordsA": ["If", "we", "are", "forced", "to", "defend", "ourselves", "against", "such", "claims,", "whether", "they", "are", "with", "or", "without", "merit", "and", "whether", "they", "are", "resolved", "in", "favor", "of,", "or", "against,", "our", "licensors", "or", "us,", "we", "may", "face", "costly", "litigation", "and", "the", "diversion", "of", "management", "s", "attention", "and", "resources."], "wordsB": ["Fewer", "than", "1", "in", "10", "patients", "say", "they", "are", "satisfied", "with", "available", "IBS", "treatments."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p4_s0", "idA": "1347613_12_item1_p56_s3", "sentA": "As a result of such disputes, we may have to develop costly non-infringing technology or enter into licensing agreements.", "sentB": "Today there are few available therapies for CIC and IBS-C, with diarrhea and nausea common side effects of such therapies.", "type": 1, "words": ["<tag1>", "As", "a", "result", "of", "such", "disputes,", "we", "may", "have", "to", "develop", "costly", "non-infringing", "technology", "or", "enter", "into", "licensing", "agreements.", "<tag2>", "Today", "there", "are", "few", "available", "therapies", "for", "CIC", "and", "IBS-C,", "with", "diarrhea", "and", "nausea", "common", "side", "effects", "of", "such", "therapies.", "<tag3>"], "wordsA": ["As", "a", "result", "of", "such", "disputes,", "we", "may", "have", "to", "develop", "costly", "non-infringing", "technology", "or", "enter", "into", "licensing", "agreements."], "wordsB": ["Today", "there", "are", "few", "available", "therapies", "for", "CIC", "and", "IBS-C,", "with", "diarrhea", "and", "nausea", "common", "side", "effects", "of", "such", "therapies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p20_s0", "idA": "1347613_12_item1_p5_s0", "sentA": "Patients will be treated with one of three doses of plecanatide (0.3, 1.0 or 3.0 mg) or placebo taken once daily over a period of 12 weeks.", "sentB": "During the 12 week treatment period patients were seen every 4 weeks.", "type": 1, "words": ["<tag1>", "Patients", "will", "be", "treated", "with", "one", "of", "three", "doses", "of", "plecanatide", "(0.3,", "1.0", "or", "3.0", "mg)", "or", "placebo", "taken", "once", "daily", "over", "a", "period", "of", "12", "weeks.", "<tag2>", "During", "the", "12", "week", "treatment", "period", "patients", "were", "seen", "every", "4", "weeks.", "<tag3>"], "wordsA": ["Patients", "will", "be", "treated", "with", "one", "of", "three", "doses", "of", "plecanatide", "(0.3,", "1.0", "or", "3.0", "mg)", "or", "placebo", "taken", "once", "daily", "over", "a", "period", "of", "12", "weeks."], "wordsB": ["During", "the", "12", "week", "treatment", "period", "patients", "were", "seen", "every", "4", "weeks."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p25_s1", "idA": "1347613_12_item1_p6_s0", "sentA": "The study s primary objective is the measure of CSBMs using a responder analysis.", "sentB": "IBS-C is the subtype plecanatide is being developed to treat.", "type": 1, "words": ["<tag1>", "The", "study", "s", "primary", "objective", "is", "the", "measure", "of", "CSBMs", "using", "a", "responder", "analysis.", "<tag2>", "IBS-C", "is", "the", "subtype", "plecanatide", "is", "being", "developed", "to", "treat.", "<tag3>"], "wordsA": ["The", "study", "s", "primary", "objective", "is", "the", "measure", "of", "CSBMs", "using", "a", "responder", "analysis."], "wordsB": ["IBS-C", "is", "the", "subtype", "plecanatide", "is", "being", "developed", "to", "treat."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p19_s0", "idA": "1347613_12_item1_p7_s0", "sentA": "In September, 2010 we completed a Phase 2a randomized, double-blind, placebo-controlled, 14-day repeat, oral, dose-ranging clinical trial of plecanatide in patients with CC.", "sentB": "The large multicenter study was a randomized, 12-week, double-blind, placebo-controlled, dose-ranging study.", "type": 1, "words": ["<tag1>", "In", "September,", "2010", "we", "completed", "a", "Phase", "2a", "randomized,", "double-blind,", "placebo-controlled,", "14-day", "repeat,", "oral,", "dose-ranging", "clinical", "trial", "of", "plecanatide", "in", "patients", "with", "CC.", "<tag2>", "The", "large", "multicenter", "study", "was", "a", "randomized,", "12-week,", "double-blind,", "placebo-controlled,", "dose-ranging", "study.", "<tag3>"], "wordsA": ["In", "September,", "2010", "we", "completed", "a", "Phase", "2a", "randomized,", "double-blind,", "placebo-controlled,", "14-day", "repeat,", "oral,", "dose-ranging", "clinical", "trial", "of", "plecanatide", "in", "patients", "with", "CC."], "wordsB": ["The", "large", "multicenter", "study", "was", "a", "randomized,", "12-week,", "double-blind,", "placebo-controlled,", "dose-ranging", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p19_s1", "idA": "1347613_12_item1_p7_s0", "sentA": "In September, 2010 we completed a Phase 2a randomized, double-blind, placebo-controlled, 14-day repeat, oral, dose-ranging clinical trial of plecanatide in patients with CC.", "sentB": "Patients completed a screening visit and a 2-week pre-treatment period to train on study procedures and establish a baseline for each patient.", "type": 1, "words": ["<tag1>", "In", "September,", "2010", "we", "completed", "a", "Phase", "2a", "randomized,", "double-blind,", "placebo-controlled,", "14-day", "repeat,", "oral,", "dose-ranging", "clinical", "trial", "of", "plecanatide", "in", "patients", "with", "CC.", "<tag2>", "Patients", "completed", "a", "screening", "visit", "and", "a", "2-week", "pre-treatment", "period", "to", "train", "on", "study", "procedures", "and", "establish", "a", "baseline", "for", "each", "patient.", "<tag3>"], "wordsA": ["In", "September,", "2010", "we", "completed", "a", "Phase", "2a", "randomized,", "double-blind,", "placebo-controlled,", "14-day", "repeat,", "oral,", "dose-ranging", "clinical", "trial", "of", "plecanatide", "in", "patients", "with", "CC."], "wordsB": ["Patients", "completed", "a", "screening", "visit", "and", "a", "2-week", "pre-treatment", "period", "to", "train", "on", "study", "procedures", "and", "establish", "a", "baseline", "for", "each", "patient."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p18_s1", "idA": "1347613_12_item1_p7_s2", "sentA": "The trial utilized 78 evaluable patients at 14 sites in the United States.", "sentB": "We intend to present full study results at a major scientific meeting in the second quarter of 2013.", "type": 1, "words": ["<tag1>", "The", "trial", "utilized", "78", "evaluable", "patients", "at", "14", "sites", "in", "the", "United", "States.", "<tag2>", "We", "intend", "to", "present", "full", "study", "results", "at", "a", "major", "scientific", "meeting", "in", "the", "second", "quarter", "of", "2013.", "<tag3>"], "wordsA": ["The", "trial", "utilized", "78", "evaluable", "patients", "at", "14", "sites", "in", "the", "United", "States."], "wordsB": ["We", "intend", "to", "present", "full", "study", "results", "at", "a", "major", "scientific", "meeting", "in", "the", "second", "quarter", "of", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p10_s1", "idA": "1347613_12_item1_p7_s4", "sentA": "The secondary objectives of this clinical trial were to assess the pharmacokinetic profile of plecanatide and to assess bowel function, including time to first bowel movement, frequency, completeness of evacuation, stool consistency, straining and abdominal discomfort, after treatment with plecanatide.", "sentB": "The LOI contemplates a low single digit royalty on net sales of plecanatide and both parties agreed not to challenge each other s patents covering certain GC-C agonists, with the exception that we retain the right to challenge Ironwood s method of use patent on plecanatide.", "type": 1, "words": ["<tag1>", "The", "secondary", "objectives", "of", "this", "clinical", "trial", "were", "to", "assess", "the", "pharmacokinetic", "profile", "of", "plecanatide", "and", "to", "assess", "bowel", "function,", "including", "time", "to", "first", "bowel", "movement,", "frequency,", "completeness", "of", "evacuation,", "stool", "consistency,", "straining", "and", "abdominal", "discomfort,", "after", "treatment", "with", "plecanatide.", "<tag2>", "The", "LOI", "contemplates", "a", "low", "single", "digit", "royalty", "on", "net", "sales", "of", "plecanatide", "and", "both", "parties", "agreed", "not", "to", "challenge", "each", "other", "s", "patents", "covering", "certain", "GC-C", "agonists,", "with", "the", "exception", "that", "we", "retain", "the", "right", "to", "challenge", "Ironwood", "s", "method", "of", "use", "patent", "on", "plecanatide.", "<tag3>"], "wordsA": ["The", "secondary", "objectives", "of", "this", "clinical", "trial", "were", "to", "assess", "the", "pharmacokinetic", "profile", "of", "plecanatide", "and", "to", "assess", "bowel", "function,", "including", "time", "to", "first", "bowel", "movement,", "frequency,", "completeness", "of", "evacuation,", "stool", "consistency,", "straining", "and", "abdominal", "discomfort,", "after", "treatment", "with", "plecanatide."], "wordsB": ["The", "LOI", "contemplates", "a", "low", "single", "digit", "royalty", "on", "net", "sales", "of", "plecanatide", "and", "both", "parties", "agreed", "not", "to", "challenge", "each", "other", "s", "patents", "covering", "certain", "GC-C", "agonists,", "with", "the", "exception", "that", "we", "retain", "the", "right", "to", "challenge", "Ironwood", "s", "method", "of", "use", "patent", "on", "plecanatide."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p82_s1", "idA": "1347613_12_item1_p7_s4", "sentA": "The secondary objectives of this clinical trial were to assess the pharmacokinetic profile of plecanatide and to assess bowel function, including time to first bowel movement, frequency, completeness of evacuation, stool consistency, straining and abdominal discomfort, after treatment with plecanatide.", "sentB": "The LOI contemplates a low single digit royalty on net sales of plecanatide and both parties agreed not to challenge each other s patents covering certain GC-C agonists, with the exception that we retain the right to challenge Ironwood s method of use patent on plecanatide.", "type": 1, "words": ["<tag1>", "The", "secondary", "objectives", "of", "this", "clinical", "trial", "were", "to", "assess", "the", "pharmacokinetic", "profile", "of", "plecanatide", "and", "to", "assess", "bowel", "function,", "including", "time", "to", "first", "bowel", "movement,", "frequency,", "completeness", "of", "evacuation,", "stool", "consistency,", "straining", "and", "abdominal", "discomfort,", "after", "treatment", "with", "plecanatide.", "<tag2>", "The", "LOI", "contemplates", "a", "low", "single", "digit", "royalty", "on", "net", "sales", "of", "plecanatide", "and", "both", "parties", "agreed", "not", "to", "challenge", "each", "other", "s", "patents", "covering", "certain", "GC-C", "agonists,", "with", "the", "exception", "that", "we", "retain", "the", "right", "to", "challenge", "Ironwood", "s", "method", "of", "use", "patent", "on", "plecanatide.", "<tag3>"], "wordsA": ["The", "secondary", "objectives", "of", "this", "clinical", "trial", "were", "to", "assess", "the", "pharmacokinetic", "profile", "of", "plecanatide", "and", "to", "assess", "bowel", "function,", "including", "time", "to", "first", "bowel", "movement,", "frequency,", "completeness", "of", "evacuation,", "stool", "consistency,", "straining", "and", "abdominal", "discomfort,", "after", "treatment", "with", "plecanatide."], "wordsB": ["The", "LOI", "contemplates", "a", "low", "single", "digit", "royalty", "on", "net", "sales", "of", "plecanatide", "and", "both", "parties", "agreed", "not", "to", "challenge", "each", "other", "s", "patents", "covering", "certain", "GC-C", "agonists,", "with", "the", "exception", "that", "we", "retain", "the", "right", "to", "challenge", "Ironwood", "s", "method", "of", "use", "patent", "on", "plecanatide."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p30_s2", "idA": "1347613_12_item1_p8_s0", "sentA": "In this clinical trial we enrolled patients that met the modified Rome III criteria of CC, a standard patient assessment tool used in the diagnosis of patients with CC.", "sentB": "To qualify for enrollment patients must meet the Rome III criteria for IBS-C as modified for this study.", "type": 1, "words": ["<tag1>", "In", "this", "clinical", "trial", "we", "enrolled", "patients", "that", "met", "the", "modified", "Rome", "III", "criteria", "of", "CC,", "a", "standard", "patient", "assessment", "tool", "used", "in", "the", "diagnosis", "of", "patients", "with", "CC.", "<tag2>", "To", "qualify", "for", "enrollment", "patients", "must", "meet", "the", "Rome", "III", "criteria", "for", "IBS-C", "as", "modified", "for", "this", "study.", "<tag3>"], "wordsA": ["In", "this", "clinical", "trial", "we", "enrolled", "patients", "that", "met", "the", "modified", "Rome", "III", "criteria", "of", "CC,", "a", "standard", "patient", "assessment", "tool", "used", "in", "the", "diagnosis", "of", "patients", "with", "CC."], "wordsB": ["To", "qualify", "for", "enrollment", "patients", "must", "meet", "the", "Rome", "III", "criteria", "for", "IBS-C", "as", "modified", "for", "this", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_13_item1_p7_s0", "idA": "1347613_12_item1_p9_s0", "sentA": "reported less than six simultaneous bowel movements, or SBMs, and less than three complete SBMs, or CSBMs, in each week during the 14-days before treatment with plecanatide or placebo.", "sentB": "Patients with CIC have had symptoms for 6 months or more and commonly have less than 3 bowel movements a week and often less than one.", "type": 1, "words": ["<tag1>", "reported", "less", "than", "six", "simultaneous", "bowel", "movements,", "or", "SBMs,", "and", "less", "than", "three", "complete", "SBMs,", "or", "CSBMs,", "in", "each", "week", "during", "the", "14-days", "before", "treatment", "with", "plecanatide", "or", "placebo.", "<tag2>", "Patients", "with", "CIC", "have", "had", "symptoms", "for", "6", "months", "or", "more", "and", "commonly", "have", "less", "than", "3", "bowel", "movements", "a", "week", "and", "often", "less", "than", "one.", "<tag3>"], "wordsA": ["reported", "less", "than", "six", "simultaneous", "bowel", "movements,", "or", "SBMs,", "and", "less", "than", "three", "complete", "SBMs,", "or", "CSBMs,", "in", "each", "week", "during", "the", "14-days", "before", "treatment", "with", "plecanatide", "or", "placebo."], "wordsB": ["Patients", "with", "CIC", "have", "had", "symptoms", "for", "6", "months", "or", "more", "and", "commonly", "have", "less", "than", "3", "bowel", "movements", "a", "week", "and", "often", "less", "than", "one."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p23_s1", "idA": "1347613_13_item1_p14_s0", "sentA": "Patients in this clinical trial received placebo or plecanatide once-daily in the morning for 14 consecutive days at oral doses of 0.3 mg, 1.0 mg, 3.0 mg or 9.0 mg, respectively.", "sentB": "The multi-center, randomized, double-blind clinical trial will compare a 4-week, dose-ranging regimen of SP-333 (1.0, 3.0 and 6.0mg) against placebo in adult patients taking opioid analgesics for chronic, non-cancer pain for at least three months.", "type": 1, "words": ["<tag1>", "Patients", "in", "this", "clinical", "trial", "received", "placebo", "or", "plecanatide", "once-daily", "in", "the", "morning", "for", "14", "consecutive", "days", "at", "oral", "doses", "of", "0.3", "mg,", "1.0", "mg,", "3.0", "mg", "or", "9.0", "mg,", "respectively.", "<tag2>", "The", "multi-center,", "randomized,", "double-blind", "clinical", "trial", "will", "compare", "a", "4-week,", "dose-ranging", "regimen", "of", "SP-333", "(1.0,", "3.0", "and", "6.0mg)", "against", "placebo", "in", "adult", "patients", "taking", "opioid", "analgesics", "for", "chronic,", "non-cancer", "pain", "for", "at", "least", "three", "months.", "<tag3>"], "wordsA": ["Patients", "in", "this", "clinical", "trial", "received", "placebo", "or", "plecanatide", "once-daily", "in", "the", "morning", "for", "14", "consecutive", "days", "at", "oral", "doses", "of", "0.3", "mg,", "1.0", "mg,", "3.0", "mg", "or", "9.0", "mg,", "respectively."], "wordsB": ["The", "multi-center,", "randomized,", "double-blind", "clinical", "trial", "will", "compare", "a", "4-week,", "dose-ranging", "regimen", "of", "SP-333", "(1.0,", "3.0", "and", "6.0mg)", "against", "placebo", "in", "adult", "patients", "taking", "opioid", "analgesics", "for", "chronic,", "non-cancer", "pain", "for", "at", "least", "three", "months."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p22_s1", "idA": "1347613_13_item1_p19_s0", "sentA": "The large multicenter study was a randomized, 12-week, double-blind, placebo-controlled, dose-ranging study.", "sentB": "The phase 2 trial is designed as a dose-ranging study to evaluate a 4-week regimen of SP-333, a once daily oral treatment, in adult patients taking opioid analgesics for chronic, non-cancer pain for at least three months.", "type": 1, "words": ["<tag1>", "The", "large", "multicenter", "study", "was", "a", "randomized,", "12-week,", "double-blind,", "placebo-controlled,", "dose-ranging", "study.", "<tag2>", "The", "phase", "2", "trial", "is", "designed", "as", "a", "dose-ranging", "study", "to", "evaluate", "a", "4-week", "regimen", "of", "SP-333,", "a", "once", "daily", "oral", "treatment,", "in", "adult", "patients", "taking", "opioid", "analgesics", "for", "chronic,", "non-cancer", "pain", "for", "at", "least", "three", "months.", "<tag3>"], "wordsA": ["The", "large", "multicenter", "study", "was", "a", "randomized,", "12-week,", "double-blind,", "placebo-controlled,", "dose-ranging", "study."], "wordsB": ["The", "phase", "2", "trial", "is", "designed", "as", "a", "dose-ranging", "study", "to", "evaluate", "a", "4-week", "regimen", "of", "SP-333,", "a", "once", "daily", "oral", "treatment,", "in", "adult", "patients", "taking", "opioid", "analgesics", "for", "chronic,", "non-cancer", "pain", "for", "at", "least", "three", "months."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p27_s2", "idA": "1347613_13_item1_p35_s0", "sentA": "There is currently no medical cure for UC.", "sentB": "The Note bears interest at six percent (6%) per annum.", "type": 1, "words": ["<tag1>", "There", "is", "currently", "no", "medical", "cure", "for", "UC.", "<tag2>", "The", "Note", "bears", "interest", "at", "six", "percent", "(6%)", "per", "annum.", "<tag3>"], "wordsA": ["There", "is", "currently", "no", "medical", "cure", "for", "UC."], "wordsB": ["The", "Note", "bears", "interest", "at", "six", "percent", "(6%)", "per", "annum."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p28_s0", "idA": "1347613_13_item1_p42_s0", "sentA": "On July 20, 2012, we entered into an Agreement and Plan of Merger (the Merger Agreement ) with Callisto Pharmaceuticals, Inc., or Callisto, as amended on October 15, 2012.", "sentB": "On July 8, 2013, ContraVir entered into a Shared Services Agreement with us, effective May 16, 2013.", "type": 1, "words": ["<tag1>", "On", "July", "20,", "2012,", "we", "entered", "into", "an", "Agreement", "and", "Plan", "of", "Merger", "(the", "Merger", "Agreement", ")", "with", "Callisto", "Pharmaceuticals,", "Inc.,", "or", "Callisto,", "as", "amended", "on", "October", "15,", "2012.", "<tag2>", "On", "July", "8,", "2013,", "ContraVir", "entered", "into", "a", "Shared", "Services", "Agreement", "with", "us,", "effective", "May", "16,", "2013.", "<tag3>"], "wordsA": ["On", "July", "20,", "2012,", "we", "entered", "into", "an", "Agreement", "and", "Plan", "of", "Merger", "(the", "Merger", "Agreement", ")", "with", "Callisto", "Pharmaceuticals,", "Inc.,", "or", "Callisto,", "as", "amended", "on", "October", "15,", "2012."], "wordsB": ["On", "July", "8,", "2013,", "ContraVir", "entered", "into", "a", "Shared", "Services", "Agreement", "with", "us,", "effective", "May", "16,", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p46_s3", "idA": "1347613_13_item1_p43_s0", "sentA": "On January 17, 2013, we completed our acquisition of Callisto, pursuant to the Merger Agreement, as amended.", "sentB": "BMS assumed the obligations under the Cardiff agreement from Inhibitex upon its acquisition of Inhibitex in January 2012.", "type": 1, "words": ["<tag1>", "On", "January", "17,", "2013,", "we", "completed", "our", "acquisition", "of", "Callisto,", "pursuant", "to", "the", "Merger", "Agreement,", "as", "amended.", "<tag2>", "BMS", "assumed", "the", "obligations", "under", "the", "Cardiff", "agreement", "from", "Inhibitex", "upon", "its", "acquisition", "of", "Inhibitex", "in", "January", "2012.", "<tag3>"], "wordsA": ["On", "January", "17,", "2013,", "we", "completed", "our", "acquisition", "of", "Callisto,", "pursuant", "to", "the", "Merger", "Agreement,", "as", "amended."], "wordsB": ["BMS", "assumed", "the", "obligations", "under", "the", "Cardiff", "agreement", "from", "Inhibitex", "upon", "its", "acquisition", "of", "Inhibitex", "in", "January", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p47_s0", "idA": "1347613_13_item1_p43_s0", "sentA": "On January 17, 2013, we completed our acquisition of Callisto, pursuant to the Merger Agreement, as amended.", "sentB": "Agreement upon its acquisition of FermaVir Pharmaceuticals, Inc. in September 2010.", "type": 1, "words": ["<tag1>", "On", "January", "17,", "2013,", "we", "completed", "our", "acquisition", "of", "Callisto,", "pursuant", "to", "the", "Merger", "Agreement,", "as", "amended.", "<tag2>", "Agreement", "upon", "its", "acquisition", "of", "FermaVir", "Pharmaceuticals,", "Inc.", "in", "September", "2010.", "<tag3>"], "wordsA": ["On", "January", "17,", "2013,", "we", "completed", "our", "acquisition", "of", "Callisto,", "pursuant", "to", "the", "Merger", "Agreement,", "as", "amended."], "wordsB": ["Agreement", "upon", "its", "acquisition", "of", "FermaVir", "Pharmaceuticals,", "Inc.", "in", "September", "2010."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p26_s2", "idA": "1347613_13_item1_p46_s0", "sentA": "On January 17, 2013, the effective date of the merger, we accounted for the merger by assuming Callisto s net liabilities, of approximately $1.7 million, principally trade payables.", "sentB": "The contribution of this asset was accounted for at our net book value which was zero.", "type": 1, "words": ["<tag1>", "On", "January", "17,", "2013,", "the", "effective", "date", "of", "the", "merger,", "we", "accounted", "for", "the", "merger", "by", "assuming", "Callisto", "s", "net", "liabilities,", "of", "approximately", "$1.7", "million,", "principally", "trade", "payables.", "<tag2>", "The", "contribution", "of", "this", "asset", "was", "accounted", "for", "at", "our", "net", "book", "value", "which", "was", "zero.", "<tag3>"], "wordsA": ["On", "January", "17,", "2013,", "the", "effective", "date", "of", "the", "merger,", "we", "accounted", "for", "the", "merger", "by", "assuming", "Callisto", "s", "net", "liabilities,", "of", "approximately", "$1.7", "million,", "principally", "trade", "payables."], "wordsB": ["The", "contribution", "of", "this", "asset", "was", "accounted", "for", "at", "our", "net", "book", "value", "which", "was", "zero."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p46_s0", "idA": "1347613_13_item1_p49_s0", "sentA": "FDA review and approval of the NDA.", "sentB": "Cardiff and Rega Foundation ( Rega ) were originally the joint owners of the Patent Rights.", "type": 1, "words": ["<tag1>", "FDA", "review", "and", "approval", "of", "the", "NDA.", "<tag2>", "Cardiff", "and", "Rega", "Foundation", "(", "Rega", ")", "were", "originally", "the", "joint", "owners", "of", "the", "Patent", "Rights.", "<tag3>"], "wordsA": ["FDA", "review", "and", "approval", "of", "the", "NDA."], "wordsB": ["Cardiff", "and", "Rega", "Foundation", "(", "Rega", ")", "were", "originally", "the", "joint", "owners", "of", "the", "Patent", "Rights."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p27_s4", "idA": "1347613_13_item1_p52_s1", "sentA": "Phase 2 usually involves studies in a limited patient population (individuals with the disease under study) to:", "sentB": "In connection with the Loan Agreement, ContraVir granted us a security interest in all of its assets, including its intellectual property, until the Note is repaid in full.", "type": 1, "words": ["<tag1>", "Phase", "2", "usually", "involves", "studies", "in", "a", "limited", "patient", "population", "(individuals", "with", "the", "disease", "under", "study)", "to:", "<tag2>", "In", "connection", "with", "the", "Loan", "Agreement,", "ContraVir", "granted", "us", "a", "security", "interest", "in", "all", "of", "its", "assets,", "including", "its", "intellectual", "property,", "until", "the", "Note", "is", "repaid", "in", "full.", "<tag3>"], "wordsA": ["Phase", "2", "usually", "involves", "studies", "in", "a", "limited", "patient", "population", "(individuals", "with", "the", "disease", "under", "study)", "to:"], "wordsB": ["In", "connection", "with", "the", "Loan", "Agreement,", "ContraVir", "granted", "us", "a", "security", "interest", "in", "all", "of", "its", "assets,", "including", "its", "intellectual", "property,", "until", "the", "Note", "is", "repaid", "in", "full."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p47_s1", "idA": "1347613_13_item1_p52_s1", "sentA": "Phase 2 usually involves studies in a limited patient population (individuals with the disease under study) to:", "sentB": "FermaVir was the successor to CRI in a merger consummated in August 2005.", "type": 1, "words": ["<tag1>", "Phase", "2", "usually", "involves", "studies", "in", "a", "limited", "patient", "population", "(individuals", "with", "the", "disease", "under", "study)", "to:", "<tag2>", "FermaVir", "was", "the", "successor", "to", "CRI", "in", "a", "merger", "consummated", "in", "August", "2005.", "<tag3>"], "wordsA": ["Phase", "2", "usually", "involves", "studies", "in", "a", "limited", "patient", "population", "(individuals", "with", "the", "disease", "under", "study)", "to:"], "wordsB": ["FermaVir", "was", "the", "successor", "to", "CRI", "in", "a", "merger", "consummated", "in", "August", "2005."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p46_s1", "idA": "1347613_13_item1_p57_s0", "sentA": "The results of the preclinical and clinical studies, together with other detailed information, including the manufacture and composition of the product candidate, are submitted to the FDA in the form of an NDA requesting approval to market the drug.", "sentB": "Pursuant to the terms of an agreement, dated September 24, 1998, as amended December 23, 2004, Cardiff received from Rega an exclusive, irrevocable worldwide license to manufacture, use, sell, or otherwise deal in or with products utilizing the Patent Rights, including the right to grant sublicenses thereunder.", "type": 1, "words": ["<tag1>", "The", "results", "of", "the", "preclinical", "and", "clinical", "studies,", "together", "with", "other", "detailed", "information,", "including", "the", "manufacture", "and", "composition", "of", "the", "product", "candidate,", "are", "submitted", "to", "the", "FDA", "in", "the", "form", "of", "an", "NDA", "requesting", "approval", "to", "market", "the", "drug.", "<tag2>", "Pursuant", "to", "the", "terms", "of", "an", "agreement,", "dated", "September", "24,", "1998,", "as", "amended", "December", "23,", "2004,", "Cardiff", "received", "from", "Rega", "an", "exclusive,", "irrevocable", "worldwide", "license", "to", "manufacture,", "use,", "sell,", "or", "otherwise", "deal", "in", "or", "with", "products", "utilizing", "the", "Patent", "Rights,", "including", "the", "right", "to", "grant", "sublicenses", "thereunder.", "<tag3>"], "wordsA": ["The", "results", "of", "the", "preclinical", "and", "clinical", "studies,", "together", "with", "other", "detailed", "information,", "including", "the", "manufacture", "and", "composition", "of", "the", "product", "candidate,", "are", "submitted", "to", "the", "FDA", "in", "the", "form", "of", "an", "NDA", "requesting", "approval", "to", "market", "the", "drug."], "wordsB": ["Pursuant", "to", "the", "terms", "of", "an", "agreement,", "dated", "September", "24,", "1998,", "as", "amended", "December", "23,", "2004,", "Cardiff", "received", "from", "Rega", "an", "exclusive,", "irrevocable", "worldwide", "license", "to", "manufacture,", "use,", "sell,", "or", "otherwise", "deal", "in", "or", "with", "products", "utilizing", "the", "Patent", "Rights,", "including", "the", "right", "to", "grant", "sublicenses", "thereunder."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p27_s5", "idA": "1347613_13_item1_p63_s2", "sentA": "The manufacturing facilities for our products must meet GMP requirements to the satisfaction of the FDA pursuant to a pre-approval inspection before we can use them to manufacture our products.", "sentB": "On October 3, 2013, our Board of Directors unanimously approved an increase in this lending facility to a total of $1,000,000.", "type": 1, "words": ["<tag1>", "The", "manufacturing", "facilities", "for", "our", "products", "must", "meet", "GMP", "requirements", "to", "the", "satisfaction", "of", "the", "FDA", "pursuant", "to", "a", "pre-approval", "inspection", "before", "we", "can", "use", "them", "to", "manufacture", "our", "products.", "<tag2>", "On", "October", "3,", "2013,", "our", "Board", "of", "Directors", "unanimously", "approved", "an", "increase", "in", "this", "lending", "facility", "to", "a", "total", "of", "$1,000,000.", "<tag3>"], "wordsA": ["The", "manufacturing", "facilities", "for", "our", "products", "must", "meet", "GMP", "requirements", "to", "the", "satisfaction", "of", "the", "FDA", "pursuant", "to", "a", "pre-approval", "inspection", "before", "we", "can", "use", "them", "to", "manufacture", "our", "products."], "wordsB": ["On", "October", "3,", "2013,", "our", "Board", "of", "Directors", "unanimously", "approved", "an", "increase", "in", "this", "lending", "facility", "to", "a", "total", "of", "$1,000,000."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p27_s3", "idA": "1347613_13_item1_p68_s0", "sentA": "Adverse event reporting and submission of periodic reports is required following FDA approval of an NDA.", "sentB": "The Note matures on the earlier of June 10, 2014 or the date that the entire principal amount and interest shall become due and payable by reason of an event of default under the Note or otherwise.", "type": 1, "words": ["<tag1>", "Adverse", "event", "reporting", "and", "submission", "of", "periodic", "reports", "is", "required", "following", "FDA", "approval", "of", "an", "NDA.", "<tag2>", "The", "Note", "matures", "on", "the", "earlier", "of", "June", "10,", "2014", "or", "the", "date", "that", "the", "entire", "principal", "amount", "and", "interest", "shall", "become", "due", "and", "payable", "by", "reason", "of", "an", "event", "of", "default", "under", "the", "Note", "or", "otherwise.", "<tag3>"], "wordsA": ["Adverse", "event", "reporting", "and", "submission", "of", "periodic", "reports", "is", "required", "following", "FDA", "approval", "of", "an", "NDA."], "wordsB": ["The", "Note", "matures", "on", "the", "earlier", "of", "June", "10,", "2014", "or", "the", "date", "that", "the", "entire", "principal", "amount", "and", "interest", "shall", "become", "due", "and", "payable", "by", "reason", "of", "an", "event", "of", "default", "under", "the", "Note", "or", "otherwise."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p48_s6", "idA": "1347613_13_item1_p81_s3", "sentA": "In addition we have 37 granted foreign patents which cover composition-of-matter of FV-100 and expire in 2027.", "sentB": "ContraVir also currently owns 6 foreign applications and 1 pending US application which cover the FV-100 process and polymorph.", "type": 1, "words": ["<tag1>", "In", "addition", "we", "have", "37", "granted", "foreign", "patents", "which", "cover", "composition-of-matter", "of", "FV-100", "and", "expire", "in", "2027.", "<tag2>", "ContraVir", "also", "currently", "owns", "6", "foreign", "applications", "and", "1", "pending", "US", "application", "which", "cover", "the", "FV-100", "process", "and", "polymorph.", "<tag3>"], "wordsA": ["In", "addition", "we", "have", "37", "granted", "foreign", "patents", "which", "cover", "composition-of-matter", "of", "FV-100", "and", "expire", "in", "2027."], "wordsB": ["ContraVir", "also", "currently", "owns", "6", "foreign", "applications", "and", "1", "pending", "US", "application", "which", "cover", "the", "FV-100", "process", "and", "polymorph."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p25_s0", "idA": "1347613_13_item1_p86_s0", "sentA": "As of March 18, 2013, we had 18 full-time employees.", "sentB": "On May 15, 2013, we formed ContraVir Pharmaceuticals, Inc. (ContraVir), a Delaware corporation, for the purpose of developing the FV-100 asset.", "type": 1, "words": ["<tag1>", "As", "of", "March", "18,", "2013,", "we", "had", "18", "full-time", "employees.", "<tag2>", "On", "May", "15,", "2013,", "we", "formed", "ContraVir", "Pharmaceuticals,", "Inc.", "(ContraVir),", "a", "Delaware", "corporation,", "for", "the", "purpose", "of", "developing", "the", "FV-100", "asset.", "<tag3>"], "wordsA": ["As", "of", "March", "18,", "2013,", "we", "had", "18", "full-time", "employees."], "wordsB": ["On", "May", "15,", "2013,", "we", "formed", "ContraVir", "Pharmaceuticals,", "Inc.", "(ContraVir),", "a", "Delaware", "corporation,", "for", "the", "purpose", "of", "developing", "the", "FV-100", "asset."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p45_s0", "idA": "1347613_13_item1_p86_s0", "sentA": "As of March 18, 2013, we had 18 full-time employees.", "sentB": "During 2013, we transferred ownership of all FV-100 intellectual property rights we acquired from Bristol-Meyers Squibb Company ( BMS ) in August 2012, to a newly formed wholly owned subsidiary, ContraVir Pharmaceuticals, Inc.( ContraVir ).", "type": 1, "words": ["<tag1>", "As", "of", "March", "18,", "2013,", "we", "had", "18", "full-time", "employees.", "<tag2>", "During", "2013,", "we", "transferred", "ownership", "of", "all", "FV-100", "intellectual", "property", "rights", "we", "acquired", "from", "Bristol-Meyers", "Squibb", "Company", "(", "BMS", ")", "in", "August", "2012,", "to", "a", "newly", "formed", "wholly", "owned", "subsidiary,", "ContraVir", "Pharmaceuticals,", "Inc.(", "ContraVir", ").", "<tag3>"], "wordsA": ["As", "of", "March", "18,", "2013,", "we", "had", "18", "full-time", "employees."], "wordsB": ["During", "2013,", "we", "transferred", "ownership", "of", "all", "FV-100", "intellectual", "property", "rights", "we", "acquired", "from", "Bristol-Meyers", "Squibb", "Company", "(", "BMS", ")", "in", "August", "2012,", "to", "a", "newly", "formed", "wholly", "owned", "subsidiary,", "ContraVir", "Pharmaceuticals,", "Inc.(", "ContraVir", ")."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p8_s1", "idA": "1347613_13_item1_p86_s0", "sentA": "As of March 18, 2013, we had 18 full-time employees.", "sentB": "On May 15, 2013, at Digestive Disease Week 2013, we presented a late-breaking abstract, the title of which is: Plecanatide, a Novel Guanylate Cyclase C (GC-C) Receptor Agonist, is Efficacious and Safe in Patients with Chronic Idiopathic Constipation (CIC): Results from a 951-Patient, 12-Week, Multi-Center Trial.", "type": 1, "words": ["<tag1>", "As", "of", "March", "18,", "2013,", "we", "had", "18", "full-time", "employees.", "<tag2>", "On", "May", "15,", "2013,", "at", "Digestive", "Disease", "Week", "2013,", "we", "presented", "a", "late-breaking", "abstract,", "the", "title", "of", "which", "is:", "Plecanatide,", "a", "Novel", "Guanylate", "Cyclase", "C", "(GC-C)", "Receptor", "Agonist,", "is", "Efficacious", "and", "Safe", "in", "Patients", "with", "Chronic", "Idiopathic", "Constipation", "(CIC):", "Results", "from", "a", "951-Patient,", "12-Week,", "Multi-Center", "Trial.", "<tag3>"], "wordsA": ["As", "of", "March", "18,", "2013,", "we", "had", "18", "full-time", "employees."], "wordsB": ["On", "May", "15,", "2013,", "at", "Digestive", "Disease", "Week", "2013,", "we", "presented", "a", "late-breaking", "abstract,", "the", "title", "of", "which", "is:", "Plecanatide,", "a", "Novel", "Guanylate", "Cyclase", "C", "(GC-C)", "Receptor", "Agonist,", "is", "Efficacious", "and", "Safe", "in", "Patients", "with", "Chronic", "Idiopathic", "Constipation", "(CIC):", "Results", "from", "a", "951-Patient,", "12-Week,", "Multi-Center", "Trial."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_14_item1_p28_s1", "idA": "1347613_13_item1_p88_s0", "sentA": "We make available free of charge through our website our Securities and Exchange Commission, or SEC, filings furnished pursuant to Section 13(a) or 15(d) of the Exchange Act as soon as reasonably practicable after we electronically file such material with, or furnish it to, the SEC.", "sentB": "Under the Shared Services Agreement, we will provide and/or make available to ContraVir various administrative, financial (including payroll functions), legal, insurance, facility, information technology, laboratory, real estate and other services to be provided by, or on behalf of, us, together with such other services as reasonably requested by ContraVir.", "type": 1, "words": ["<tag1>", "We", "make", "available", "free", "of", "charge", "through", "our", "website", "our", "Securities", "and", "Exchange", "Commission,", "or", "SEC,", "filings", "furnished", "pursuant", "to", "Section", "13(a)", "or", "15(d)", "of", "the", "Exchange", "Act", "as", "soon", "as", "reasonably", "practicable", "after", "we", "electronically", "file", "such", "material", "with,", "or", "furnish", "it", "to,", "the", "SEC.", "<tag2>", "Under", "the", "Shared", "Services", "Agreement,", "we", "will", "provide", "and/or", "make", "available", "to", "ContraVir", "various", "administrative,", "financial", "(including", "payroll", "functions),", "legal,", "insurance,", "facility,", "information", "technology,", "laboratory,", "real", "estate", "and", "other", "services", "to", "be", "provided", "by,", "or", "on", "behalf", "of,", "us,", "together", "with", "such", "other", "services", "as", "reasonably", "requested", "by", "ContraVir.", "<tag3>"], "wordsA": ["We", "make", "available", "free", "of", "charge", "through", "our", "website", "our", "Securities", "and", "Exchange", "Commission,", "or", "SEC,", "filings", "furnished", "pursuant", "to", "Section", "13(a)", "or", "15(d)", "of", "the", "Exchange", "Act", "as", "soon", "as", "reasonably", "practicable", "after", "we", "electronically", "file", "such", "material", "with,", "or", "furnish", "it", "to,", "the", "SEC."], "wordsB": ["Under", "the", "Shared", "Services", "Agreement,", "we", "will", "provide", "and/or", "make", "available", "to", "ContraVir", "various", "administrative,", "financial", "(including", "payroll", "functions),", "legal,", "insurance,", "facility,", "information", "technology,", "laboratory,", "real", "estate", "and", "other", "services", "to", "be", "provided", "by,", "or", "on", "behalf", "of,", "us,", "together", "with", "such", "other", "services", "as", "reasonably", "requested", "by", "ContraVir."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p34_s1", "idA": "1347613_14_item1_p14_s1", "sentA": "A quarter of patients describe their abdominal pain as constant.", "sentB": "Increasing efficacy was also observed at the higher dose range in other key secondary endpoints including overall responder rate (the end point for FDA approval) and abdominal pain responder rate.", "type": 1, "words": ["<tag1>", "A", "quarter", "of", "patients", "describe", "their", "abdominal", "pain", "as", "constant.", "<tag2>", "Increasing", "efficacy", "was", "also", "observed", "at", "the", "higher", "dose", "range", "in", "other", "key", "secondary", "endpoints", "including", "overall", "responder", "rate", "(the", "end", "point", "for", "FDA", "approval)", "and", "abdominal", "pain", "responder", "rate.", "<tag3>"], "wordsA": ["A", "quarter", "of", "patients", "describe", "their", "abdominal", "pain", "as", "constant."], "wordsB": ["Increasing", "efficacy", "was", "also", "observed", "at", "the", "higher", "dose", "range", "in", "other", "key", "secondary", "endpoints", "including", "overall", "responder", "rate", "(the", "end", "point", "for", "FDA", "approval)", "and", "abdominal", "pain", "responder", "rate."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p21_s3", "idA": "1347613_14_item1_p19_s0", "sentA": "On December 24, 2013, we announced that we had closed patient enrollment and expect to report top line data in the second quarter of 2014.", "sentB": "In the fourth quarter of this year, we plan to file our first NDA with FDA for plecanatide in the CIC indication.", "type": 1, "words": ["<tag1>", "On", "December", "24,", "2013,", "we", "announced", "that", "we", "had", "closed", "patient", "enrollment", "and", "expect", "to", "report", "top", "line", "data", "in", "the", "second", "quarter", "of", "2014.", "<tag2>", "In", "the", "fourth", "quarter", "of", "this", "year,", "we", "plan", "to", "file", "our", "first", "NDA", "with", "FDA", "for", "plecanatide", "in", "the", "CIC", "indication.", "<tag3>"], "wordsA": ["On", "December", "24,", "2013,", "we", "announced", "that", "we", "had", "closed", "patient", "enrollment", "and", "expect", "to", "report", "top", "line", "data", "in", "the", "second", "quarter", "of", "2014."], "wordsB": ["In", "the", "fourth", "quarter", "of", "this", "year,", "we", "plan", "to", "file", "our", "first", "NDA", "with", "FDA", "for", "plecanatide", "in", "the", "CIC", "indication."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p4_s1", "idA": "1347613_14_item1_p20_s1", "sentA": "SP-333 is a synthetic analog of uroguanylin, a natriuretic hormone that is normally produced in the body s intestinal tract.", "sentB": "SP-333 is designed to be a highly potent and proteolytically stable analog of the naturally occurring GI peptide, uroguanylin, displaying significant resistance to proteolysis in gastric intestinal fluids.", "type": 1, "words": ["<tag1>", "SP-333", "is", "a", "synthetic", "analog", "of", "uroguanylin,", "a", "natriuretic", "hormone", "that", "is", "normally", "produced", "in", "the", "body", "s", "intestinal", "tract.", "<tag2>", "SP-333", "is", "designed", "to", "be", "a", "highly", "potent", "and", "proteolytically", "stable", "analog", "of", "the", "naturally", "occurring", "GI", "peptide,", "uroguanylin,", "displaying", "significant", "resistance", "to", "proteolysis", "in", "gastric", "intestinal", "fluids.", "<tag3>"], "wordsA": ["SP-333", "is", "a", "synthetic", "analog", "of", "uroguanylin,", "a", "natriuretic", "hormone", "that", "is", "normally", "produced", "in", "the", "body", "s", "intestinal", "tract."], "wordsB": ["SP-333", "is", "designed", "to", "be", "a", "highly", "potent", "and", "proteolytically", "stable", "analog", "of", "the", "naturally", "occurring", "GI", "peptide,", "uroguanylin,", "displaying", "significant", "resistance", "to", "proteolysis", "in", "gastric", "intestinal", "fluids."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p34_s0", "idA": "1347613_14_item1_p23_s1", "sentA": "The multi-center, randomized, double-blind clinical trial will compare a 4-week, dose-ranging regimen of SP-333 (1.0, 3.0 and 6.0mg) against placebo in adult patients taking opioid analgesics for chronic, non-cancer pain for at least three months.", "sentB": "Plecanatide 1.0, 3.0 and 9.0 mg doses demonstrated statistically significant improvement in complete spontaneous bowel movement (CSBM) frequency, the trial s primary endpoint, with the highest two doses showing the greatest response (increase from baseline of 2.12, 2.74, 2.44 and 1.27 for 1.0, 3.0, 9.0 mg and placebo dose groups, respectively).", "type": 1, "words": ["<tag1>", "The", "multi-center,", "randomized,", "double-blind", "clinical", "trial", "will", "compare", "a", "4-week,", "dose-ranging", "regimen", "of", "SP-333", "(1.0,", "3.0", "and", "6.0mg)", "against", "placebo", "in", "adult", "patients", "taking", "opioid", "analgesics", "for", "chronic,", "non-cancer", "pain", "for", "at", "least", "three", "months.", "<tag2>", "Plecanatide", "1.0,", "3.0", "and", "9.0", "mg", "doses", "demonstrated", "statistically", "significant", "improvement", "in", "complete", "spontaneous", "bowel", "movement", "(CSBM)", "frequency,", "the", "trial", "s", "primary", "endpoint,", "with", "the", "highest", "two", "doses", "showing", "the", "greatest", "response", "(increase", "from", "baseline", "of", "2.12,", "2.74,", "2.44", "and", "1.27", "for", "1.0,", "3.0,", "9.0", "mg", "and", "placebo", "dose", "groups,", "respectively).", "<tag3>"], "wordsA": ["The", "multi-center,", "randomized,", "double-blind", "clinical", "trial", "will", "compare", "a", "4-week,", "dose-ranging", "regimen", "of", "SP-333", "(1.0,", "3.0", "and", "6.0mg)", "against", "placebo", "in", "adult", "patients", "taking", "opioid", "analgesics", "for", "chronic,", "non-cancer", "pain", "for", "at", "least", "three", "months."], "wordsB": ["Plecanatide", "1.0,", "3.0", "and", "9.0", "mg", "doses", "demonstrated", "statistically", "significant", "improvement", "in", "complete", "spontaneous", "bowel", "movement", "(CSBM)", "frequency,", "the", "trial", "s", "primary", "endpoint,", "with", "the", "highest", "two", "doses", "showing", "the", "greatest", "response", "(increase", "from", "baseline", "of", "2.12,", "2.74,", "2.44", "and", "1.27", "for", "1.0,", "3.0,", "9.0", "mg", "and", "placebo", "dose", "groups,", "respectively)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p61_s1", "idA": "1347613_14_item1_p23_s3", "sentA": "The primary endpoint of the study is mean change from baseline in the number of SBMs during the 4-week treatment period.", "sentB": "An opposition hearing was held December 14, 2011, which resulted in the European Patent Office issuing the following statement: Account being taken of the amendments made by the patent proprietor during the opposition proceedings, the patent and the invention to which it relates are found to meet the requirements of the European Patent Convention (Art.101(3)(a)EPC).", "type": 1, "words": ["<tag1>", "The", "primary", "endpoint", "of", "the", "study", "is", "mean", "change", "from", "baseline", "in", "the", "number", "of", "SBMs", "during", "the", "4-week", "treatment", "period.", "<tag2>", "An", "opposition", "hearing", "was", "held", "December", "14,", "2011,", "which", "resulted", "in", "the", "European", "Patent", "Office", "issuing", "the", "following", "statement:", "Account", "being", "taken", "of", "the", "amendments", "made", "by", "the", "patent", "proprietor", "during", "the", "opposition", "proceedings,", "the", "patent", "and", "the", "invention", "to", "which", "it", "relates", "are", "found", "to", "meet", "the", "requirements", "of", "the", "European", "Patent", "Convention", "(Art.101(3)(a)EPC).", "<tag3>"], "wordsA": ["The", "primary", "endpoint", "of", "the", "study", "is", "mean", "change", "from", "baseline", "in", "the", "number", "of", "SBMs", "during", "the", "4-week", "treatment", "period."], "wordsB": ["An", "opposition", "hearing", "was", "held", "December", "14,", "2011,", "which", "resulted", "in", "the", "European", "Patent", "Office", "issuing", "the", "following", "statement:", "Account", "being", "taken", "of", "the", "amendments", "made", "by", "the", "patent", "proprietor", "during", "the", "opposition", "proceedings,", "the", "patent", "and", "the", "invention", "to", "which", "it", "relates", "are", "found", "to", "meet", "the", "requirements", "of", "the", "European", "Patent", "Convention", "(Art.101(3)(a)EPC)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p9_s1", "idA": "1347613_14_item1_p27_s2", "sentA": "The Note bears interest at six percent (6%) per annum.", "sentB": "The notes are unsecured, senior obligations and bear interest at a rate of 7.50% per year, payable semiannually in arrears on May 1 and November 1 of each year, beginning on May 1, 2015.", "type": 1, "words": ["<tag1>", "The", "Note", "bears", "interest", "at", "six", "percent", "(6%)", "per", "annum.", "<tag2>", "The", "notes", "are", "unsecured,", "senior", "obligations", "and", "bear", "interest", "at", "a", "rate", "of", "7.50%", "per", "year,", "payable", "semiannually", "in", "arrears", "on", "May", "1", "and", "November", "1", "of", "each", "year,", "beginning", "on", "May", "1,", "2015.", "<tag3>"], "wordsA": ["The", "Note", "bears", "interest", "at", "six", "percent", "(6%)", "per", "annum."], "wordsB": ["The", "notes", "are", "unsecured,", "senior", "obligations", "and", "bear", "interest", "at", "a", "rate", "of", "7.50%", "per", "year,", "payable", "semiannually", "in", "arrears", "on", "May", "1", "and", "November", "1", "of", "each", "year,", "beginning", "on", "May", "1,", "2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p10_s0", "idA": "1347613_14_item1_p32_s1", "sentA": "As a result of the Merger, each outstanding share of Callisto common stock was converted into the right to receive 0.1799 of one share of our common stock and the 22,295,000 shares of our common stock held by Callisto were canceled.", "sentB": "notes will mature on November 1, 2019, unless earlier purchased or converted.", "type": 1, "words": ["<tag1>", "As", "a", "result", "of", "the", "Merger,", "each", "outstanding", "share", "of", "Callisto", "common", "stock", "was", "converted", "into", "the", "right", "to", "receive", "0.1799", "of", "one", "share", "of", "our", "common", "stock", "and", "the", "22,295,000", "shares", "of", "our", "common", "stock", "held", "by", "Callisto", "were", "canceled.", "<tag2>", "notes", "will", "mature", "on", "November", "1,", "2019,", "unless", "earlier", "purchased", "or", "converted.", "<tag3>"], "wordsA": ["As", "a", "result", "of", "the", "Merger,", "each", "outstanding", "share", "of", "Callisto", "common", "stock", "was", "converted", "into", "the", "right", "to", "receive", "0.1799", "of", "one", "share", "of", "our", "common", "stock", "and", "the", "22,295,000", "shares", "of", "our", "common", "stock", "held", "by", "Callisto", "were", "canceled."], "wordsB": ["notes", "will", "mature", "on", "November", "1,", "2019,", "unless", "earlier", "purchased", "or", "converted."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p34_s2", "idA": "1347613_14_item1_p32_s1", "sentA": "As a result of the Merger, each outstanding share of Callisto common stock was converted into the right to receive 0.1799 of one share of our common stock and the 22,295,000 shares of our common stock held by Callisto were canceled.", "sentB": "All doses were safe and well tolerated with no treatment-related serious adverse events.", "type": 1, "words": ["<tag1>", "As", "a", "result", "of", "the", "Merger,", "each", "outstanding", "share", "of", "Callisto", "common", "stock", "was", "converted", "into", "the", "right", "to", "receive", "0.1799", "of", "one", "share", "of", "our", "common", "stock", "and", "the", "22,295,000", "shares", "of", "our", "common", "stock", "held", "by", "Callisto", "were", "canceled.", "<tag2>", "All", "doses", "were", "safe", "and", "well", "tolerated", "with", "no", "treatment-related", "serious", "adverse", "events.", "<tag3>"], "wordsA": ["As", "a", "result", "of", "the", "Merger,", "each", "outstanding", "share", "of", "Callisto", "common", "stock", "was", "converted", "into", "the", "right", "to", "receive", "0.1799", "of", "one", "share", "of", "our", "common", "stock", "and", "the", "22,295,000", "shares", "of", "our", "common", "stock", "held", "by", "Callisto", "were", "canceled."], "wordsB": ["All", "doses", "were", "safe", "and", "well", "tolerated", "with", "no", "treatment-related", "serious", "adverse", "events."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p0_s0", "idA": "1347613_14_item1_p36_s0", "sentA": "Pharmaceuticals America, Inc., Sucampo Pharmaceuticals, Inc., Salix Pharmaceuticals, Inc. and Shire Plc.", "sentB": "Unless the context requires otherwise, the words Synergy, the Company, we, us, refer to Synergy Pharmaceuticals Inc. and Subsidiaries.", "type": 1, "words": ["<tag1>", "Pharmaceuticals", "America,", "Inc.,", "Sucampo", "Pharmaceuticals,", "Inc.,", "Salix", "Pharmaceuticals,", "Inc.", "and", "Shire", "Plc.", "<tag2>", "Unless", "the", "context", "requires", "otherwise,", "the", "words", "Synergy,", "the", "Company,", "we,", "us,", "refer", "to", "Synergy", "Pharmaceuticals", "Inc.", "and", "Subsidiaries.", "<tag3>"], "wordsA": ["Pharmaceuticals", "America,", "Inc.,", "Sucampo", "Pharmaceuticals,", "Inc.,", "Salix", "Pharmaceuticals,", "Inc.", "and", "Shire", "Plc."], "wordsB": ["Unless", "the", "context", "requires", "otherwise,", "the", "words", "Synergy,", "the", "Company,", "we,", "us,", "refer", "to", "Synergy", "Pharmaceuticals", "Inc.", "and", "Subsidiaries."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p45_s2", "idA": "1347613_14_item1_p41_s1", "sentA": "Accordingly, patents or other proprietary rights are an essential element of our business.", "sentB": "In consideration for such services, ContraVir paid fees to us sufficient to allow us to recover all of our direct and indirect costs incurred in providing those services.", "type": 1, "words": ["<tag1>", "Accordingly,", "patents", "or", "other", "proprietary", "rights", "are", "an", "essential", "element", "of", "our", "business.", "<tag2>", "In", "consideration", "for", "such", "services,", "ContraVir", "paid", "fees", "to", "us", "sufficient", "to", "allow", "us", "to", "recover", "all", "of", "our", "direct", "and", "indirect", "costs", "incurred", "in", "providing", "those", "services.", "<tag3>"], "wordsA": ["Accordingly,", "patents", "or", "other", "proprietary", "rights", "are", "an", "essential", "element", "of", "our", "business."], "wordsB": ["In", "consideration", "for", "such", "services,", "ContraVir", "paid", "fees", "to", "us", "sufficient", "to", "allow", "us", "to", "recover", "all", "of", "our", "direct", "and", "indirect", "costs", "incurred", "in", "providing", "those", "services."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p61_s2", "idA": "1347613_14_item1_p42_s3", "sentA": "A third patent covers the composition-of-matter of SP-333 issued on February 1, 2011 and expires in 2028.", "sentB": "In particular, the composition-of-matter claim covering plecanatide was upheld.", "type": 1, "words": ["<tag1>", "A", "third", "patent", "covers", "the", "composition-of-matter", "of", "SP-333", "issued", "on", "February", "1,", "2011", "and", "expires", "in", "2028.", "<tag2>", "In", "particular,", "the", "composition-of-matter", "claim", "covering", "plecanatide", "was", "upheld.", "<tag3>"], "wordsA": ["A", "third", "patent", "covers", "the", "composition-of-matter", "of", "SP-333", "issued", "on", "February", "1,", "2011", "and", "expires", "in", "2028."], "wordsB": ["In", "particular,", "the", "composition-of-matter", "claim", "covering", "plecanatide", "was", "upheld."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p40_s0", "idA": "1347613_14_item1_p53_s4", "sentA": "These agreements, if necessary, may be unavailable on terms acceptable to us, or at all.", "sentB": "SP-333 was safe and well tolerated at all doses.", "type": 1, "words": ["<tag1>", "These", "agreements,", "if", "necessary,", "may", "be", "unavailable", "on", "terms", "acceptable", "to", "us,", "or", "at", "all.", "<tag2>", "SP-333", "was", "safe", "and", "well", "tolerated", "at", "all", "doses.", "<tag3>"], "wordsA": ["These", "agreements,", "if", "necessary,", "may", "be", "unavailable", "on", "terms", "acceptable", "to", "us,", "or", "at", "all."], "wordsB": ["SP-333", "was", "safe", "and", "well", "tolerated", "at", "all", "doses."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p8_s0", "idA": "1347613_14_item1_p53_s4", "sentA": "These agreements, if necessary, may be unavailable on terms acceptable to us, or at all.", "sentB": "SP-333 was safe and well tolerated at all doses.", "type": 1, "words": ["<tag1>", "These", "agreements,", "if", "necessary,", "may", "be", "unavailable", "on", "terms", "acceptable", "to", "us,", "or", "at", "all.", "<tag2>", "SP-333", "was", "safe", "and", "well", "tolerated", "at", "all", "doses.", "<tag3>"], "wordsA": ["These", "agreements,", "if", "necessary,", "may", "be", "unavailable", "on", "terms", "acceptable", "to", "us,", "or", "at", "all."], "wordsB": ["SP-333", "was", "safe", "and", "well", "tolerated", "at", "all", "doses."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p12_s1", "idA": "1347613_14_item1_p55_s1", "sentA": "No manufacturer may market a new drug until it has submitted an New Drug Application, or NDA, to the FDA, and the FDA has approved it.", "sentB": "The net proceeds from this offering were approximately $187.3 million, after deducting estimated expenses and the initial purchasers discount.", "type": 1, "words": ["<tag1>", "No", "manufacturer", "may", "market", "a", "new", "drug", "until", "it", "has", "submitted", "an", "New", "Drug", "Application,", "or", "NDA,", "to", "the", "FDA,", "and", "the", "FDA", "has", "approved", "it.", "<tag2>", "The", "net", "proceeds", "from", "this", "offering", "were", "approximately", "$187.3", "million,", "after", "deducting", "estimated", "expenses", "and", "the", "initial", "purchasers", "discount.", "<tag3>"], "wordsA": ["No", "manufacturer", "may", "market", "a", "new", "drug", "until", "it", "has", "submitted", "an", "New", "Drug", "Application,", "or", "NDA,", "to", "the", "FDA,", "and", "the", "FDA", "has", "approved", "it."], "wordsB": ["The", "net", "proceeds", "from", "this", "offering", "were", "approximately", "$187.3", "million,", "after", "deducting", "estimated", "expenses", "and", "the", "initial", "purchasers", "discount."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p11_s1", "idA": "1347613_14_item1_p56_s0", "sentA": "FDA review and approval of the NDA.", "sentB": "In such case, the repurchase price would generally be 100% of the principal amount of the notes plus any accrued and unpaid interest.", "type": 1, "words": ["<tag1>", "FDA", "review", "and", "approval", "of", "the", "NDA.", "<tag2>", "In", "such", "case,", "the", "repurchase", "price", "would", "generally", "be", "100%", "of", "the", "principal", "amount", "of", "the", "notes", "plus", "any", "accrued", "and", "unpaid", "interest.", "<tag3>"], "wordsA": ["FDA", "review", "and", "approval", "of", "the", "NDA."], "wordsB": ["In", "such", "case,", "the", "repurchase", "price", "would", "generally", "be", "100%", "of", "the", "principal", "amount", "of", "the", "notes", "plus", "any", "accrued", "and", "unpaid", "interest."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_15_item1_p33_s1", "idA": "1347613_14_item1_p57_s7", "sentA": "An institutional review board may also require the clinical trial at the site to be halted, either temporarily or permanently, for failure to comply with the institutional review board s requirements or may impose other conditions.", "sentB": "The data were presented at the American College of Gastroenterology s 2014 Annual Scientific Meeting in Philadelphia, Pennsylvania.", "type": 1, "words": ["<tag1>", "An", "institutional", "review", "board", "may", "also", "require", "the", "clinical", "trial", "at", "the", "site", "to", "be", "halted,", "either", "temporarily", "or", "permanently,", "for", "failure", "to", "comply", "with", "the", "institutional", "review", "board", "s", "requirements", "or", "may", "impose", "other", "conditions.", "<tag2>", "The", "data", "were", "presented", "at", "the", "American", "College", "of", "Gastroenterology", "s", "2014", "Annual", "Scientific", "Meeting", "in", "Philadelphia,", "Pennsylvania.", "<tag3>"], "wordsA": ["An", "institutional", "review", "board", "may", "also", "require", "the", "clinical", "trial", "at", "the", "site", "to", "be", "halted,", "either", "temporarily", "or", "permanently,", "for", "failure", "to", "comply", "with", "the", "institutional", "review", "board", "s", "requirements", "or", "may", "impose", "other", "conditions."], "wordsB": ["The", "data", "were", "presented", "at", "the", "American", "College", "of", "Gastroenterology", "s", "2014", "Annual", "Scientific", "Meeting", "in", "Philadelphia,", "Pennsylvania."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p13_s0", "idA": "1347613_15_item1_p14_s0", "sentA": "Plecanatide is a synthetic analog of uroguanylin, a natural human peptide that regulates ion and fluid transport in the intestine.", "sentB": "Plecanatide is designed to mimic the function of uroguanylin by working locally in the upper GI tract to stimulate digestive fluid movement and support regular bowel function.", "type": 1, "words": ["<tag1>", "Plecanatide", "is", "a", "synthetic", "analog", "of", "uroguanylin,", "a", "natural", "human", "peptide", "that", "regulates", "ion", "and", "fluid", "transport", "in", "the", "intestine.", "<tag2>", "Plecanatide", "is", "designed", "to", "mimic", "the", "function", "of", "uroguanylin", "by", "working", "locally", "in", "the", "upper", "GI", "tract", "to", "stimulate", "digestive", "fluid", "movement", "and", "support", "regular", "bowel", "function.", "<tag3>"], "wordsA": ["Plecanatide", "is", "a", "synthetic", "analog", "of", "uroguanylin,", "a", "natural", "human", "peptide", "that", "regulates", "ion", "and", "fluid", "transport", "in", "the", "intestine."], "wordsB": ["Plecanatide", "is", "designed", "to", "mimic", "the", "function", "of", "uroguanylin", "by", "working", "locally", "in", "the", "upper", "GI", "tract", "to", "stimulate", "digestive", "fluid", "movement", "and", "support", "regular", "bowel", "function."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p3_s1", "idA": "1347613_15_item1_p14_s0", "sentA": "Plecanatide is a synthetic analog of uroguanylin, a natural human peptide that regulates ion and fluid transport in the intestine.", "sentB": "Plecanatide is designed to mimic the function of uroguanylin by working locally in the upper GI tract to stimulate digestive fluid movement and support regular bowel function.", "type": 1, "words": ["<tag1>", "Plecanatide", "is", "a", "synthetic", "analog", "of", "uroguanylin,", "a", "natural", "human", "peptide", "that", "regulates", "ion", "and", "fluid", "transport", "in", "the", "intestine.", "<tag2>", "Plecanatide", "is", "designed", "to", "mimic", "the", "function", "of", "uroguanylin", "by", "working", "locally", "in", "the", "upper", "GI", "tract", "to", "stimulate", "digestive", "fluid", "movement", "and", "support", "regular", "bowel", "function.", "<tag3>"], "wordsA": ["Plecanatide", "is", "a", "synthetic", "analog", "of", "uroguanylin,", "a", "natural", "human", "peptide", "that", "regulates", "ion", "and", "fluid", "transport", "in", "the", "intestine."], "wordsB": ["Plecanatide", "is", "designed", "to", "mimic", "the", "function", "of", "uroguanylin", "by", "working", "locally", "in", "the", "upper", "GI", "tract", "to", "stimulate", "digestive", "fluid", "movement", "and", "support", "regular", "bowel", "function."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p18_s1", "idA": "1347613_15_item1_p16_s0", "sentA": "Patients diagnosed with CIC have had symptoms for 6 months or more, and commonly have less than 3 bowel movements a week and often less than one.", "sentB": "Rome 3 requires patients to fulfill the criteria over the last 3 months with symptom onset at least 6 months prior to diagnosis.", "type": 1, "words": ["<tag1>", "Patients", "diagnosed", "with", "CIC", "have", "had", "symptoms", "for", "6", "months", "or", "more,", "and", "commonly", "have", "less", "than", "3", "bowel", "movements", "a", "week", "and", "often", "less", "than", "one.", "<tag2>", "Rome", "3", "requires", "patients", "to", "fulfill", "the", "criteria", "over", "the", "last", "3", "months", "with", "symptom", "onset", "at", "least", "6", "months", "prior", "to", "diagnosis.", "<tag3>"], "wordsA": ["Patients", "diagnosed", "with", "CIC", "have", "had", "symptoms", "for", "6", "months", "or", "more,", "and", "commonly", "have", "less", "than", "3", "bowel", "movements", "a", "week", "and", "often", "less", "than", "one."], "wordsB": ["Rome", "3", "requires", "patients", "to", "fulfill", "the", "criteria", "over", "the", "last", "3", "months", "with", "symptom", "onset", "at", "least", "6", "months", "prior", "to", "diagnosis."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p20_s2", "idA": "1347613_15_item1_p18_s3", "sentA": "The primary endpoint of the study is the proportion of patients who are overall responders for the 12-week treatment period.", "sentB": "The observed improvements began at Week 1, continued throughout the 12-week treatment period, and returned towards baseline with no indication of an exaggerated or rebound effect following discontinuation of treatment.", "type": 1, "words": ["<tag1>", "The", "primary", "endpoint", "of", "the", "study", "is", "the", "proportion", "of", "patients", "who", "are", "overall", "responders", "for", "the", "12-week", "treatment", "period.", "<tag2>", "The", "observed", "improvements", "began", "at", "Week", "1,", "continued", "throughout", "the", "12-week", "treatment", "period,", "and", "returned", "towards", "baseline", "with", "no", "indication", "of", "an", "exaggerated", "or", "rebound", "effect", "following", "discontinuation", "of", "treatment.", "<tag3>"], "wordsA": ["The", "primary", "endpoint", "of", "the", "study", "is", "the", "proportion", "of", "patients", "who", "are", "overall", "responders", "for", "the", "12-week", "treatment", "period."], "wordsB": ["The", "observed", "improvements", "began", "at", "Week", "1,", "continued", "throughout", "the", "12-week", "treatment", "period,", "and", "returned", "towards", "baseline", "with", "no", "indication", "of", "an", "exaggerated", "or", "rebound", "effect", "following", "discontinuation", "of", "treatment."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p23_s4", "idA": "1347613_15_item1_p18_s3", "sentA": "The primary endpoint of the study is the proportion of patients who are overall responders for the 12-week treatment period.", "sentB": "The observed improvements began at Week 1, continued throughout the 12-week treatment period, and returned towards baseline with no indication of an exaggerated or rebound effect following discontinuation of treatment.", "type": 1, "words": ["<tag1>", "The", "primary", "endpoint", "of", "the", "study", "is", "the", "proportion", "of", "patients", "who", "are", "overall", "responders", "for", "the", "12-week", "treatment", "period.", "<tag2>", "The", "observed", "improvements", "began", "at", "Week", "1,", "continued", "throughout", "the", "12-week", "treatment", "period,", "and", "returned", "towards", "baseline", "with", "no", "indication", "of", "an", "exaggerated", "or", "rebound", "effect", "following", "discontinuation", "of", "treatment.", "<tag3>"], "wordsA": ["The", "primary", "endpoint", "of", "the", "study", "is", "the", "proportion", "of", "patients", "who", "are", "overall", "responders", "for", "the", "12-week", "treatment", "period."], "wordsB": ["The", "observed", "improvements", "began", "at", "Week", "1,", "continued", "throughout", "the", "12-week", "treatment", "period,", "and", "returned", "towards", "baseline", "with", "no", "indication", "of", "an", "exaggerated", "or", "rebound", "effect", "following", "discontinuation", "of", "treatment."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p24_s1", "idA": "1347613_15_item1_p34_s0", "sentA": "Plecanatide 1.0, 3.0 and 9.0 mg doses demonstrated statistically significant improvement in complete spontaneous bowel movement (CSBM) frequency, the trial s primary endpoint, with the highest two doses showing the greatest response (increase from baseline of 2.12, 2.74, 2.44 and 1.27 for 1.0, 3.0, 9.0 mg and placebo dose groups, respectively).", "sentB": "Overall, the rates of withdrawal from treatment because of an adverse event were low (3.2% in 3.0 mg and 3.8% in 6.0 mg dose groups compared to 3.0% in placebo) and discontinuations due to diarrhea were infrequent (1.1% in 3.0 mg and 1.1% in 6.0 mg dose groups compared to 0.4% in placebo).", "type": 1, "words": ["<tag1>", "Plecanatide", "1.0,", "3.0", "and", "9.0", "mg", "doses", "demonstrated", "statistically", "significant", "improvement", "in", "complete", "spontaneous", "bowel", "movement", "(CSBM)", "frequency,", "the", "trial", "s", "primary", "endpoint,", "with", "the", "highest", "two", "doses", "showing", "the", "greatest", "response", "(increase", "from", "baseline", "of", "2.12,", "2.74,", "2.44", "and", "1.27", "for", "1.0,", "3.0,", "9.0", "mg", "and", "placebo", "dose", "groups,", "respectively).", "<tag2>", "Overall,", "the", "rates", "of", "withdrawal", "from", "treatment", "because", "of", "an", "adverse", "event", "were", "low", "(3.2%", "in", "3.0", "mg", "and", "3.8%", "in", "6.0", "mg", "dose", "groups", "compared", "to", "3.0%", "in", "placebo)", "and", "discontinuations", "due", "to", "diarrhea", "were", "infrequent", "(1.1%", "in", "3.0", "mg", "and", "1.1%", "in", "6.0", "mg", "dose", "groups", "compared", "to", "0.4%", "in", "placebo).", "<tag3>"], "wordsA": ["Plecanatide", "1.0,", "3.0", "and", "9.0", "mg", "doses", "demonstrated", "statistically", "significant", "improvement", "in", "complete", "spontaneous", "bowel", "movement", "(CSBM)", "frequency,", "the", "trial", "s", "primary", "endpoint,", "with", "the", "highest", "two", "doses", "showing", "the", "greatest", "response", "(increase", "from", "baseline", "of", "2.12,", "2.74,", "2.44", "and", "1.27", "for", "1.0,", "3.0,", "9.0", "mg", "and", "placebo", "dose", "groups,", "respectively)."], "wordsB": ["Overall,", "the", "rates", "of", "withdrawal", "from", "treatment", "because", "of", "an", "adverse", "event", "were", "low", "(3.2%", "in", "3.0", "mg", "and", "3.8%", "in", "6.0", "mg", "dose", "groups", "compared", "to", "3.0%", "in", "placebo)", "and", "discontinuations", "due", "to", "diarrhea", "were", "infrequent", "(1.1%", "in", "3.0", "mg", "and", "1.1%", "in", "6.0", "mg", "dose", "groups", "compared", "to", "0.4%", "in", "placebo)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p31_s0", "idA": "1347613_15_item1_p38_s1", "sentA": "The multi-center, randomized, double-blind clinical trial will compare a 4-week, dose-ranging regimen of SP-333 (1.0, 3.0 and 6.0mg) against placebo in adult patients taking opioid analgesics for chronic, non-cancer pain for at least three months.", "sentB": "Patients with IBS-C are defined by Rome III Criteria as having a history of constipation and abdominal pain for at least 6 months, including hard or lumpy stools for 25% or more of defecations, loose or watery stools for 25% or less of defecations, and abdominal pain or discomfort for 3 days or more per month for the last 3 months.", "type": 1, "words": ["<tag1>", "The", "multi-center,", "randomized,", "double-blind", "clinical", "trial", "will", "compare", "a", "4-week,", "dose-ranging", "regimen", "of", "SP-333", "(1.0,", "3.0", "and", "6.0mg)", "against", "placebo", "in", "adult", "patients", "taking", "opioid", "analgesics", "for", "chronic,", "non-cancer", "pain", "for", "at", "least", "three", "months.", "<tag2>", "Patients", "with", "IBS-C", "are", "defined", "by", "Rome", "III", "Criteria", "as", "having", "a", "history", "of", "constipation", "and", "abdominal", "pain", "for", "at", "least", "6", "months,", "including", "hard", "or", "lumpy", "stools", "for", "25%", "or", "more", "of", "defecations,", "loose", "or", "watery", "stools", "for", "25%", "or", "less", "of", "defecations,", "and", "abdominal", "pain", "or", "discomfort", "for", "3", "days", "or", "more", "per", "month", "for", "the", "last", "3", "months.", "<tag3>"], "wordsA": ["The", "multi-center,", "randomized,", "double-blind", "clinical", "trial", "will", "compare", "a", "4-week,", "dose-ranging", "regimen", "of", "SP-333", "(1.0,", "3.0", "and", "6.0mg)", "against", "placebo", "in", "adult", "patients", "taking", "opioid", "analgesics", "for", "chronic,", "non-cancer", "pain", "for", "at", "least", "three", "months."], "wordsB": ["Patients", "with", "IBS-C", "are", "defined", "by", "Rome", "III", "Criteria", "as", "having", "a", "history", "of", "constipation", "and", "abdominal", "pain", "for", "at", "least", "6", "months,", "including", "hard", "or", "lumpy", "stools", "for", "25%", "or", "more", "of", "defecations,", "loose", "or", "watery", "stools", "for", "25%", "or", "less", "of", "defecations,", "and", "abdominal", "pain", "or", "discomfort", "for", "3", "days", "or", "more", "per", "month", "for", "the", "last", "3", "months."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p22_s0", "idA": "1347613_15_item1_p41_s0", "sentA": "On August 17, 2012, we entered into an Asset Purchase Agreement with Bristol-Myers Squibb Company and acquired certain assets related to FV-100, an orally available nucleoside analog, for the treatment of shingles, a severe, painful skin rash caused by reactivation of the varicella zoster virus the virus that causes chickenpox.", "sentB": "No clinically relevant abnormalities were observed in serum chemistries, hematology, urinalysis, ECG or vital signs measurements.", "type": 1, "words": ["<tag1>", "On", "August", "17,", "2012,", "we", "entered", "into", "an", "Asset", "Purchase", "Agreement", "with", "Bristol-Myers", "Squibb", "Company", "and", "acquired", "certain", "assets", "related", "to", "FV-100,", "an", "orally", "available", "nucleoside", "analog,", "for", "the", "treatment", "of", "shingles,", "a", "severe,", "painful", "skin", "rash", "caused", "by", "reactivation", "of", "the", "varicella", "zoster", "virus", "the", "virus", "that", "causes", "chickenpox.", "<tag2>", "No", "clinically", "relevant", "abnormalities", "were", "observed", "in", "serum", "chemistries,", "hematology,", "urinalysis,", "ECG", "or", "vital", "signs", "measurements.", "<tag3>"], "wordsA": ["On", "August", "17,", "2012,", "we", "entered", "into", "an", "Asset", "Purchase", "Agreement", "with", "Bristol-Myers", "Squibb", "Company", "and", "acquired", "certain", "assets", "related", "to", "FV-100,", "an", "orally", "available", "nucleoside", "analog,", "for", "the", "treatment", "of", "shingles,", "a", "severe,", "painful", "skin", "rash", "caused", "by", "reactivation", "of", "the", "varicella", "zoster", "virus", "the", "virus", "that", "causes", "chickenpox."], "wordsB": ["No", "clinically", "relevant", "abnormalities", "were", "observed", "in", "serum", "chemistries,", "hematology,", "urinalysis,", "ECG", "or", "vital", "signs", "measurements."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p25_s0", "idA": "1347613_15_item1_p41_s0", "sentA": "On August 17, 2012, we entered into an Asset Purchase Agreement with Bristol-Myers Squibb Company and acquired certain assets related to FV-100, an orally available nucleoside analog, for the treatment of shingles, a severe, painful skin rash caused by reactivation of the varicella zoster virus the virus that causes chickenpox.", "sentB": "No clinically relevant abnormalities were observed in serum chemistries, hematology, urinalysis, ECG or vital signs measurements.", "type": 1, "words": ["<tag1>", "On", "August", "17,", "2012,", "we", "entered", "into", "an", "Asset", "Purchase", "Agreement", "with", "Bristol-Myers", "Squibb", "Company", "and", "acquired", "certain", "assets", "related", "to", "FV-100,", "an", "orally", "available", "nucleoside", "analog,", "for", "the", "treatment", "of", "shingles,", "a", "severe,", "painful", "skin", "rash", "caused", "by", "reactivation", "of", "the", "varicella", "zoster", "virus", "the", "virus", "that", "causes", "chickenpox.", "<tag2>", "No", "clinically", "relevant", "abnormalities", "were", "observed", "in", "serum", "chemistries,", "hematology,", "urinalysis,", "ECG", "or", "vital", "signs", "measurements.", "<tag3>"], "wordsA": ["On", "August", "17,", "2012,", "we", "entered", "into", "an", "Asset", "Purchase", "Agreement", "with", "Bristol-Myers", "Squibb", "Company", "and", "acquired", "certain", "assets", "related", "to", "FV-100,", "an", "orally", "available", "nucleoside", "analog,", "for", "the", "treatment", "of", "shingles,", "a", "severe,", "painful", "skin", "rash", "caused", "by", "reactivation", "of", "the", "varicella", "zoster", "virus", "the", "virus", "that", "causes", "chickenpox."], "wordsB": ["No", "clinically", "relevant", "abnormalities", "were", "observed", "in", "serum", "chemistries,", "hematology,", "urinalysis,", "ECG", "or", "vital", "signs", "measurements."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p34_s2", "idA": "1347613_15_item1_p41_s0", "sentA": "On August 17, 2012, we entered into an Asset Purchase Agreement with Bristol-Myers Squibb Company and acquired certain assets related to FV-100, an orally available nucleoside analog, for the treatment of shingles, a severe, painful skin rash caused by reactivation of the varicella zoster virus the virus that causes chickenpox.", "sentB": "In these earlier animal studies, oral treatment with dolcanatide was shown to ameliorate DSS- and TNBS-induced acute colitis in murine models and ameliorate spontaneous colitis in T-cell receptor alpha knockout mice.", "type": 1, "words": ["<tag1>", "On", "August", "17,", "2012,", "we", "entered", "into", "an", "Asset", "Purchase", "Agreement", "with", "Bristol-Myers", "Squibb", "Company", "and", "acquired", "certain", "assets", "related", "to", "FV-100,", "an", "orally", "available", "nucleoside", "analog,", "for", "the", "treatment", "of", "shingles,", "a", "severe,", "painful", "skin", "rash", "caused", "by", "reactivation", "of", "the", "varicella", "zoster", "virus", "the", "virus", "that", "causes", "chickenpox.", "<tag2>", "In", "these", "earlier", "animal", "studies,", "oral", "treatment", "with", "dolcanatide", "was", "shown", "to", "ameliorate", "DSS-", "and", "TNBS-induced", "acute", "colitis", "in", "murine", "models", "and", "ameliorate", "spontaneous", "colitis", "in", "T-cell", "receptor", "alpha", "knockout", "mice.", "<tag3>"], "wordsA": ["On", "August", "17,", "2012,", "we", "entered", "into", "an", "Asset", "Purchase", "Agreement", "with", "Bristol-Myers", "Squibb", "Company", "and", "acquired", "certain", "assets", "related", "to", "FV-100,", "an", "orally", "available", "nucleoside", "analog,", "for", "the", "treatment", "of", "shingles,", "a", "severe,", "painful", "skin", "rash", "caused", "by", "reactivation", "of", "the", "varicella", "zoster", "virus", "the", "virus", "that", "causes", "chickenpox."], "wordsB": ["In", "these", "earlier", "animal", "studies,", "oral", "treatment", "with", "dolcanatide", "was", "shown", "to", "ameliorate", "DSS-", "and", "TNBS-induced", "acute", "colitis", "in", "murine", "models", "and", "ameliorate", "spontaneous", "colitis", "in", "T-cell", "receptor", "alpha", "knockout", "mice."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p6_s0", "idA": "1347613_15_item1_p5_s0", "sentA": "On January 8, 2015 and January 29, 2015 we announced that we had completed patient enrollment in the first and second of two pivotal phase 3 trials, respectively, which are evaluating the safety and efficacy of two plecanatide doses (3.0 and 6.0 mg) in patients with CIC.", "sentB": "On February 16, 2016, we announced that we have entered into a research collaboration agreement with BIND Therapeutics to engineer ACCURINS decorated with our proprietary uroguanylin analogs to explore the potential targeting of guanylate cyclase-C (GC-C) receptors expressed on tumors, specifically GI malignancies.", "type": 1, "words": ["<tag1>", "On", "January", "8,", "2015", "and", "January", "29,", "2015", "we", "announced", "that", "we", "had", "completed", "patient", "enrollment", "in", "the", "first", "and", "second", "of", "two", "pivotal", "phase", "3", "trials,", "respectively,", "which", "are", "evaluating", "the", "safety", "and", "efficacy", "of", "two", "plecanatide", "doses", "(3.0", "and", "6.0", "mg)", "in", "patients", "with", "CIC.", "<tag2>", "On", "February", "16,", "2016,", "we", "announced", "that", "we", "have", "entered", "into", "a", "research", "collaboration", "agreement", "with", "BIND", "Therapeutics", "to", "engineer", "ACCURINS", "decorated", "with", "our", "proprietary", "uroguanylin", "analogs", "to", "explore", "the", "potential", "targeting", "of", "guanylate", "cyclase-C", "(GC-C)", "receptors", "expressed", "on", "tumors,", "specifically", "GI", "malignancies.", "<tag3>"], "wordsA": ["On", "January", "8,", "2015", "and", "January", "29,", "2015", "we", "announced", "that", "we", "had", "completed", "patient", "enrollment", "in", "the", "first", "and", "second", "of", "two", "pivotal", "phase", "3", "trials,", "respectively,", "which", "are", "evaluating", "the", "safety", "and", "efficacy", "of", "two", "plecanatide", "doses", "(3.0", "and", "6.0", "mg)", "in", "patients", "with", "CIC."], "wordsB": ["On", "February", "16,", "2016,", "we", "announced", "that", "we", "have", "entered", "into", "a", "research", "collaboration", "agreement", "with", "BIND", "Therapeutics", "to", "engineer", "ACCURINS", "decorated", "with", "our", "proprietary", "uroguanylin", "analogs", "to", "explore", "the", "potential", "targeting", "of", "guanylate", "cyclase-C", "(GC-C)", "receptors", "expressed", "on", "tumors,", "specifically", "GI", "malignancies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p21_s1", "idA": "1347613_15_item1_p6_s0", "sentA": "On December 18, 2014 we announced the initiation of the first of two planned pivotal phase 3 clinical trials evaluating the safety and efficacy of 3.0 and 6.0 mg plecanatide, once-daily oral tablets, for the treatment of irritable bowel syndrome with constipation (IBS-C).", "sentB": "Overall, the rates of withdrawal from treatment because of an adverse event were low (5.1 % in 3.0 mg and 5.0% in 6.0 mg dose groups compared to 1.3% in placebo) and discontinuations due to diarrhea were infrequent (2.7% in 3.0 mg and 2.4% in 6.0 mg dose groups compared to 0.4% in placebo).", "type": 1, "words": ["<tag1>", "On", "December", "18,", "2014", "we", "announced", "the", "initiation", "of", "the", "first", "of", "two", "planned", "pivotal", "phase", "3", "clinical", "trials", "evaluating", "the", "safety", "and", "efficacy", "of", "3.0", "and", "6.0", "mg", "plecanatide,", "once-daily", "oral", "tablets,", "for", "the", "treatment", "of", "irritable", "bowel", "syndrome", "with", "constipation", "(IBS-C).", "<tag2>", "Overall,", "the", "rates", "of", "withdrawal", "from", "treatment", "because", "of", "an", "adverse", "event", "were", "low", "(5.1", "%", "in", "3.0", "mg", "and", "5.0%", "in", "6.0", "mg", "dose", "groups", "compared", "to", "1.3%", "in", "placebo)", "and", "discontinuations", "due", "to", "diarrhea", "were", "infrequent", "(2.7%", "in", "3.0", "mg", "and", "2.4%", "in", "6.0", "mg", "dose", "groups", "compared", "to", "0.4%", "in", "placebo).", "<tag3>"], "wordsA": ["On", "December", "18,", "2014", "we", "announced", "the", "initiation", "of", "the", "first", "of", "two", "planned", "pivotal", "phase", "3", "clinical", "trials", "evaluating", "the", "safety", "and", "efficacy", "of", "3.0", "and", "6.0", "mg", "plecanatide,", "once-daily", "oral", "tablets,", "for", "the", "treatment", "of", "irritable", "bowel", "syndrome", "with", "constipation", "(IBS-C)."], "wordsB": ["Overall,", "the", "rates", "of", "withdrawal", "from", "treatment", "because", "of", "an", "adverse", "event", "were", "low", "(5.1", "%", "in", "3.0", "mg", "and", "5.0%", "in", "6.0", "mg", "dose", "groups", "compared", "to", "1.3%", "in", "placebo)", "and", "discontinuations", "due", "to", "diarrhea", "were", "infrequent", "(2.7%", "in", "3.0", "mg", "and", "2.4%", "in", "6.0", "mg", "dose", "groups", "compared", "to", "0.4%", "in", "placebo)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p1_s1", "idA": "1347613_15_item1_p70_s0", "sentA": "We believe that our product candidates will be regulated by the FDA as drugs.", "sentB": "Our proprietary GI platform includes two lead product candidates plecanatide and dolcanatide.", "type": 1, "words": ["<tag1>", "We", "believe", "that", "our", "product", "candidates", "will", "be", "regulated", "by", "the", "FDA", "as", "drugs.", "<tag2>", "Our", "proprietary", "GI", "platform", "includes", "two", "lead", "product", "candidates", "plecanatide", "and", "dolcanatide.", "<tag3>"], "wordsA": ["We", "believe", "that", "our", "product", "candidates", "will", "be", "regulated", "by", "the", "FDA", "as", "drugs."], "wordsB": ["Our", "proprietary", "GI", "platform", "includes", "two", "lead", "product", "candidates", "plecanatide", "and", "dolcanatide."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p17_s3", "idA": "1347613_15_item1_p72_s0", "sentA": "Preclinical tests include laboratory evaluation of the product candidate, as well as animal studies to assess the potential safety and efficacy of the product candidate.", "sentB": "Plecanatide has the potential to be the first drug approved for CIC using the more stringent regulatory requirement for durability of the overall response.", "type": 1, "words": ["<tag1>", "Preclinical", "tests", "include", "laboratory", "evaluation", "of", "the", "product", "candidate,", "as", "well", "as", "animal", "studies", "to", "assess", "the", "potential", "safety", "and", "efficacy", "of", "the", "product", "candidate.", "<tag2>", "Plecanatide", "has", "the", "potential", "to", "be", "the", "first", "drug", "approved", "for", "CIC", "using", "the", "more", "stringent", "regulatory", "requirement", "for", "durability", "of", "the", "overall", "response.", "<tag3>"], "wordsA": ["Preclinical", "tests", "include", "laboratory", "evaluation", "of", "the", "product", "candidate,", "as", "well", "as", "animal", "studies", "to", "assess", "the", "potential", "safety", "and", "efficacy", "of", "the", "product", "candidate."], "wordsB": ["Plecanatide", "has", "the", "potential", "to", "be", "the", "first", "drug", "approved", "for", "CIC", "using", "the", "more", "stringent", "regulatory", "requirement", "for", "durability", "of", "the", "overall", "response."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p6_s1", "idA": "1347613_15_item1_p72_s0", "sentA": "Preclinical tests include laboratory evaluation of the product candidate, as well as animal studies to assess the potential safety and efficacy of the product candidate.", "sentB": "Upon achievement of proof-of-concept, we anticipate expanding the collaboration to enhance the potential effect of uroguanylin-based ACCURINS by incorporating therapeutic payloads.", "type": 1, "words": ["<tag1>", "Preclinical", "tests", "include", "laboratory", "evaluation", "of", "the", "product", "candidate,", "as", "well", "as", "animal", "studies", "to", "assess", "the", "potential", "safety", "and", "efficacy", "of", "the", "product", "candidate.", "<tag2>", "Upon", "achievement", "of", "proof-of-concept,", "we", "anticipate", "expanding", "the", "collaboration", "to", "enhance", "the", "potential", "effect", "of", "uroguanylin-based", "ACCURINS", "by", "incorporating", "therapeutic", "payloads.", "<tag3>"], "wordsA": ["Preclinical", "tests", "include", "laboratory", "evaluation", "of", "the", "product", "candidate,", "as", "well", "as", "animal", "studies", "to", "assess", "the", "potential", "safety", "and", "efficacy", "of", "the", "product", "candidate."], "wordsB": ["Upon", "achievement", "of", "proof-of-concept,", "we", "anticipate", "expanding", "the", "collaboration", "to", "enhance", "the", "potential", "effect", "of", "uroguanylin-based", "ACCURINS", "by", "incorporating", "therapeutic", "payloads."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p30_s0", "idA": "1347613_15_item1_p72_s3", "sentA": "The IND will automatically become effective 30 days after its receipt by the FDA, unless the FDA raises concerns or questions before that time about the conduct of the proposed trials.", "sentB": "An Overall Responder, as defined by the FDA, is a patient who is a weekly responder (i.e. meets both a 30% abdominal pain intensity reduction and stool frequency increase criteria in the same week) for at least 6 of the 12 treatment weeks.", "type": 1, "words": ["<tag1>", "The", "IND", "will", "automatically", "become", "effective", "30", "days", "after", "its", "receipt", "by", "the", "FDA,", "unless", "the", "FDA", "raises", "concerns", "or", "questions", "before", "that", "time", "about", "the", "conduct", "of", "the", "proposed", "trials.", "<tag2>", "An", "Overall", "Responder,", "as", "defined", "by", "the", "FDA,", "is", "a", "patient", "who", "is", "a", "weekly", "responder", "(i.e.", "meets", "both", "a", "30%", "abdominal", "pain", "intensity", "reduction", "and", "stool", "frequency", "increase", "criteria", "in", "the", "same", "week)", "for", "at", "least", "6", "of", "the", "12", "treatment", "weeks.", "<tag3>"], "wordsA": ["The", "IND", "will", "automatically", "become", "effective", "30", "days", "after", "its", "receipt", "by", "the", "FDA,", "unless", "the", "FDA", "raises", "concerns", "or", "questions", "before", "that", "time", "about", "the", "conduct", "of", "the", "proposed", "trials."], "wordsB": ["An", "Overall", "Responder,", "as", "defined", "by", "the", "FDA,", "is", "a", "patient", "who", "is", "a", "weekly", "responder", "(i.e.", "meets", "both", "a", "30%", "abdominal", "pain", "intensity", "reduction", "and", "stool", "frequency", "increase", "criteria", "in", "the", "same", "week)", "for", "at", "least", "6", "of", "the", "12", "treatment", "weeks."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p34_s1", "idA": "1347613_15_item1_p84_s2", "sentA": "The results of preclinical studies and initial clinical trials of our product candidates are not necessarily predictive of the results from large-scale clinical trials, and clinical trials may be subject to additional costs, delays or modifications due to a number of factors, including difficulty in obtaining enough patients, investigators or product candidate supply.", "sentB": "We have demonstrated the potential anti-inflammatory role of uroguanylin and uroguanylin analogs in a number of preclinical colitis models.", "type": 1, "words": ["<tag1>", "The", "results", "of", "preclinical", "studies", "and", "initial", "clinical", "trials", "of", "our", "product", "candidates", "are", "not", "necessarily", "predictive", "of", "the", "results", "from", "large-scale", "clinical", "trials,", "and", "clinical", "trials", "may", "be", "subject", "to", "additional", "costs,", "delays", "or", "modifications", "due", "to", "a", "number", "of", "factors,", "including", "difficulty", "in", "obtaining", "enough", "patients,", "investigators", "or", "product", "candidate", "supply.", "<tag2>", "We", "have", "demonstrated", "the", "potential", "anti-inflammatory", "role", "of", "uroguanylin", "and", "uroguanylin", "analogs", "in", "a", "number", "of", "preclinical", "colitis", "models.", "<tag3>"], "wordsA": ["The", "results", "of", "preclinical", "studies", "and", "initial", "clinical", "trials", "of", "our", "product", "candidates", "are", "not", "necessarily", "predictive", "of", "the", "results", "from", "large-scale", "clinical", "trials,", "and", "clinical", "trials", "may", "be", "subject", "to", "additional", "costs,", "delays", "or", "modifications", "due", "to", "a", "number", "of", "factors,", "including", "difficulty", "in", "obtaining", "enough", "patients,", "investigators", "or", "product", "candidate", "supply."], "wordsB": ["We", "have", "demonstrated", "the", "potential", "anti-inflammatory", "role", "of", "uroguanylin", "and", "uroguanylin", "analogs", "in", "a", "number", "of", "preclinical", "colitis", "models."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_16_item1_p6_s2", "idA": "1347613_15_item1_p95_s0", "sentA": "Information found on our website is not incorporated by reference into this report.", "sentB": "This early research collaboration is not expected to have a material financial impact on us or BIND Therapeutics.", "type": 1, "words": ["<tag1>", "Information", "found", "on", "our", "website", "is", "not", "incorporated", "by", "reference", "into", "this", "report.", "<tag2>", "This", "early", "research", "collaboration", "is", "not", "expected", "to", "have", "a", "material", "financial", "impact", "on", "us", "or", "BIND", "Therapeutics.", "<tag3>"], "wordsA": ["Information", "found", "on", "our", "website", "is", "not", "incorporated", "by", "reference", "into", "this", "report."], "wordsB": ["This", "early", "research", "collaboration", "is", "not", "expected", "to", "have", "a", "material", "financial", "impact", "on", "us", "or", "BIND", "Therapeutics."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p97_s1", "idA": "1347613_16_item1_p10_s0", "sentA": "We have completed patient enrollment in our ongoing open-label, long-term safety trial with plecanatide for CIC.", "sentB": "Approximately 20 were in our scientific and drug development organization, 12 were in technical operations and quality assurance, 56 were in our sales and commercial team, and 28 were in general and administrative functions.", "type": 1, "words": ["<tag1>", "We", "have", "completed", "patient", "enrollment", "in", "our", "ongoing", "open-label,", "long-term", "safety", "trial", "with", "plecanatide", "for", "CIC.", "<tag2>", "Approximately", "20", "were", "in", "our", "scientific", "and", "drug", "development", "organization,", "12", "were", "in", "technical", "operations", "and", "quality", "assurance,", "56", "were", "in", "our", "sales", "and", "commercial", "team,", "and", "28", "were", "in", "general", "and", "administrative", "functions.", "<tag3>"], "wordsA": ["We", "have", "completed", "patient", "enrollment", "in", "our", "ongoing", "open-label,", "long-term", "safety", "trial", "with", "plecanatide", "for", "CIC."], "wordsB": ["Approximately", "20", "were", "in", "our", "scientific", "and", "drug", "development", "organization,", "12", "were", "in", "technical", "operations", "and", "quality", "assurance,", "56", "were", "in", "our", "sales", "and", "commercial", "team,", "and", "28", "were", "in", "general", "and", "administrative", "functions."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p7_s0", "idA": "1347613_16_item1_p10_s2", "sentA": "The objective of this trial is to evaluate the long-term safety and tolerability of plecanatide in patients with CIC.", "sentB": "People with CIC have persistent symptoms of difficult-to-pass and infrequent bowel movements.", "type": 1, "words": ["<tag1>", "The", "objective", "of", "this", "trial", "is", "to", "evaluate", "the", "long-term", "safety", "and", "tolerability", "of", "plecanatide", "in", "patients", "with", "CIC.", "<tag2>", "People", "with", "CIC", "have", "persistent", "symptoms", "of", "difficult-to-pass", "and", "infrequent", "bowel", "movements.", "<tag3>"], "wordsA": ["The", "objective", "of", "this", "trial", "is", "to", "evaluate", "the", "long-term", "safety", "and", "tolerability", "of", "plecanatide", "in", "patients", "with", "CIC."], "wordsB": ["People", "with", "CIC", "have", "persistent", "symptoms", "of", "difficult-to-pass", "and", "infrequent", "bowel", "movements."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p7_s3", "idA": "1347613_16_item1_p10_s2", "sentA": "The objective of this trial is to evaluate the long-term safety and tolerability of plecanatide in patients with CIC.", "sentB": "For those patients with persistent symptoms, prescription therapy is recommended.", "type": 1, "words": ["<tag1>", "The", "objective", "of", "this", "trial", "is", "to", "evaluate", "the", "long-term", "safety", "and", "tolerability", "of", "plecanatide", "in", "patients", "with", "CIC.", "<tag2>", "For", "those", "patients", "with", "persistent", "symptoms,", "prescription", "therapy", "is", "recommended.", "<tag3>"], "wordsA": ["The", "objective", "of", "this", "trial", "is", "to", "evaluate", "the", "long-term", "safety", "and", "tolerability", "of", "plecanatide", "in", "patients", "with", "CIC."], "wordsB": ["For", "those", "patients", "with", "persistent", "symptoms,", "prescription", "therapy", "is", "recommended."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p61_s5", "idA": "1347613_16_item1_p14_s1", "sentA": "Both trials included a two-week pre-treatment baseline period, a 12-week treatment period, and a two-week post-treatment period.", "sentB": "A Notice of Allowance was mailed on February 10, 2017 for US14/845,644 and a Notice of Allowance was mailed on February 24, 2017 for US13/421,769.", "type": 1, "words": ["<tag1>", "Both", "trials", "included", "a", "two-week", "pre-treatment", "baseline", "period,", "a", "12-week", "treatment", "period,", "and", "a", "two-week", "post-treatment", "period.", "<tag2>", "A", "Notice", "of", "Allowance", "was", "mailed", "on", "February", "10,", "2017", "for", "US14/845,644", "and", "a", "Notice", "of", "Allowance", "was", "mailed", "on", "February", "24,", "2017", "for", "US13/421,769.", "<tag3>"], "wordsA": ["Both", "trials", "included", "a", "two-week", "pre-treatment", "baseline", "period,", "a", "12-week", "treatment", "period,", "and", "a", "two-week", "post-treatment", "period."], "wordsB": ["A", "Notice", "of", "Allowance", "was", "mailed", "on", "February", "10,", "2017", "for", "US14/845,644", "and", "a", "Notice", "of", "Allowance", "was", "mailed", "on", "February", "24,", "2017", "for", "US13/421,769."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p57_s1", "idA": "1347613_16_item1_p17_s0", "sentA": "The primary endpoint for both trials was the proportion of durable overall complete spontaneous bowl movement (CSBM) responders (%), which is the current regulatory endpoint required for U.S. approval in CIC.", "sentB": "We continue to pursue additional commercial supply agreements with additional manufacturers for TRULANCE for U.S. and worldwide use.", "type": 1, "words": ["<tag1>", "The", "primary", "endpoint", "for", "both", "trials", "was", "the", "proportion", "of", "durable", "overall", "complete", "spontaneous", "bowl", "movement", "(CSBM)", "responders", "(%),", "which", "is", "the", "current", "regulatory", "endpoint", "required", "for", "U.S.", "approval", "in", "CIC.", "<tag2>", "We", "continue", "to", "pursue", "additional", "commercial", "supply", "agreements", "with", "additional", "manufacturers", "for", "TRULANCE", "for", "U.S.", "and", "worldwide", "use.", "<tag3>"], "wordsA": ["The", "primary", "endpoint", "for", "both", "trials", "was", "the", "proportion", "of", "durable", "overall", "complete", "spontaneous", "bowl", "movement", "(CSBM)", "responders", "(%),", "which", "is", "the", "current", "regulatory", "endpoint", "required", "for", "U.S.", "approval", "in", "CIC."], "wordsB": ["We", "continue", "to", "pursue", "additional", "commercial", "supply", "agreements", "with", "additional", "manufacturers", "for", "TRULANCE", "for", "U.S.", "and", "worldwide", "use."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p8_s1", "idA": "1347613_16_item1_p23_s3", "sentA": "Stool consistency was the key secondary endpoint reported with top-line analyses; both 3.0 mg and 6.0 mg plecanatide doses showed statistically significant improvement from baseline in Bristol Stool Form Scale (BSFS) scores compared to placebo (mean increase of 1.49 in 3.0 mg and 1.50 in 6.0 mg dose groups compared to a mean increase of 0.87 in placebo; p 0.001 for both doses).", "sentB": "IBS can be subtyped by the predominant stool form as measured by the Bristol Stool Form Scale (BSFS): constipation (IBS-C), diarrhea (IBS-D), or mixed (IBS-M).", "type": 1, "words": ["<tag1>", "Stool", "consistency", "was", "the", "key", "secondary", "endpoint", "reported", "with", "top-line", "analyses;", "both", "3.0", "mg", "and", "6.0", "mg", "plecanatide", "doses", "showed", "statistically", "significant", "improvement", "from", "baseline", "in", "Bristol", "Stool", "Form", "Scale", "(BSFS)", "scores", "compared", "to", "placebo", "(mean", "increase", "of", "1.49", "in", "3.0", "mg", "and", "1.50", "in", "6.0", "mg", "dose", "groups", "compared", "to", "a", "mean", "increase", "of", "0.87", "in", "placebo;", "p", "0.001", "for", "both", "doses).", "<tag2>", "IBS", "can", "be", "subtyped", "by", "the", "predominant", "stool", "form", "as", "measured", "by", "the", "Bristol", "Stool", "Form", "Scale", "(BSFS):", "constipation", "(IBS-C),", "diarrhea", "(IBS-D),", "or", "mixed", "(IBS-M).", "<tag3>"], "wordsA": ["Stool", "consistency", "was", "the", "key", "secondary", "endpoint", "reported", "with", "top-line", "analyses;", "both", "3.0", "mg", "and", "6.0", "mg", "plecanatide", "doses", "showed", "statistically", "significant", "improvement", "from", "baseline", "in", "Bristol", "Stool", "Form", "Scale", "(BSFS)", "scores", "compared", "to", "placebo", "(mean", "increase", "of", "1.49", "in", "3.0", "mg", "and", "1.50", "in", "6.0", "mg", "dose", "groups", "compared", "to", "a", "mean", "increase", "of", "0.87", "in", "placebo;", "p", "0.001", "for", "both", "doses)."], "wordsB": ["IBS", "can", "be", "subtyped", "by", "the", "predominant", "stool", "form", "as", "measured", "by", "the", "Bristol", "Stool", "Form", "Scale", "(BSFS):", "constipation", "(IBS-C),", "diarrhea", "(IBS-D),", "or", "mixed", "(IBS-M)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p57_s0", "idA": "1347613_16_item1_p26_s0", "sentA": "We have completed enrollment into our ongoing CIC open-label, long-term safety trial with plecanatide.", "sentB": "We have entered into arrangements with third party manufacturers for the production of TRULANCE.", "type": 1, "words": ["<tag1>", "We", "have", "completed", "enrollment", "into", "our", "ongoing", "CIC", "open-label,", "long-term", "safety", "trial", "with", "plecanatide.", "<tag2>", "We", "have", "entered", "into", "arrangements", "with", "third", "party", "manufacturers", "for", "the", "production", "of", "TRULANCE.", "<tag3>"], "wordsA": ["We", "have", "completed", "enrollment", "into", "our", "ongoing", "CIC", "open-label,", "long-term", "safety", "trial", "with", "plecanatide."], "wordsB": ["We", "have", "entered", "into", "arrangements", "with", "third", "party", "manufacturers", "for", "the", "production", "of", "TRULANCE."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p19_s1", "idA": "1347613_16_item1_p29_s0", "sentA": "The primary efficacy endpoint for both trials is the percentage of patients who are Overall Responders during the 12 week treatment period.", "sentB": "TRULANCE can be swallowed whole or crushed in applesauce for those who are unable to swallow medication.", "type": 1, "words": ["<tag1>", "The", "primary", "efficacy", "endpoint", "for", "both", "trials", "is", "the", "percentage", "of", "patients", "who", "are", "Overall", "Responders", "during", "the", "12", "week", "treatment", "period.", "<tag2>", "TRULANCE", "can", "be", "swallowed", "whole", "or", "crushed", "in", "applesauce", "for", "those", "who", "are", "unable", "to", "swallow", "medication.", "<tag3>"], "wordsA": ["The", "primary", "efficacy", "endpoint", "for", "both", "trials", "is", "the", "percentage", "of", "patients", "who", "are", "Overall", "Responders", "during", "the", "12", "week", "treatment", "period."], "wordsB": ["TRULANCE", "can", "be", "swallowed", "whole", "or", "crushed", "in", "applesauce", "for", "those", "who", "are", "unable", "to", "swallow", "medication."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p6_s0", "idA": "1347613_16_item1_p2_s1", "sentA": "Plecanatide is our first uroguanylin analog currently being evaluated for use as a once-daily tablet for two functional GI disorders, chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C).", "sentB": "CIC and IBS-C CIC and IBS-C are chronic, functional GI disorders that afflict millions of people worldwide.", "type": 1, "words": ["<tag1>", "Plecanatide", "is", "our", "first", "uroguanylin", "analog", "currently", "being", "evaluated", "for", "use", "as", "a", "once-daily", "tablet", "for", "two", "functional", "GI", "disorders,", "chronic", "idiopathic", "constipation", "(CIC)", "and", "irritable", "bowel", "syndrome", "with", "constipation", "(IBS-C).", "<tag2>", "CIC", "and", "IBS-C", "CIC", "and", "IBS-C", "are", "chronic,", "functional", "GI", "disorders", "that", "afflict", "millions", "of", "people", "worldwide.", "<tag3>"], "wordsA": ["Plecanatide", "is", "our", "first", "uroguanylin", "analog", "currently", "being", "evaluated", "for", "use", "as", "a", "once-daily", "tablet", "for", "two", "functional", "GI", "disorders,", "chronic", "idiopathic", "constipation", "(CIC)", "and", "irritable", "bowel", "syndrome", "with", "constipation", "(IBS-C)."], "wordsB": ["CIC", "and", "IBS-C", "CIC", "and", "IBS-C", "are", "chronic,", "functional", "GI", "disorders", "that", "afflict", "millions", "of", "people", "worldwide."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p9_s0", "idA": "1347613_16_item1_p35_s1", "sentA": "Analysis of the data indicates clear signals of improvement in dolcanatide-treated patients compared with placebo-treated patients.", "sentB": "Some of the IBS treatment approaches recognized by the American College of Gastroenterology (ACG), including specialized diets, fiber, and psychological interventions, may not always effectively address abdominal pain and discomfort experienced by these patients.", "type": 1, "words": ["<tag1>", "Analysis", "of", "the", "data", "indicates", "clear", "signals", "of", "improvement", "in", "dolcanatide-treated", "patients", "compared", "with", "placebo-treated", "patients.", "<tag2>", "Some", "of", "the", "IBS", "treatment", "approaches", "recognized", "by", "the", "American", "College", "of", "Gastroenterology", "(ACG),", "including", "specialized", "diets,", "fiber,", "and", "psychological", "interventions,", "may", "not", "always", "effectively", "address", "abdominal", "pain", "and", "discomfort", "experienced", "by", "these", "patients.", "<tag3>"], "wordsA": ["Analysis", "of", "the", "data", "indicates", "clear", "signals", "of", "improvement", "in", "dolcanatide-treated", "patients", "compared", "with", "placebo-treated", "patients."], "wordsB": ["Some", "of", "the", "IBS", "treatment", "approaches", "recognized", "by", "the", "American", "College", "of", "Gastroenterology", "(ACG),", "including", "specialized", "diets,", "fiber,", "and", "psychological", "interventions,", "may", "not", "always", "effectively", "address", "abdominal", "pain", "and", "discomfort", "experienced", "by", "these", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p1_s1", "idA": "1347613_16_item1_p36_s1", "sentA": "We are currently evaluating how best to move dolcanatide forward in clinical development to treat ulcerative colitis.", "sentB": "Any other trademarks reference in this Form 10-K are the property of their respective owners.", "type": 1, "words": ["<tag1>", "We", "are", "currently", "evaluating", "how", "best", "to", "move", "dolcanatide", "forward", "in", "clinical", "development", "to", "treat", "ulcerative", "colitis.", "<tag2>", "Any", "other", "trademarks", "reference", "in", "this", "Form", "10-K", "are", "the", "property", "of", "their", "respective", "owners.", "<tag3>"], "wordsA": ["We", "are", "currently", "evaluating", "how", "best", "to", "move", "dolcanatide", "forward", "in", "clinical", "development", "to", "treat", "ulcerative", "colitis."], "wordsB": ["Any", "other", "trademarks", "reference", "in", "this", "Form", "10-K", "are", "the", "property", "of", "their", "respective", "owners."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p27_s0", "idA": "1347613_16_item1_p36_s1", "sentA": "We are currently evaluating how best to move dolcanatide forward in clinical development to treat ulcerative colitis.", "sentB": "Implemented our third party logistics (3PL) distribution network.", "type": 1, "words": ["<tag1>", "We", "are", "currently", "evaluating", "how", "best", "to", "move", "dolcanatide", "forward", "in", "clinical", "development", "to", "treat", "ulcerative", "colitis.", "<tag2>", "Implemented", "our", "third", "party", "logistics", "(3PL)", "distribution", "network.", "<tag3>"], "wordsA": ["We", "are", "currently", "evaluating", "how", "best", "to", "move", "dolcanatide", "forward", "in", "clinical", "development", "to", "treat", "ulcerative", "colitis."], "wordsB": ["Implemented", "our", "third", "party", "logistics", "(3PL)", "distribution", "network."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p32_s0", "idA": "1347613_16_item1_p36_s1", "sentA": "We are currently evaluating how best to move dolcanatide forward in clinical development to treat ulcerative colitis.", "sentB": "Conducted multiple advisory boards with national and regional GI key opinion leaders, other healthcare providers and payers.", "type": 1, "words": ["<tag1>", "We", "are", "currently", "evaluating", "how", "best", "to", "move", "dolcanatide", "forward", "in", "clinical", "development", "to", "treat", "ulcerative", "colitis.", "<tag2>", "Conducted", "multiple", "advisory", "boards", "with", "national", "and", "regional", "GI", "key", "opinion", "leaders,", "other", "healthcare", "providers", "and", "payers.", "<tag3>"], "wordsA": ["We", "are", "currently", "evaluating", "how", "best", "to", "move", "dolcanatide", "forward", "in", "clinical", "development", "to", "treat", "ulcerative", "colitis."], "wordsB": ["Conducted", "multiple", "advisory", "boards", "with", "national", "and", "regional", "GI", "key", "opinion", "leaders,", "other", "healthcare", "providers", "and", "payers."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p35_s0", "idA": "1347613_16_item1_p36_s1", "sentA": "We are currently evaluating how best to move dolcanatide forward in clinical development to treat ulcerative colitis.", "sentB": "Finalized TRULANCE core marketing strategies and launch tactics, including a compliant, value-optimizing, cost effective promotional mix to reach the broadest universe of prescribers.", "type": 1, "words": ["<tag1>", "We", "are", "currently", "evaluating", "how", "best", "to", "move", "dolcanatide", "forward", "in", "clinical", "development", "to", "treat", "ulcerative", "colitis.", "<tag2>", "Finalized", "TRULANCE", "core", "marketing", "strategies", "and", "launch", "tactics,", "including", "a", "compliant,", "value-optimizing,", "cost", "effective", "promotional", "mix", "to", "reach", "the", "broadest", "universe", "of", "prescribers.", "<tag3>"], "wordsA": ["We", "are", "currently", "evaluating", "how", "best", "to", "move", "dolcanatide", "forward", "in", "clinical", "development", "to", "treat", "ulcerative", "colitis."], "wordsB": ["Finalized", "TRULANCE", "core", "marketing", "strategies", "and", "launch", "tactics,", "including", "a", "compliant,", "value-optimizing,", "cost", "effective", "promotional", "mix", "to", "reach", "the", "broadest", "universe", "of", "prescribers."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p38_s0", "idA": "1347613_16_item1_p36_s1", "sentA": "We are currently evaluating how best to move dolcanatide forward in clinical development to treat ulcerative colitis.", "sentB": "Utilizing a hybrid sales model to reach key prescribers and influencers at launch.", "type": 1, "words": ["<tag1>", "We", "are", "currently", "evaluating", "how", "best", "to", "move", "dolcanatide", "forward", "in", "clinical", "development", "to", "treat", "ulcerative", "colitis.", "<tag2>", "Utilizing", "a", "hybrid", "sales", "model", "to", "reach", "key", "prescribers", "and", "influencers", "at", "launch.", "<tag3>"], "wordsA": ["We", "are", "currently", "evaluating", "how", "best", "to", "move", "dolcanatide", "forward", "in", "clinical", "development", "to", "treat", "ulcerative", "colitis."], "wordsB": ["Utilizing", "a", "hybrid", "sales", "model", "to", "reach", "key", "prescribers", "and", "influencers", "at", "launch."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p55_s0", "idA": "1347613_16_item1_p36_s1", "sentA": "We are currently evaluating how best to move dolcanatide forward in clinical development to treat ulcerative colitis.", "sentB": "Manufacturing and Supply We currently manage our global supply and distribution of TRULANCE through third party contract manufacturers.", "type": 1, "words": ["<tag1>", "We", "are", "currently", "evaluating", "how", "best", "to", "move", "dolcanatide", "forward", "in", "clinical", "development", "to", "treat", "ulcerative", "colitis.", "<tag2>", "Manufacturing", "and", "Supply", "We", "currently", "manage", "our", "global", "supply", "and", "distribution", "of", "TRULANCE", "through", "third", "party", "contract", "manufacturers.", "<tag3>"], "wordsA": ["We", "are", "currently", "evaluating", "how", "best", "to", "move", "dolcanatide", "forward", "in", "clinical", "development", "to", "treat", "ulcerative", "colitis."], "wordsB": ["Manufacturing", "and", "Supply", "We", "currently", "manage", "our", "global", "supply", "and", "distribution", "of", "TRULANCE", "through", "third", "party", "contract", "manufacturers."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p8_s0", "idA": "1347613_16_item1_p39_s0", "sentA": "The biopharmaceutical industry is characterized by rapidly evolving technology and intense competition.", "sentB": "Irritable bowel syndrome (IBS) is characterized by recurrent abdominal pain associated with 2 or more of the following criteria: related to defecation, associated with a change in the frequency of stool, or associated with a change in the form (appearance) of the stool.", "type": 1, "words": ["<tag1>", "The", "biopharmaceutical", "industry", "is", "characterized", "by", "rapidly", "evolving", "technology", "and", "intense", "competition.", "<tag2>", "Irritable", "bowel", "syndrome", "(IBS)", "is", "characterized", "by", "recurrent", "abdominal", "pain", "associated", "with", "2", "or", "more", "of", "the", "following", "criteria:", "related", "to", "defecation,", "associated", "with", "a", "change", "in", "the", "frequency", "of", "stool,", "or", "associated", "with", "a", "change", "in", "the", "form", "(appearance)", "of", "the", "stool.", "<tag3>"], "wordsA": ["The", "biopharmaceutical", "industry", "is", "characterized", "by", "rapidly", "evolving", "technology", "and", "intense", "competition."], "wordsB": ["Irritable", "bowel", "syndrome", "(IBS)", "is", "characterized", "by", "recurrent", "abdominal", "pain", "associated", "with", "2", "or", "more", "of", "the", "following", "criteria:", "related", "to", "defecation,", "associated", "with", "a", "change", "in", "the", "frequency", "of", "stool,", "or", "associated", "with", "a", "change", "in", "the", "form", "(appearance)", "of", "the", "stool."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p7_s4", "idA": "1347613_16_item1_p39_s1", "sentA": "Our competitors include major pharmaceutical and biotechnology companies focusing on GI such as Ironwood Pharmaceuticals, Inc., Allergan plc, Takeda Pharmaceuticals America, Inc., Sucampo Pharmaceuticals, Inc., AstraZeneca, Valeant Pharmaceuticals International, Inc. and Shire, Plc.", "sentB": "Many patients taking prescription medications fail to respond to therapy, or suffer from treatment-related adverse events, such as nausea and diarrhea.", "type": 1, "words": ["<tag1>", "Our", "competitors", "include", "major", "pharmaceutical", "and", "biotechnology", "companies", "focusing", "on", "GI", "such", "as", "Ironwood", "Pharmaceuticals,", "Inc.,", "Allergan", "plc,", "Takeda", "Pharmaceuticals", "America,", "Inc.,", "Sucampo", "Pharmaceuticals,", "Inc.,", "AstraZeneca,", "Valeant", "Pharmaceuticals", "International,", "Inc.", "and", "Shire,", "Plc.", "<tag2>", "Many", "patients", "taking", "prescription", "medications", "fail", "to", "respond", "to", "therapy,", "or", "suffer", "from", "treatment-related", "adverse", "events,", "such", "as", "nausea", "and", "diarrhea.", "<tag3>"], "wordsA": ["Our", "competitors", "include", "major", "pharmaceutical", "and", "biotechnology", "companies", "focusing", "on", "GI", "such", "as", "Ironwood", "Pharmaceuticals,", "Inc.,", "Allergan", "plc,", "Takeda", "Pharmaceuticals", "America,", "Inc.,", "Sucampo", "Pharmaceuticals,", "Inc.,", "AstraZeneca,", "Valeant", "Pharmaceuticals", "International,", "Inc.", "and", "Shire,", "Plc."], "wordsB": ["Many", "patients", "taking", "prescription", "medications", "fail", "to", "respond", "to", "therapy,", "or", "suffer", "from", "treatment-related", "adverse", "events,", "such", "as", "nausea", "and", "diarrhea."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p11_s0", "idA": "1347613_16_item1_p3_s1", "sentA": "Plecanatide is designed to mimic the function of uroguanylin by working locally in the upper GI tract to stimulate digestive fluid movement and support regular bowel function.", "sentB": "Uroguanylin, a guanylate cyclase-C (GC-C) receptor agonist, is thought to work in a pH-sensitive manner primarily in the small intestine to stimulate fluid secretion.", "type": 1, "words": ["<tag1>", "Plecanatide", "is", "designed", "to", "mimic", "the", "function", "of", "uroguanylin", "by", "working", "locally", "in", "the", "upper", "GI", "tract", "to", "stimulate", "digestive", "fluid", "movement", "and", "support", "regular", "bowel", "function.", "<tag2>", "Uroguanylin,", "a", "guanylate", "cyclase-C", "(GC-C)", "receptor", "agonist,", "is", "thought", "to", "work", "in", "a", "pH-sensitive", "manner", "primarily", "in", "the", "small", "intestine", "to", "stimulate", "fluid", "secretion.", "<tag3>"], "wordsA": ["Plecanatide", "is", "designed", "to", "mimic", "the", "function", "of", "uroguanylin", "by", "working", "locally", "in", "the", "upper", "GI", "tract", "to", "stimulate", "digestive", "fluid", "movement", "and", "support", "regular", "bowel", "function."], "wordsB": ["Uroguanylin,", "a", "guanylate", "cyclase-C", "(GC-C)", "receptor", "agonist,", "is", "thought", "to", "work", "in", "a", "pH-sensitive", "manner", "primarily", "in", "the", "small", "intestine", "to", "stimulate", "fluid", "secretion."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p11_s1", "idA": "1347613_16_item1_p3_s1", "sentA": "Plecanatide is designed to mimic the function of uroguanylin by working locally in the upper GI tract to stimulate digestive fluid movement and support regular bowel function.", "sentB": "Uroguanylin stimulates fluid secretion into the lumen of the intestinal tract and maintains stool consistency that is necessary for normal bowel function.", "type": 1, "words": ["<tag1>", "Plecanatide", "is", "designed", "to", "mimic", "the", "function", "of", "uroguanylin", "by", "working", "locally", "in", "the", "upper", "GI", "tract", "to", "stimulate", "digestive", "fluid", "movement", "and", "support", "regular", "bowel", "function.", "<tag2>", "Uroguanylin", "stimulates", "fluid", "secretion", "into", "the", "lumen", "of", "the", "intestinal", "tract", "and", "maintains", "stool", "consistency", "that", "is", "necessary", "for", "normal", "bowel", "function.", "<tag3>"], "wordsA": ["Plecanatide", "is", "designed", "to", "mimic", "the", "function", "of", "uroguanylin", "by", "working", "locally", "in", "the", "upper", "GI", "tract", "to", "stimulate", "digestive", "fluid", "movement", "and", "support", "regular", "bowel", "function."], "wordsB": ["Uroguanylin", "stimulates", "fluid", "secretion", "into", "the", "lumen", "of", "the", "intestinal", "tract", "and", "maintains", "stool", "consistency", "that", "is", "necessary", "for", "normal", "bowel", "function."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p44_s0", "idA": "1347613_16_item1_p3_s4", "sentA": "We intend to file our second NDA with plecanatide for IBS-C by year-end 2016.", "sentB": "Medical education efforts have been ongoing since March 2016.", "type": 1, "words": ["<tag1>", "We", "intend", "to", "file", "our", "second", "NDA", "with", "plecanatide", "for", "IBS-C", "by", "year-end", "2016.", "<tag2>", "Medical", "education", "efforts", "have", "been", "ongoing", "since", "March", "2016.", "<tag3>"], "wordsA": ["We", "intend", "to", "file", "our", "second", "NDA", "with", "plecanatide", "for", "IBS-C", "by", "year-end", "2016."], "wordsB": ["Medical", "education", "efforts", "have", "been", "ongoing", "since", "March", "2016."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p50_s1", "idA": "1347613_16_item1_p43_s0", "sentA": "We are able to protect our technology from unauthorized use by third parties only to the extent that it is covered by valid and enforceable patents or is effectively maintained as a trade secret or is protected by confidentiality agreements.", "sentB": "We are exploring OIC as a potential lifecycle growth opportunity for TRULANCE.", "type": 1, "words": ["<tag1>", "We", "are", "able", "to", "protect", "our", "technology", "from", "unauthorized", "use", "by", "third", "parties", "only", "to", "the", "extent", "that", "it", "is", "covered", "by", "valid", "and", "enforceable", "patents", "or", "is", "effectively", "maintained", "as", "a", "trade", "secret", "or", "is", "protected", "by", "confidentiality", "agreements.", "<tag2>", "We", "are", "exploring", "OIC", "as", "a", "potential", "lifecycle", "growth", "opportunity", "for", "TRULANCE.", "<tag3>"], "wordsA": ["We", "are", "able", "to", "protect", "our", "technology", "from", "unauthorized", "use", "by", "third", "parties", "only", "to", "the", "extent", "that", "it", "is", "covered", "by", "valid", "and", "enforceable", "patents", "or", "is", "effectively", "maintained", "as", "a", "trade", "secret", "or", "is", "protected", "by", "confidentiality", "agreements."], "wordsB": ["We", "are", "exploring", "OIC", "as", "a", "potential", "lifecycle", "growth", "opportunity", "for", "TRULANCE."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p39_s1", "idA": "1347613_16_item1_p43_s1", "sentA": "Accordingly, patents or other proprietary rights are an essential element of our business.", "sentB": "These prescribers, which include gastroenterologists and primary care physicians, will be the focus of our field force at launch.", "type": 1, "words": ["<tag1>", "Accordingly,", "patents", "or", "other", "proprietary", "rights", "are", "an", "essential", "element", "of", "our", "business.", "<tag2>", "These", "prescribers,", "which", "include", "gastroenterologists", "and", "primary", "care", "physicians,", "will", "be", "the", "focus", "of", "our", "field", "force", "at", "launch.", "<tag3>"], "wordsA": ["Accordingly,", "patents", "or", "other", "proprietary", "rights", "are", "an", "essential", "element", "of", "our", "business."], "wordsB": ["These", "prescribers,", "which", "include", "gastroenterologists", "and", "primary", "care", "physicians,", "will", "be", "the", "focus", "of", "our", "field", "force", "at", "launch."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p37_s0", "idA": "1347613_16_item1_p44_s9", "sentA": "A ninth patent granted on July 30, 2013 covers another composition-of-matter related to certain analogs of plecanatide and will expire in 2029.", "sentB": "Finalized pricing strategy for TRULANCE and will launch with a wholesale acquisition cost (WAC) of $353.48.", "type": 1, "words": ["<tag1>", "A", "ninth", "patent", "granted", "on", "July", "30,", "2013", "covers", "another", "composition-of-matter", "related", "to", "certain", "analogs", "of", "plecanatide", "and", "will", "expire", "in", "2029.", "<tag2>", "Finalized", "pricing", "strategy", "for", "TRULANCE", "and", "will", "launch", "with", "a", "wholesale", "acquisition", "cost", "(WAC)", "of", "$353.48.", "<tag3>"], "wordsA": ["A", "ninth", "patent", "granted", "on", "July", "30,", "2013", "covers", "another", "composition-of-matter", "related", "to", "certain", "analogs", "of", "plecanatide", "and", "will", "expire", "in", "2029."], "wordsB": ["Finalized", "pricing", "strategy", "for", "TRULANCE", "and", "will", "launch", "with", "a", "wholesale", "acquisition", "cost", "(WAC)", "of", "$353.48."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p55_s1", "idA": "1347613_16_item1_p4_s0", "sentA": "Dolcanatide is our second uroguanylin analog currently being explored for inflammatory bowel disease (IBD).", "sentB": "It is our objective to produce safe, pure and effective medicine.", "type": 1, "words": ["<tag1>", "Dolcanatide", "is", "our", "second", "uroguanylin", "analog", "currently", "being", "explored", "for", "inflammatory", "bowel", "disease", "(IBD).", "<tag2>", "It", "is", "our", "objective", "to", "produce", "safe,", "pure", "and", "effective", "medicine.", "<tag3>"], "wordsA": ["Dolcanatide", "is", "our", "second", "uroguanylin", "analog", "currently", "being", "explored", "for", "inflammatory", "bowel", "disease", "(IBD)."], "wordsB": ["It", "is", "our", "objective", "to", "produce", "safe,", "pure", "and", "effective", "medicine."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p61_s4", "idA": "1347613_16_item1_p51_s0", "sentA": "We assumed the obligations under the Cardiff Agreement from BMS pursuant to the terms of the BMS Agreement.", "sentB": "The two other allowed applications relate to the formulations and method of using TRULANCE for treating constipation.", "type": 1, "words": ["<tag1>", "We", "assumed", "the", "obligations", "under", "the", "Cardiff", "Agreement", "from", "BMS", "pursuant", "to", "the", "terms", "of", "the", "BMS", "Agreement.", "<tag2>", "The", "two", "other", "allowed", "applications", "relate", "to", "the", "formulations", "and", "method", "of", "using", "TRULANCE", "for", "treating", "constipation.", "<tag3>"], "wordsA": ["We", "assumed", "the", "obligations", "under", "the", "Cardiff", "Agreement", "from", "BMS", "pursuant", "to", "the", "terms", "of", "the", "BMS", "Agreement."], "wordsB": ["The", "two", "other", "allowed", "applications", "relate", "to", "the", "formulations", "and", "method", "of", "using", "TRULANCE", "for", "treating", "constipation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p42_s0", "idA": "1347613_16_item1_p53_s5", "sentA": "Accordingly, we cannot ensure that employees, consultants or third parties will not breach the confidentiality provisions in our contracts, infringe or misappropriate our trade secrets and other proprietary rights or that measures we are taking to protect our proprietary rights will be adequate.", "sentB": "Partnered with Publicis Touchpoint Solutions, Inc. who have hired highly experienced sales representatives that will be fully dedicated to TRULANCE at launch.", "type": 1, "words": ["<tag1>", "Accordingly,", "we", "cannot", "ensure", "that", "employees,", "consultants", "or", "third", "parties", "will", "not", "breach", "the", "confidentiality", "provisions", "in", "our", "contracts,", "infringe", "or", "misappropriate", "our", "trade", "secrets", "and", "other", "proprietary", "rights", "or", "that", "measures", "we", "are", "taking", "to", "protect", "our", "proprietary", "rights", "will", "be", "adequate.", "<tag2>", "Partnered", "with", "Publicis", "Touchpoint", "Solutions,", "Inc.", "who", "have", "hired", "highly", "experienced", "sales", "representatives", "that", "will", "be", "fully", "dedicated", "to", "TRULANCE", "at", "launch.", "<tag3>"], "wordsA": ["Accordingly,", "we", "cannot", "ensure", "that", "employees,", "consultants", "or", "third", "parties", "will", "not", "breach", "the", "confidentiality", "provisions", "in", "our", "contracts,", "infringe", "or", "misappropriate", "our", "trade", "secrets", "and", "other", "proprietary", "rights", "or", "that", "measures", "we", "are", "taking", "to", "protect", "our", "proprietary", "rights", "will", "be", "adequate."], "wordsB": ["Partnered", "with", "Publicis", "Touchpoint", "Solutions,", "Inc.", "who", "have", "hired", "highly", "experienced", "sales", "representatives", "that", "will", "be", "fully", "dedicated", "to", "TRULANCE", "at", "launch."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p19_s0", "idA": "1347613_16_item1_p54_s2", "sentA": "If we are forced to defend ourselves against such claims, whether they are with or without merit and whether they are resolved in favor of, or against, our licensors or us, we may face costly litigation and the diversion of management s attention and resources.", "sentB": "The recommended adult dosage of TRULANCE is 3 mg taken orally, once daily, with or without food.", "type": 1, "words": ["<tag1>", "If", "we", "are", "forced", "to", "defend", "ourselves", "against", "such", "claims,", "whether", "they", "are", "with", "or", "without", "merit", "and", "whether", "they", "are", "resolved", "in", "favor", "of,", "or", "against,", "our", "licensors", "or", "us,", "we", "may", "face", "costly", "litigation", "and", "the", "diversion", "of", "management", "s", "attention", "and", "resources.", "<tag2>", "The", "recommended", "adult", "dosage", "of", "TRULANCE", "is", "3", "mg", "taken", "orally,", "once", "daily,", "with", "or", "without", "food.", "<tag3>"], "wordsA": ["If", "we", "are", "forced", "to", "defend", "ourselves", "against", "such", "claims,", "whether", "they", "are", "with", "or", "without", "merit", "and", "whether", "they", "are", "resolved", "in", "favor", "of,", "or", "against,", "our", "licensors", "or", "us,", "we", "may", "face", "costly", "litigation", "and", "the", "diversion", "of", "management", "s", "attention", "and", "resources."], "wordsB": ["The", "recommended", "adult", "dosage", "of", "TRULANCE", "is", "3", "mg", "taken", "orally,", "once", "daily,", "with", "or", "without", "food."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p40_s0", "idA": "1347613_16_item1_p54_s2", "sentA": "If we are forced to defend ourselves against such claims, whether they are with or without merit and whether they are resolved in favor of, or against, our licensors or us, we may face costly litigation and the diversion of management s attention and resources.", "sentB": "Hired Synergy Regional Business Directors averaging 11 years of management experience and over 10 years in relevant GI fields.", "type": 1, "words": ["<tag1>", "If", "we", "are", "forced", "to", "defend", "ourselves", "against", "such", "claims,", "whether", "they", "are", "with", "or", "without", "merit", "and", "whether", "they", "are", "resolved", "in", "favor", "of,", "or", "against,", "our", "licensors", "or", "us,", "we", "may", "face", "costly", "litigation", "and", "the", "diversion", "of", "management", "s", "attention", "and", "resources.", "<tag2>", "Hired", "Synergy", "Regional", "Business", "Directors", "averaging", "11", "years", "of", "management", "experience", "and", "over", "10", "years", "in", "relevant", "GI", "fields.", "<tag3>"], "wordsA": ["If", "we", "are", "forced", "to", "defend", "ourselves", "against", "such", "claims,", "whether", "they", "are", "with", "or", "without", "merit", "and", "whether", "they", "are", "resolved", "in", "favor", "of,", "or", "against,", "our", "licensors", "or", "us,", "we", "may", "face", "costly", "litigation", "and", "the", "diversion", "of", "management", "s", "attention", "and", "resources."], "wordsB": ["Hired", "Synergy", "Regional", "Business", "Directors", "averaging", "11", "years", "of", "management", "experience", "and", "over", "10", "years", "in", "relevant", "GI", "fields."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p4_s0", "idA": "1347613_16_item1_p54_s2", "sentA": "If we are forced to defend ourselves against such claims, whether they are with or without merit and whether they are resolved in favor of, or against, our licensors or us, we may face costly litigation and the diversion of management s attention and resources.", "sentB": "The recommended adult dosage of TRULANCE is 3 mg taken orally, once daily, with or without food.", "type": 1, "words": ["<tag1>", "If", "we", "are", "forced", "to", "defend", "ourselves", "against", "such", "claims,", "whether", "they", "are", "with", "or", "without", "merit", "and", "whether", "they", "are", "resolved", "in", "favor", "of,", "or", "against,", "our", "licensors", "or", "us,", "we", "may", "face", "costly", "litigation", "and", "the", "diversion", "of", "management", "s", "attention", "and", "resources.", "<tag2>", "The", "recommended", "adult", "dosage", "of", "TRULANCE", "is", "3", "mg", "taken", "orally,", "once", "daily,", "with", "or", "without", "food.", "<tag3>"], "wordsA": ["If", "we", "are", "forced", "to", "defend", "ourselves", "against", "such", "claims,", "whether", "they", "are", "with", "or", "without", "merit", "and", "whether", "they", "are", "resolved", "in", "favor", "of,", "or", "against,", "our", "licensors", "or", "us,", "we", "may", "face", "costly", "litigation", "and", "the", "diversion", "of", "management", "s", "attention", "and", "resources."], "wordsB": ["The", "recommended", "adult", "dosage", "of", "TRULANCE", "is", "3", "mg", "taken", "orally,", "once", "daily,", "with", "or", "without", "food."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p41_s0", "idA": "1347613_16_item1_p55_s1", "sentA": "The Federal Food and Drug Administration, and Cosmetic Act and other federal and state statutes and regulations, govern, among other things, the research, development, testing, manufacture, storage, recordkeeping, approval, labeling, promotion and marketing, distribution, post-approval monitoring and reporting, sampling, and import and export of pharmaceutical products.", "sentB": "Hired Synergy Regional GI Account Specialists averaging 13 years of pharmaceutical experience and 8.5 years of GI experience.", "type": 1, "words": ["<tag1>", "The", "Federal", "Food", "and", "Drug", "Administration,", "and", "Cosmetic", "Act", "and", "other", "federal", "and", "state", "statutes", "and", "regulations,", "govern,", "among", "other", "things,", "the", "research,", "development,", "testing,", "manufacture,", "storage,", "recordkeeping,", "approval,", "labeling,", "promotion", "and", "marketing,", "distribution,", "post-approval", "monitoring", "and", "reporting,", "sampling,", "and", "import", "and", "export", "of", "pharmaceutical", "products.", "<tag2>", "Hired", "Synergy", "Regional", "GI", "Account", "Specialists", "averaging", "13", "years", "of", "pharmaceutical", "experience", "and", "8.5", "years", "of", "GI", "experience.", "<tag3>"], "wordsA": ["The", "Federal", "Food", "and", "Drug", "Administration,", "and", "Cosmetic", "Act", "and", "other", "federal", "and", "state", "statutes", "and", "regulations,", "govern,", "among", "other", "things,", "the", "research,", "development,", "testing,", "manufacture,", "storage,", "recordkeeping,", "approval,", "labeling,", "promotion", "and", "marketing,", "distribution,", "post-approval", "monitoring", "and", "reporting,", "sampling,", "and", "import", "and", "export", "of", "pharmaceutical", "products."], "wordsB": ["Hired", "Synergy", "Regional", "GI", "Account", "Specialists", "averaging", "13", "years", "of", "pharmaceutical", "experience", "and", "8.5", "years", "of", "GI", "experience."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p43_s0", "idA": "1347613_16_item1_p55_s1", "sentA": "The Federal Food and Drug Administration, and Cosmetic Act and other federal and state statutes and regulations, govern, among other things, the research, development, testing, manufacture, storage, recordkeeping, approval, labeling, promotion and marketing, distribution, post-approval monitoring and reporting, sampling, and import and export of pharmaceutical products.", "sentB": "Our Publicis Touchpoint sales representatives have an average of 11.5 years of pharmaceutical experience, and nearly 6 years of GI experience, with over 90% coming from other peer GI and PCP companies.", "type": 1, "words": ["<tag1>", "The", "Federal", "Food", "and", "Drug", "Administration,", "and", "Cosmetic", "Act", "and", "other", "federal", "and", "state", "statutes", "and", "regulations,", "govern,", "among", "other", "things,", "the", "research,", "development,", "testing,", "manufacture,", "storage,", "recordkeeping,", "approval,", "labeling,", "promotion", "and", "marketing,", "distribution,", "post-approval", "monitoring", "and", "reporting,", "sampling,", "and", "import", "and", "export", "of", "pharmaceutical", "products.", "<tag2>", "Our", "Publicis", "Touchpoint", "sales", "representatives", "have", "an", "average", "of", "11.5", "years", "of", "pharmaceutical", "experience,", "and", "nearly", "6", "years", "of", "GI", "experience,", "with", "over", "90%", "coming", "from", "other", "peer", "GI", "and", "PCP", "companies.", "<tag3>"], "wordsA": ["The", "Federal", "Food", "and", "Drug", "Administration,", "and", "Cosmetic", "Act", "and", "other", "federal", "and", "state", "statutes", "and", "regulations,", "govern,", "among", "other", "things,", "the", "research,", "development,", "testing,", "manufacture,", "storage,", "recordkeeping,", "approval,", "labeling,", "promotion", "and", "marketing,", "distribution,", "post-approval", "monitoring", "and", "reporting,", "sampling,", "and", "import", "and", "export", "of", "pharmaceutical", "products."], "wordsB": ["Our", "Publicis", "Touchpoint", "sales", "representatives", "have", "an", "average", "of", "11.5", "years", "of", "pharmaceutical", "experience,", "and", "nearly", "6", "years", "of", "GI", "experience,", "with", "over", "90%", "coming", "from", "other", "peer", "GI", "and", "PCP", "companies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p30_s0", "idA": "1347613_16_item1_p57_s0", "sentA": "Our product candidates are regulated by the FDA as drugs.", "sentB": "We are very encouraged by the feedback we have received from our market research, advisory boards and field-based customer meetings.", "type": 1, "words": ["<tag1>", "Our", "product", "candidates", "are", "regulated", "by", "the", "FDA", "as", "drugs.", "<tag2>", "We", "are", "very", "encouraged", "by", "the", "feedback", "we", "have", "received", "from", "our", "market", "research,", "advisory", "boards", "and", "field-based", "customer", "meetings.", "<tag3>"], "wordsA": ["Our", "product", "candidates", "are", "regulated", "by", "the", "FDA", "as", "drugs."], "wordsB": ["We", "are", "very", "encouraged", "by", "the", "feedback", "we", "have", "received", "from", "our", "market", "research,", "advisory", "boards", "and", "field-based", "customer", "meetings."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p28_s0", "idA": "1347613_16_item1_p69_s2", "sentA": "Before approving an NDA, the FDA will typically inspect the facilities at which the product candidate is manufactured and will not approve the product candidate unless GMP compliance is satisfactory.", "sentB": "Trade and sample stock manufactured and on-track for launch this quarter.", "type": 1, "words": ["<tag1>", "Before", "approving", "an", "NDA,", "the", "FDA", "will", "typically", "inspect", "the", "facilities", "at", "which", "the", "product", "candidate", "is", "manufactured", "and", "will", "not", "approve", "the", "product", "candidate", "unless", "GMP", "compliance", "is", "satisfactory.", "<tag2>", "Trade", "and", "sample", "stock", "manufactured", "and", "on-track", "for", "launch", "this", "quarter.", "<tag3>"], "wordsA": ["Before", "approving", "an", "NDA,", "the", "FDA", "will", "typically", "inspect", "the", "facilities", "at", "which", "the", "product", "candidate", "is", "manufactured", "and", "will", "not", "approve", "the", "product", "candidate", "unless", "GMP", "compliance", "is", "satisfactory."], "wordsB": ["Trade", "and", "sample", "stock", "manufactured", "and", "on-track", "for", "launch", "this", "quarter."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p56_s0", "idA": "1347613_16_item1_p69_s3", "sentA": "FDA also typically inspects facilities responsible for performing animal testing, as well as clinical investigators who participate in clinical trials.", "sentB": "TRULANCE production consists of three phases-manufacture of (i) the active pharmaceutical ingredient, or API (sometimes referred to as drug substance), (ii) manufacture of drug product and (iii) manufacture of packaged finished goods, as well as distribution agreements.", "type": 1, "words": ["<tag1>", "FDA", "also", "typically", "inspects", "facilities", "responsible", "for", "performing", "animal", "testing,", "as", "well", "as", "clinical", "investigators", "who", "participate", "in", "clinical", "trials.", "<tag2>", "TRULANCE", "production", "consists", "of", "three", "phases-manufacture", "of", "(i)", "the", "active", "pharmaceutical", "ingredient,", "or", "API", "(sometimes", "referred", "to", "as", "drug", "substance),", "(ii)", "manufacture", "of", "drug", "product", "and", "(iii)", "manufacture", "of", "packaged", "finished", "goods,", "as", "well", "as", "distribution", "agreements.", "<tag3>"], "wordsA": ["FDA", "also", "typically", "inspects", "facilities", "responsible", "for", "performing", "animal", "testing,", "as", "well", "as", "clinical", "investigators", "who", "participate", "in", "clinical", "trials."], "wordsB": ["TRULANCE", "production", "consists", "of", "three", "phases-manufacture", "of", "(i)", "the", "active", "pharmaceutical", "ingredient,", "or", "API", "(sometimes", "referred", "to", "as", "drug", "substance),", "(ii)", "manufacture", "of", "drug", "product", "and", "(iii)", "manufacture", "of", "packaged", "finished", "goods,", "as", "well", "as", "distribution", "agreements."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p2_s2", "idA": "1347613_16_item1_p6_s0", "sentA": "On February 16, 2016, we announced that we have entered into a research collaboration agreement with BIND Therapeutics to engineer ACCURINS decorated with our proprietary uroguanylin analogs to explore the potential targeting of guanylate cyclase-C (GC-C) receptors expressed on tumors, specifically GI malignancies.", "sentB": "We discovered, are developing and control 100% worldwide rights to our proprietary uroguanylin analog platform.", "type": 1, "words": ["<tag1>", "On", "February", "16,", "2016,", "we", "announced", "that", "we", "have", "entered", "into", "a", "research", "collaboration", "agreement", "with", "BIND", "Therapeutics", "to", "engineer", "ACCURINS", "decorated", "with", "our", "proprietary", "uroguanylin", "analogs", "to", "explore", "the", "potential", "targeting", "of", "guanylate", "cyclase-C", "(GC-C)", "receptors", "expressed", "on", "tumors,", "specifically", "GI", "malignancies.", "<tag2>", "We", "discovered,", "are", "developing", "and", "control", "100%", "worldwide", "rights", "to", "our", "proprietary", "uroguanylin", "analog", "platform.", "<tag3>"], "wordsA": ["On", "February", "16,", "2016,", "we", "announced", "that", "we", "have", "entered", "into", "a", "research", "collaboration", "agreement", "with", "BIND", "Therapeutics", "to", "engineer", "ACCURINS", "decorated", "with", "our", "proprietary", "uroguanylin", "analogs", "to", "explore", "the", "potential", "targeting", "of", "guanylate", "cyclase-C", "(GC-C)", "receptors", "expressed", "on", "tumors,", "specifically", "GI", "malignancies."], "wordsB": ["We", "discovered,", "are", "developing", "and", "control", "100%", "worldwide", "rights", "to", "our", "proprietary", "uroguanylin", "analog", "platform."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p8_s2", "idA": "1347613_16_item1_p70_s1", "sentA": "The time and expense required to perform the clinical testing necessary to obtain FDA approval for regulated products can frequently exceed the time and expense of the research and development initially required to create the product.", "sentB": "Those within the IBS-C subtype experience Bristol types 1 or 2 (hard or lumpy) stools more than 25 percent of the time they have an abnormal bowel movement, and Bristol types 6 or 7 (loose or watery) stools less than 25 percent of the time they have an abnormal bowel movement.", "type": 1, "words": ["<tag1>", "The", "time", "and", "expense", "required", "to", "perform", "the", "clinical", "testing", "necessary", "to", "obtain", "FDA", "approval", "for", "regulated", "products", "can", "frequently", "exceed", "the", "time", "and", "expense", "of", "the", "research", "and", "development", "initially", "required", "to", "create", "the", "product.", "<tag2>", "Those", "within", "the", "IBS-C", "subtype", "experience", "Bristol", "types", "1", "or", "2", "(hard", "or", "lumpy)", "stools", "more", "than", "25", "percent", "of", "the", "time", "they", "have", "an", "abnormal", "bowel", "movement,", "and", "Bristol", "types", "6", "or", "7", "(loose", "or", "watery)", "stools", "less", "than", "25", "percent", "of", "the", "time", "they", "have", "an", "abnormal", "bowel", "movement.", "<tag3>"], "wordsA": ["The", "time", "and", "expense", "required", "to", "perform", "the", "clinical", "testing", "necessary", "to", "obtain", "FDA", "approval", "for", "regulated", "products", "can", "frequently", "exceed", "the", "time", "and", "expense", "of", "the", "research", "and", "development", "initially", "required", "to", "create", "the", "product."], "wordsB": ["Those", "within", "the", "IBS-C", "subtype", "experience", "Bristol", "types", "1", "or", "2", "(hard", "or", "lumpy)", "stools", "more", "than", "25", "percent", "of", "the", "time", "they", "have", "an", "abnormal", "bowel", "movement,", "and", "Bristol", "types", "6", "or", "7", "(loose", "or", "watery)", "stools", "less", "than", "25", "percent", "of", "the", "time", "they", "have", "an", "abnormal", "bowel", "movement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p7_s1", "idA": "1347613_16_item1_p70_s3", "sentA": "Failure by us to obtain, or any delay in obtaining, regulatory approvals or in complying with requirements could adversely affect the commercialization of product candidates and our ability to receive product or royalty revenues.", "sentB": "In addition to physical symptoms including abdominal bloating and discomfort, CIC can adversely affect an individual s quality of life, including increasing stress levels and anxiety.", "type": 1, "words": ["<tag1>", "Failure", "by", "us", "to", "obtain,", "or", "any", "delay", "in", "obtaining,", "regulatory", "approvals", "or", "in", "complying", "with", "requirements", "could", "adversely", "affect", "the", "commercialization", "of", "product", "candidates", "and", "our", "ability", "to", "receive", "product", "or", "royalty", "revenues.", "<tag2>", "In", "addition", "to", "physical", "symptoms", "including", "abdominal", "bloating", "and", "discomfort,", "CIC", "can", "adversely", "affect", "an", "individual", "s", "quality", "of", "life,", "including", "increasing", "stress", "levels", "and", "anxiety.", "<tag3>"], "wordsA": ["Failure", "by", "us", "to", "obtain,", "or", "any", "delay", "in", "obtaining,", "regulatory", "approvals", "or", "in", "complying", "with", "requirements", "could", "adversely", "affect", "the", "commercialization", "of", "product", "candidates", "and", "our", "ability", "to", "receive", "product", "or", "royalty", "revenues."], "wordsB": ["In", "addition", "to", "physical", "symptoms", "including", "abdominal", "bloating", "and", "discomfort,", "CIC", "can", "adversely", "affect", "an", "individual", "s", "quality", "of", "life,", "including", "increasing", "stress", "levels", "and", "anxiety."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p26_s0", "idA": "1347613_16_item1_p72_s1", "sentA": "GMP regulations require among other things, quality control and quality assurance as well as the corresponding maintenance of records and documentation.", "sentB": "Established a robust supply chain process and quality management system.", "type": 1, "words": ["<tag1>", "GMP", "regulations", "require", "among", "other", "things,", "quality", "control", "and", "quality", "assurance", "as", "well", "as", "the", "corresponding", "maintenance", "of", "records", "and", "documentation.", "<tag2>", "Established", "a", "robust", "supply", "chain", "process", "and", "quality", "management", "system.", "<tag3>"], "wordsA": ["GMP", "regulations", "require", "among", "other", "things,", "quality", "control", "and", "quality", "assurance", "as", "well", "as", "the", "corresponding", "maintenance", "of", "records", "and", "documentation."], "wordsB": ["Established", "a", "robust", "supply", "chain", "process", "and", "quality", "management", "system."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p7_s2", "idA": "1347613_16_item1_p74_s0", "sentA": "Although physicians may prescribe legally available drugs for off-label uses, manufacturers may not market or promote such off-label uses.", "sentB": "Many patients attempt to manage CIC symptoms with improved diet, fiber, and over-the-counter laxatives; however, these options can be ineffective or may not provide long-term relief.", "type": 1, "words": ["<tag1>", "Although", "physicians", "may", "prescribe", "legally", "available", "drugs", "for", "off-label", "uses,", "manufacturers", "may", "not", "market", "or", "promote", "such", "off-label", "uses.", "<tag2>", "Many", "patients", "attempt", "to", "manage", "CIC", "symptoms", "with", "improved", "diet,", "fiber,", "and", "over-the-counter", "laxatives;", "however,", "these", "options", "can", "be", "ineffective", "or", "may", "not", "provide", "long-term", "relief.", "<tag3>"], "wordsA": ["Although", "physicians", "may", "prescribe", "legally", "available", "drugs", "for", "off-label", "uses,", "manufacturers", "may", "not", "market", "or", "promote", "such", "off-label", "uses."], "wordsB": ["Many", "patients", "attempt", "to", "manage", "CIC", "symptoms", "with", "improved", "diet,", "fiber,", "and", "over-the-counter", "laxatives;", "however,", "these", "options", "can", "be", "ineffective", "or", "may", "not", "provide", "long-term", "relief."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p29_s0", "idA": "1347613_16_item1_p75_s0", "sentA": "Changes to some of the conditions established in an approved application, including changes in indications, labeling, or manufacturing processes or facilities, require submission and FDA approval of a new NDA or NDA supplement before the change can be implemented.", "sentB": "Launching TRULANCE 3 mg in an innovative 30-count blister pack.", "type": 1, "words": ["<tag1>", "Changes", "to", "some", "of", "the", "conditions", "established", "in", "an", "approved", "application,", "including", "changes", "in", "indications,", "labeling,", "or", "manufacturing", "processes", "or", "facilities,", "require", "submission", "and", "FDA", "approval", "of", "a", "new", "NDA", "or", "NDA", "supplement", "before", "the", "change", "can", "be", "implemented.", "<tag2>", "Launching", "TRULANCE", "3", "mg", "in", "an", "innovative", "30-count", "blister", "pack.", "<tag3>"], "wordsA": ["Changes", "to", "some", "of", "the", "conditions", "established", "in", "an", "approved", "application,", "including", "changes", "in", "indications,", "labeling,", "or", "manufacturing", "processes", "or", "facilities,", "require", "submission", "and", "FDA", "approval", "of", "a", "new", "NDA", "or", "NDA", "supplement", "before", "the", "change", "can", "be", "implemented."], "wordsB": ["Launching", "TRULANCE", "3", "mg", "in", "an", "innovative", "30-count", "blister", "pack."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p36_s0", "idA": "1347613_16_item1_p7_s2", "sentA": "If approved, we plan to launch plecanatide with the CIC indication in the first quarter of 2017.", "sentB": "Co-pay card programs and other patient assistance programs in place which will help us achieve access in 2017.", "type": 1, "words": ["<tag1>", "If", "approved,", "we", "plan", "to", "launch", "plecanatide", "with", "the", "CIC", "indication", "in", "the", "first", "quarter", "of", "2017.", "<tag2>", "Co-pay", "card", "programs", "and", "other", "patient", "assistance", "programs", "in", "place", "which", "will", "help", "us", "achieve", "access", "in", "2017.", "<tag3>"], "wordsA": ["If", "approved,", "we", "plan", "to", "launch", "plecanatide", "with", "the", "CIC", "indication", "in", "the", "first", "quarter", "of", "2017."], "wordsB": ["Co-pay", "card", "programs", "and", "other", "patient", "assistance", "programs", "in", "place", "which", "will", "help", "us", "achieve", "access", "in", "2017."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_17_item1_p31_s0", "idA": "1347613_16_item1_p8_s1", "sentA": "Analysis of the data indicates clear signals of improvement in dolcanatide-treated patients compared with placebo-treated patients.", "sentB": "Completed extensive market research with more than 2,700 healthcare providers and over 5,300 patients.", "type": 1, "words": ["<tag1>", "Analysis", "of", "the", "data", "indicates", "clear", "signals", "of", "improvement", "in", "dolcanatide-treated", "patients", "compared", "with", "placebo-treated", "patients.", "<tag2>", "Completed", "extensive", "market", "research", "with", "more", "than", "2,700", "healthcare", "providers", "and", "over", "5,300", "patients.", "<tag3>"], "wordsA": ["Analysis", "of", "the", "data", "indicates", "clear", "signals", "of", "improvement", "in", "dolcanatide-treated", "patients", "compared", "with", "placebo-treated", "patients."], "wordsB": ["Completed", "extensive", "market", "research", "with", "more", "than", "2,700", "healthcare", "providers", "and", "over", "5,300", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_18_item1_p12_s2", "idA": "1347613_17_item1_p25_s0", "sentA": "The IBS-C pre-NDA meeting with the FDA was completed in September 2016.", "sentB": "As agreed with the FDA following Trulance approval in the CIC indication, we continue with the execution of a milk-only lactation study and the assessment of GC-C receptor density in infants and children (age 0-6 years).", "type": 1, "words": ["<tag1>", "The", "IBS-C", "pre-NDA", "meeting", "with", "the", "FDA", "was", "completed", "in", "September", "2016.", "<tag2>", "As", "agreed", "with", "the", "FDA", "following", "Trulance", "approval", "in", "the", "CIC", "indication,", "we", "continue", "with", "the", "execution", "of", "a", "milk-only", "lactation", "study", "and", "the", "assessment", "of", "GC-C", "receptor", "density", "in", "infants", "and", "children", "(age", "0-6", "years).", "<tag3>"], "wordsA": ["The", "IBS-C", "pre-NDA", "meeting", "with", "the", "FDA", "was", "completed", "in", "September", "2016."], "wordsB": ["As", "agreed", "with", "the", "FDA", "following", "Trulance", "approval", "in", "the", "CIC", "indication,", "we", "continue", "with", "the", "execution", "of", "a", "milk-only", "lactation", "study", "and", "the", "assessment", "of", "GC-C", "receptor", "density", "in", "infants", "and", "children", "(age", "0-6", "years)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_18_item1_p26_s2", "idA": "1347613_17_item1_p4_s1", "sentA": "TRULANCE will be available in the U.S. the first quarter of 2017.", "sentB": "One issued on April 4, 2017 and the other issued on April 11, 2017.", "type": 1, "words": ["<tag1>", "TRULANCE", "will", "be", "available", "in", "the", "U.S.", "the", "first", "quarter", "of", "2017.", "<tag2>", "One", "issued", "on", "April", "4,", "2017", "and", "the", "other", "issued", "on", "April", "11,", "2017.", "<tag3>"], "wordsA": ["TRULANCE", "will", "be", "available", "in", "the", "U.S.", "the", "first", "quarter", "of", "2017."], "wordsB": ["One", "issued", "on", "April", "4,", "2017", "and", "the", "other", "issued", "on", "April", "11,", "2017."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1347613_18_item1_p12_s1", "idA": "1347613_17_item1_p76_s0", "sentA": "Preclinical tests include laboratory evaluation of the product candidate, as well as animal studies to assess the potential safety and efficacy of the product candidate.", "sentB": "In addition, development and validation of an anti-drug antibody assay is underway to assess patient clinical trial samples for the potential presence of anti-plecanatide antibodies.", "type": 1, "words": ["<tag1>", "Preclinical", "tests", "include", "laboratory", "evaluation", "of", "the", "product", "candidate,", "as", "well", "as", "animal", "studies", "to", "assess", "the", "potential", "safety", "and", "efficacy", "of", "the", "product", "candidate.", "<tag2>", "In", "addition,", "development", "and", "validation", "of", "an", "anti-drug", "antibody", "assay", "is", "underway", "to", "assess", "patient", "clinical", "trial", "samples", "for", "the", "potential", "presence", "of", "anti-plecanatide", "antibodies.", "<tag3>"], "wordsA": ["Preclinical", "tests", "include", "laboratory", "evaluation", "of", "the", "product", "candidate,", "as", "well", "as", "animal", "studies", "to", "assess", "the", "potential", "safety", "and", "efficacy", "of", "the", "product", "candidate."], "wordsB": ["In", "addition,", "development", "and", "validation", "of", "an", "anti-drug", "antibody", "assay", "is", "underway", "to", "assess", "patient", "clinical", "trial", "samples", "for", "the", "potential", "presence", "of", "anti-plecanatide", "antibodies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
